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Abstract: 
Tuberculosis (TB) is a disease that results from infection by Mycobacterium tuberculosis 
which is the most common infecting organism. The Directly Observed Treatment Short 
Course (DOTS) regime which is a combination of the drugs (isoniazid, ethambutol, 
pyrazinamide and rifampicin) has contributed significantly towards the decrease in the 
number of incidences of this disease. However, incomplete implementation of the DOTS 
campaign has been a major cause of the high occurrences of the drug resistant strains of 
Mycobacterium tuberculosis coupled with the spread of HIV/Aids in tuberculosis-endemic 
regions. This results from the fact that fully susceptible tuberculosis develops secondary 
resistance during therapy due to inappropriate dosing of treatment, inadequate treatment, non-
adherence to the prescribed regimen or using low quality medication. A fast and reliable 
detection method, such as biosensing, for the determination of the TB drugs metabolic profile 
is, therefore, essential for the appropriate dosing of these drugs. In this thesis, nanobiosensors 
for the determination of the biotransformation of TB drugs were developed with cytochrome 
P450-2E1 (CYP2E1) isoenzyme electrodeposited on gold electrodes derivatised with silver 
nanoparticulate/poly(8-anilino-1-naphthalene sulphonic acid) (PVP-AgNPs/PANSA). This 
study firstly reports the development and characterization of PVP-AgNPs, PANSA and PVP-
AgNPs/PANSA nanocomposite on gold. AFM and TEM analyses revealed highly 
electroactive nanocomposites whose morphogy and properties were essential for the 
immobilization of CYP2E1. Secondly, the development and characterization of Au/PVP-
AgNPs/PANSA/CYP2E1, Au/PVP-AgNPs/PANSA/SA-CYP2E1 and Au/PVP-
AgNPs/PANSA/EG-CYP2E1 nanobiosensors are reported.  AFM studies displayed globular 
morphologies with large roughness for the enzyme modified electrodes as opposed to those 
electrodes without enzymes. Finally, the biotransformation of standard solutions of TB drugs 
(isoniazid, ethambutol, pyrazinamide and rifampicin) in pH 7.4, 0.1 M phosphate buffer 
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solution is reported. The biotransformations of the TB drugs were successfully studied using 
cyclic voltammetry (CV), square wave voltammetry (SWV), differential voltammetry (DPV) 
and steady state amperometry under aerobic conditions. Very good detection limits were 
obtained for the standard solutions of TB drugs and were found to be in the micromolar 
range. The detection limit values for the individual TB drugs were 0.55 µM (isoniazid), 0.7 
µM (ethambutol), 0.054 µM (pyrazinamide) and 0.05 µM (rifampicin). The detection limit 
results showed that the nanobiosensors were more sensitive and suitable for the determination 
of the respective drugs in plasma and serum. 
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nanobiosensor. 
 
Figure 6.10: (A) CV and (B) DPV responses at different rifampicin concentrations for the 
Au/PVP-AgNPs/PANSA/EG-CYP2E1 nanobiosensor. 
 
Figure 6.11: Steady state responses of rifampicin at applied potential of -250 mV with 
response time of 25 s. 
 
Figure 6.12: Calibration curve of rifampicin for the Au/PVP-AgNPs/PANSA/EG-CYP2E1 
nanobiosensor  
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CHAPTER ONE 
 
 
Introduction 
 
 
 
Summary 
 
 
This chapter gives a brief background on the aspects involved in this project namely; sensors, 
conducting polymers, cytochrome enzymes with particular emphasis on CYP2E1, 
Tuberculosis and Tuberculosis treatments drugs. Focused in this chapter is the relationship 
between these aspects and their contribution towards the success of this study. Also included 
in this chapter are the project’s rationale and motivation, the aim and specific objectives of 
the study as well as the thesis outline. 
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1.1 Background: 
 
 
Mycobacterial infections are among the most difficult of all bacterial infections to 
treat, let alone to cure. Mycobacteria are slow growing organisms making them relatively 
resistant to antibiotics, an activity of which tends to depend on how rapidly the cells are 
dividing.  At times mycobacterial cells can be dormant thus making them completely resistant 
to many drugs, or at times are slowly killed by drugs that are active. A substantial proportion 
of mycobacterial cells are intracellular, residing within macrophages making then 
inaccessible to drugs that struggle to penetrate. These are organisms notorious for developing 
resistance to any single drug therefore, combination drug therapy is usually required to 
overcome these obstacles and prevent the emergence of resistance during the course of 
therapy. Chemotherapy is another route for the eradication of mycobacteria but is a slow 
means of therapy, in which treatment can go on for months to years depending on the drugs 
used.  
One of the main subjects of this study is tuberculosis, which is a disease resultant 
from infection by Mycobacterium tuberculosis the most common infecting organism. There 
are however other mycobacteria such as Mycobacterium bovis, which is uncommon due to 
the virtual eradication of bovine tuberculosis from cattle and Mycobacterium africanum, 
which is found in certain areas of Africa. After the initial infection by Mycobacterium 
tuberculosis, which in most cases passes without being noticed, the disease can follow a 
variety of clinical courses sometimes lying dormant for months or years before being 
reactivated. The disease is chiefly associated with the lungs but can occur in many other 
organs. There is a clear distinction between tuberculosis infection and tuberculosis disease. In 
the latter, one or more body parts indicate bacteriological, clinical and radiographic evidence 
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of the disease; while in the former the tubercle bacilli are established in the host, but there are 
no symptoms or detectable evidence of the disease. 
Of great interest is the fact that over the last century, there has been a stead decline in 
both these incidences and death rate probably as a result of improved social conditions, better 
nutrition and less overcrowding. The last few decades have seen a rapid decline through 
vaccination and case-finding programmes such that tuberculosis has now become less of a 
public health problem.  However in undeveloped countries and developing countries such as 
South Africa, tuberculosis continues to remain a problem especially with the emergence of 
drug resistant strains and the high rates of HIV/Aids. Incidences of tuberculosis are 
dependent on a variety of factors such as age, race, geography and social conditions. In 
developing countries incidences can only be estimated, while in developed countries such as 
the America and the United Kingdom, tuberculosis is a notifiable disease.  
The most recent global estimates of tuberculosis indicate that one third of the world’s 
population has been infected with Mycobacterium tuberculosis, and new infections are 
occurring at a rate of one per second (Castagnolo et al. 2009). According to the World Health 
Organization, there are an estimated 2 billion people infected with tuberculosis (Hernandez et 
al. 2008) with an estimated 8-9 million new cases reported annually and an estimated 3 
million human deaths occurring mostly in Africa and Asia where infections are stabilizing or 
slowly falling in some regions (Eoh et al. 2009; Castagnolo et al. 2009). The continuing high 
levels of tuberculosis risks in these countries is thought to be attributed to deteriorating public 
infrastructure and in large by the compromised immune systems of individuals as a result of 
HIV/Aids (Castagnolo et al. 2009; Wang et al. 2009;  Eoh et al. 2009; Schweon et al. 2009). 
Although the directly observed treatment short course; (DOTS) regime has contributed 
significantly towards the falling incidences of tuberculosis, incomplete implementation of the 
campaign has also been a major cause of the high occurrences of the drug resistant strains of 
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Mycobacterium tuberculosis coupled with the spread of HIV/Aids in tuberculosis-endemic 
regions (Wallis et al. 2009; Zvavamwe et al. 2009). This stems from the fact that patients 
with fully susceptible tuberculosis develop secondary resistance during therapy as a result of 
inappropriate dosing of treatment, inadequate treatment, not taking the prescribed regimen 
appropriately or using low quality medication. Multidrug-resistant TB (MDR-TB) and 
extensively drug resistant TB (XRD-TB) are more difficult to treat than sensitive tuberculosis 
since they require the administration of expensive and less effective second line drugs for 
longer treatment durations than first line drugs (Eoh et al. 2009; Orenstein et al. 2009). It is 
therefore acknowledged that new approaches are required in order to promptly address the 
issue of patients falling ill as a result of inappropriate dosing of treatment and inadequate 
treatment administration. 
To achieve that, a device with a fast response time coupled with enhanced 
performance and increased sensitivity is essential (Popovtzer et al. 2006). This form of 
device can only be obtained by miniaturizing bulky laboratory equipment and integrating 
them onto single microchips. Miniaturization is highly important because of convenience, 
portability, low costs, high resolution results, ease of operation, rapidity of analyses, handling 
reduced amounts of chemical or sample consumption (Grudpan et al. 2009; Popovtzer et al. 
2006; Chikkaveeraiah et al. 2009). One of the most popular and elegant miniaturization 
methods is the incorporation of chemical process techniques and procedures into 
electrochemical nanobiosensors. An electrochemical nanobiosensor consists of one part 
where the requisite chemical or physical processes are performed and another part for 
information acquisition (Muchindu et al. 2010).  These nanobiosensors can be constructed if 
the sensing materials are modified with biological elements such as DNA and enzymes. 
Electrochemical nanobiosensors possess bioactive substances which are responsible for the 
determination of the sensitivity of the sensor and transducers which provide the sensitivity 
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and also convert the recognition event into measurable signals (Nyholm et al. 2005; Mathebe 
et al. 2004). By replacing classical sensor materials with conducting polymers has achieved 
better selectivity and fast responses in electrochemical nanobiosensors by exploiting either 
the intrinsic or extrinsic functions of polymers. This has given polymers tremendous 
recognition in the field of artificial sensors for mimicking natural sensing organs due to their 
ease of coating onto electrode surfaces (Xia et al. 2010; Gerard et al. 2002; Adhikari et al. 
2004). Immobilizing metal nanoparticles onto conducting polymers allow for even better 
responses and better functioning of biological compounds. 
The present study was focused on the development of an electrochemical 
nanobiosensor system, which was suitable for the appropriate dosing of clinically, diagnosed 
patients by the measurement of tuberculosis treatment drugs namely; Isoniazid (INH), 
Rifampin (RIF), Pyrazinamide  (PYR) and Ehambutol (ETH).  When constructed this device 
was tailored to match the individual demands of the specified drugs. 
  Current literature suggests that each of the above mentioned drugs are metabolised in 
the liver individually by different enzymes. Isoniazid is an arylamine and is metabolised via 
acetylation by the important Phase II enzyme, N-acetyltranferase (Chen et al. 2009). There is 
however some literature which suggests CYP2E1 to be involved in the metabolism of 
isoniazid. Pyrazinamide is metabolised to 5-hydroxypyrazinamide by the molybdenum iron-
sulphur flavin hydroxylase enzyme, xanthine oxidase/xanthine dehydrogenase (Yamamoto et 
al. 1991; Rasoulzadeh et al. 2009). Even though these enzymes are known for the 
metabolism of these two compounds, our study has introduced a new biotransformation 
method by studying the metabolism of these drugs; including RIF and EMB using the 
enzyme Cytocrome P450-2E1 (CYP2E1) coupled to a nanocomposite of poly(8-anilino-1-
naphthalene sulphonic acid) PANSA and silver nanoparticles (PVP-AgNPs). 
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The techniques currently available for quantifying the levels of INH, RIF, PYR and 
ETH and their metabolites in urine and plasma are high performance liquid chromatography, 
thin layer chromatography and gas chromatography methods. These are accurate and well 
established techniques however production of results is time consuming and substantial 
sample preparation is required (Owino et al. 2008; Arotiba et al. 2007). These factors pose a 
problem when dealing with cases of drug resistance and severe side effects among 
tuberculosis diagnosed patients, since the level of drugs in their systems cannot be promptly 
studied to allow for the appropriate assistance to be delivered. Therefore, electrochemical 
nanobiosensors were established which have reduced sample preparation time allowing for 
point of care analyses.  
In this study, the electrochemical interaction between Cytocrome P450-2E1 
(CYP2E1) and INH, RIF, PYR and ETH mediated by poly(8-anilino -1-naphthalene 
sulphonic acid modified with silver nanoparticles was investigated.  
The following section illustrates the aims and objectives of the study. 
 
1.2 Research Aims: 
The aim of this study was to develop silver modified nanobiosensors for profiling the 
drug biotransformation of TB treatment drug. This was based on nanobiosensors developed 
from gold electrodes using cytochrome P450 (CYP2E1) and   nanostructured poly(8-anilino-
1- naphthalene sulphonic acid) composites modified with silver nanoparticles. The study had 
the following objectives:  
1. Synthesis of poly(8-anilino-1-naphthalene suphonic acid) (PANSA). 
2. Synthesis of silver nanoparticles (PVP-AgNPs). 
3. Preparation of PANSA-PVPAgNPs nanocomposite. 
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4. Characterization of the PANSA, PVP-AgNPs, PANSA/PVP-AgNPs nanocomposite 
using TEM, UV-Vis, AFM, CV, DPV, SWV. 
5. Fabrication of nanobiosensors with genetically engineered enzyme namely; 
cytchrome P450 2E1 (CYP2E1) on gold electrodes.  
6. Determining the amperometric responses of the CYP2E1 nanobiosensors to Isoniazid, 
Rifampin, Pyrazinamide and Ethambutol. 
7. Development of kinetic models for the reactivities of the TB treatment drug (INH, 
RIF, PYR and ETH) metabolism biosensors. 
8. Parameter optimisation and calibration of the nanobiosensors systems.  
 
1.3 Rationale and Motivation: 
This study sought to combine the bioelectronics and bioelectrochemistry of enzyme 
isoforms with the electron mediating ability and conductivity of electroactive nanopolymers 
coupled with metal nanomaterials, for the electrochemical study and modelling of TB 
treatment drug metabolism. The materials of interest in this study are PANSA (synthesized 
from a derivative of naphthalene sulphonic acid, 8-anilino-1-naphthalene sulfonic acid 
(ANSA) and PVP-AgNPs (synthesized from polyvinylpyrrolidone and AgNO3).  
The specific application of the proposed nanosensor system for the elucidation of the 
metabolism of TB treatment drugs namely; Isoniazid, Rifampin, Pyrazinamide and 
Ethambutol is being proposed. The feasibility of this study is borne from that fact that a 
number of studies have suggested N-acetyltranferase to be the major enzyme catalysing INH 
(Martins et al. 2008; Chen et al. 2009) and xanthine oxidase/xanthine dehydrogenase towards 
the metabolism of  PYR to 5-hydroxypyrazinamide (Yamamoto et al. 1991; Rasoulzadeh et 
al. 2009). However a new approach has been established in this study through the use of 
CYP2E1 for the biotransformation of these TB drugs including RIF and ETH. The design of 
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the resultant device is to eliminate the need for N-transferase and xanthine oxidase 
physiological or artificial co-factors in the biocatalysis of the metabolism of TB treatments 
drugs, by combining the use of genetically engineered CYP2E1 and cathodic polarization of 
the enzyme immobilized in the PANSA/PVP-AgNPs nanocomposite as the source of the 
requisite electrons.  
Clinically it is important to determine the CYP2E1 profile of patients before and after 
the administration of Isoniazid, Rifampin, Pyrazinamide and Ethambutol in order to provide 
the adequate treatment and appropriate dosing of treatment. The status of the metabolism of 
the TB drugs in patients would be evaluated by the use of the nanobiosensor systems 
consisting of PANSA modified with PVP-AgNPs and samples of plasma and urine. This will 
allow on-site real time application of the nanobiosensors and point of care diagnosis for 
patients. 
1.4 Thesis lay-out: 
This thesis consists of seven chapters. 
Chapter 1 presents a brief background on the project, rationale and motivation, as well as the 
research aim and objectives. 
Chapter 2 provides a detailed literature review. 
Chapter 3 consists of detailed procedures used for the success of this work. Also included in 
this chapter are the lists of materials and instruments used. 
Chapter 4 provides the morphological and amperometric results obtained from the 
nanomaterials; PANSA, PVP-AgNPs and PANSA/PVP-AgNPs synthesized in this work 
while 
Chapter 5 illustrates the morphological and amperometric results for the developed 
PANSA/PVP-AgNPs/CYP2E1 nanobiosensors. 
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Chapter 6 consist of results on INH, ETH, PYR and RIF detection. 
Chapter 7 is the general conclusion, recommendations and future work. 
 
The following chapter provides the literature review. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
	
 
10	
 
1.5 References: 
Adhikari B.; Majumdar S.,‘Polymers in sensor applications’ (2004) Progress in Polymer 
Science 29 pg 699-766. 
 
Arotiba, O. A.; Ignaszak, A.; Malgas, R.; Al-Ahmed, A.; Baker, P. G. L.;  Iwuoha, E. I., ‘An 
electrochemical DNA biosensor developed on novel multinuclear nickel (II) salicylaldimine 
metallodendrimer platform’ (2007)  Electrochimica Acta 53 pg 1689-1696. 
 
Castagnolo D.; Radi M.; Botta M., ‘Synthesis and biological evaluation of new 
enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis’ (2009) 
Bioorganic & Medicinal Chemistry Letter 19 pg 2203-2205. 
 
Chen B.; Cai W.; Cao X., ‘Estimating N-transferase metabolic activity and pharmacokinetics 
parameters of isonizid from genotypes in Chinese subjects’ (2009), Clinica Chimica Acta 405 
pg 25-29. 
 
Chikkaveeraiah B.V.; Liu H., ‘A microfluidic electrochemical device for high sensitivity 
biosensig: Detection of nanomolar hydrogen peroxide’ (2009) Electrochemisry 
Communications 11 pg 819-820. 
 
Eoh H.; Brennan P.J., ‘The Mycobacterium tuberculosis MEP (2C-methyl-D-erythritol 4-
phosphate) pathway as a new drug target’ (2009) Tuberculosis 89 pg 1-2. 
 
Gerard M.; Chaubey A.; Malhotra B. D., ‘Application of conducting polymers to biosensors’ 
(2002)  Biosensors and Bioelectronics 17 pg 345-359. 
 
Hernandez C.; Cetner A., ‘Tuberculosis in the age of biologic therapy’ (2008) Journal of 
American Academy of Dermatology 59 No 3 pg 363-364. 
 
Mathebe N. G. R.; Morrin A.; Iwuoha E. I., ‘Electrochemistry and scanning electon 
microscopy of polyaniline/peroxidase-based biosensor’ (2004) Talanta 64 pg 115-120. 
 
Muchindu M.; Waryo T.; Arotiba, O.; Baker, P. G. L.; Iwuoha, E. I., ‘Electrochemical nitrite 
nanosensor developed with amine- and sulphate-functionalised polystyrene latex beads self-
assembled on polyaniline’ (2010)  Electrochimica Acta 55 pg 4274-4280. 
 
Nyholm L., ‘Electrochemical techniques for lab-on-a-chip application’ (2005) Analyst 130 pg 
599-600. 
 
Orenstein E.; Basu S., ‘Treatment outcomes among patients with multidrug-resistant 
tuberculosis: systematic review and meta-analysis’ (2009) Lancet Infectious Disease 9 pg 
153-154. 
 
 
 
 
	
	
 
11	
 
Owino J.H.O.; Arotiba O.A., ‘Electrochemical Immunosensor Based on Polythionine/Gold 
nanoparticles for the Determination of Aflatoxin B1’ (2008) Sensors 8 pg 8263-8264. 
 
Popovtzer R.; Neufeld T., ‘Electrochemical detection of biological reactions using novel 
nano-bio-chip array’ (2006) Sensors and Actuators B 119 pg 664-665. 
 
Rasoulzadeh F.; Jabary H.N., ‘Fluorescence quenching study of quercetin interaction with 
bovine milk xanthine oxidase’ (2009) Spectrchimica Acta Part A: Molecular and 
Biomolecular Spectroscopy 72 pg 190-191. 
 
Schweon S.J., ‘Tuberculosis Update’ (2009) Journal of Radiology and Nursing 28 pg 12-14. 
 
Xia, L.; Wei, Z.; Wan, M., ‘Conducting polymer nanostructures and their application in 
biosensors’ (2010) Journal of Colloid and Interface Science 341 pg 1-11. 
 
Yamamoto T.; Kario K., ‘A case of Xanthinuria: A study on the Metabolism of Pyrazinamide 
and Allopurinol’ (1991) Japan Journal of Medicine 30 pg 430-431. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
	
 
12	
 
 
 
 
 
CHAPTER 2 
 
Literature Review 
 
Summary 
 
Electroanalytical Chemistry has played an important role in the ever changing panorama of 
diversified and extremely different scientific and industrial research. Electroanalysis is a 
major part involving the application of one or more electrochemical techniques to monitor 
and study measurements of specific interest. Therefore, the implementation of measurement 
systems affordable to most analysts has been assumed by scientists as a clear demand, in 
such a way that new developments have to be cost-effective, possess fully integrated systems, 
be capable of carrying out in situ, real-time and flow-monitoring studies such as biosensor 
systems. Over the past four decades, there has been a tremendous activity and widespread 
interest in the area of biosensors. Analyte recognition is among the major processes involved 
in any biosensor system. As a result of their speed, portability, specificity and low cost, 
biosensors have found a wide range of application; ranging from point-of-care testing 
(physicians office), bedside monitoring, home self testing and emergency-room screening. 
This chapter focuses on the background of the study through the description of various 
aspects involved in the study such as Biosensors, Enzymes, and Tuberculosis etc.  
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2.1 Biosensors: 
 
Interest in the development and exploitation of analytical devices for quantification, 
detection and monitoring of specific chemical species and reactions has led to the emergence 
of biosensors. With biosensors representing an emerging new trend in diagnostic technology, 
metabolites such as urea, cholesterol, glucose and lactate in whole blood have been estimated 
(Gerard et al. 2002).  There are various definitions attributed to biosensors depending on the 
field of application involved. These devices are sometimes known as optrodes, 
immunosensors, resonant mirrors, biochips etc. The most common definition of a biosensor 
is; an analytical device which incorporates intimate and deliberate combination of a specific 
biological compound and a physical entity. The role of the biological compound is to create a 
recognition event while the physical entity transduces the recognition event (Paddle et al. 
1996). These features are clearly indicated in Figure 2.1. 
 
Figure 2.1: Components of a biosensor 
 
A successful biosensor possesses some beneficial features such as; the bioactive 
substance should be highly specific for the purpose of the analyses. The reaction, which takes 
place, should be independent of physical parameters such as stirring, pH and temperature as 
 
 
 
 
	
	
 
14	
 
this would allow minimal pre-treatment of samples prior to analysis. The obtained response 
after analysis should be accurate, precise, reproducible and linear over the useful analytical 
range and should be free from electrical noise. Most importantly, the complete biosensor 
should be cheap, small, portable and capable of being operated by semi-skilled operators 
(Ryan-Byrne et al. 1997). 
Biosensors can be divided into three generations depending on their level of 
integration. The first generation comprises of a biocatalyst that is either bound or entrapped 
in a membrane. The second generation of biosensors involves the adsorption of the biological 
components to the transducer surface thereby eliminating semi-permeable membranes. In the 
third generation, there is a direct binding of the biocatalyst to an electronic device that 
transduces and amplifies the signal. Some potential applications of biosensors are in clinical 
diagnosis, agricultural and horticultural analysis, pollution, water and microbial 
contamination analysis. 
 
2.1.1 Biocomponents: 
In biosensors, biocomponents also known as receptors, biological components or 
bioactive materials are compounds or materials that give biosensors their selectivity 
characteristics. In most cases these biocomponents undergo reactions with their respective 
analytes which is denoted by an end signal. Various biocomponents have been employed in 
sensor construction. Within a biosensor the recognition biocomponent incorporated possess 
some level of sensitivity although it may be vulnerable to extreme conditions such as pH, 
ionic strength and temperature. Most of these biocomponents including antibodies, enzymes 
and cells have very short lifetimes in solution and have to be fixed in a suitable matrix. 
Therefore, immobilization of these compounds is of critical importance to allow their 
stability although their activities are sometimes reduced (Gerard et al. 2002). A number of 
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techniques such as cross-linking, physical adsorption, gel entrapment, covalent binding etc. 
have been used to assist immobilization of biocomponents in various matrices as shown in 
Table 2.1.  
The following section gives indication of a few commonly used biocomponents. Plant 
tissues as well as some sections of mammals have been employed in the construction of 
biosensors resulting in sensor systems with greater selectivity’s when compared to those 
constructed with bacterial cells. This is due to the fact that plants and animals are not 
metabolically versatile. Each type of tissue slice functions the best when the appropriate 
analyte is present. Different types of tissues and their corresponding analytes are shown in 
Table 2.2 (D’Orazio et al. 2003).  
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Table 2.1: Conventional immobilization methods 
Method Advantage Disadvantage Example Reference  
 
Physical 
adsorption 
 
Method is low 
cost. 
No modification 
of the 
biocomponent. 
Underlying matrix 
can be 
regenerated. 
 
High diffusion 
barrier. 
Binding forces are 
susceptible to 
changes in pH, 
temperature and 
ionic strength. 
 
Adsorption of 
horseradish 
peroxidase 
(HRP) on totally 
cinnamoylated 
derivatives of D-
glucosome and 
D-Manitol in the 
form of glassy 
beads for 
hydrogen 
peroxide 
detection. 
 
Gerard et al. 
2002 
 
 
Entrapment 
 
Method is low 
cost. 
Only physical 
contact of 
biocomponent 
near transducer. 
 
High diffusion 
barrier. 
 
Entrapment of D-
fructose-5-
dehydrogenase 
onto a platinum 
electrode to 
produce a 
biosensor, which 
was used for the 
fructose 
detection. 
 
 
Gerard et al. 
2002 
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Cross-
linking 
 
 
Moderate cost. 
Minimum loss of 
biocomponent. 
 
 
Harsh treatment of 
biocomponent by 
toxic chemicals 
 
 
Linking the 
enzyme 
tyrosinase (Tyr) 
in the presence of 
the mediator 
NQS for the 
determination of 
dichlorvos 
organophosphate 
pesticides. 
 
 
Gerard et al. 
2002 
 
Covalent 
bonding 
 
Very stable under 
adverse 
conditions. 
Low diffusional 
resistance. 
 
Matrix is not 
regenerable. 
Harsh treatment of 
toxic chemicals. 
 
Binding of 
oxalate oxidase 
and horse radish 
peroxidase and 
incorporated into 
carbon paste 
modified 
electrode with 
silica gel coated 
with titanium 
oxide containing 
toluidine blue for 
the detection of 
oxalate. 
 
Gerard et al. 
2002 
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Table 2.2:  Some tissues used in biosensor construction and their respective analytes 
Tissue Analyte Reference 
Mouse intestinal mucosa Adenosine D’Orazio et al. 2003 
Cucumber leaf Cysteine D’Orazio et al. 2003 
Banana pulp Dopamine D’Orazio et al. 2003 
Yellow squash Glutamate D’Orazio et al. 2003 
Bovine liver H2O2 D’Orazio et al. 2003 
Corn kernel Pyruvate D’Orazio et al. 2003 
Sugar beet Tyrosine D’Orazio et al. 2003 
 
Whole microbial cells are also widely utilized in the study of biosensors and are often 
used when the desired enzyme is either unstable or difficult to purify. A slight disadvantage 
associated with these biosensors in that they have a slow response time and require frequent 
calibration. These biosensors have been constructed to analyse ammonia, antibiotics, enzyme 
activities, sugars, peptides, vitamins, nitrates, alcohols, biological oxygen demand and 
organic acids (Conn et al. 1987). 
 
2.1.1.1 Enzymes: 
 
Of all biocomponents, enzymes are the most widely used  and research has shown that 
most enzymes have been successfully used in the construction of biosensor These 
components are unique since they are a combination of selectivity and sensitivity and they 
allow for a wide selection of transducers to be used (Conn et al. 1987). An enzyme sensor 
can be considered as a combination of transducer and a thin enzymatic layer, which is 
responsible for measuring the concentration of the substrate. In close proximity to the 
enzyme, is the sensitive surface of the transducer with the assumption that there is no mass 
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transfer across the interface. The external surface of the biocomponent is kept immersed in 
solution containing the substrate of interest. In doing so, the substrate migrates towards the 
interior of the enzyme and is converted into products when it reacts with the immobilized 
enzyme (Adhikari et al. 2004). Signals of enzyme sensors are strongly influenced towards 
their application by inhibition, temperature and pH dependence (D’Orazio et al. 2003) which 
in turn affects the reaction between the immobilized enzyme and the substrate.  
In this study cytochrome P450-2E1 was employed in the construction of a 
nanobiosensor used for the determination of tuberculosis treatment drugs. 
 
2.1.1.2 Characteristics of Immobilized Enzymes: 
 
Immobilized enzymes are significantly affected by factors such as activity and 
stability therefore, it is of importance that the percentage of immobilized enzyme together 
with enzyme activity remaining after immobilization should always be included, along with 
the experimental conditions which are well suited for the determination of interest. Enzyme 
activity which is the most important factor especially towards the comparison of 
immobilization techniques is often unavailable. It is important that one knows the amount of 
enzyme immobilized onto a support and this is usually achieved by measuring the amount of 
enzyme remaining in the supernatant after immobilization and then subtracting this from the 
amount which was originally present. A fraction of difficulty usually arises in the 
determination of the absolute activity of the enzyme on the support after immobilization. 
Measuring this factor therefore involves the mass transfer as well as diffusional restrictions in 
the experimental method being used (Worsfold et al. 1995). 
The stability of the immobilized enzyme with respect to time, temperature, storage 
conditions and at times experimental variables are critical performance indicators that should 
be noted. This issue can be addressed through various methods; however the most popular 
 
 
 
 
	
	
 
20	
 
and highly recommended is the storage of enzyme under normal operating conditions in an 
appropriate buffer solution. After a fixed time period the activity of the enzyme is monitored 
following the same procedure as that for the determination of the enzyme activity after 
immobilization. Because each enzyme has its own lifetime and maximum analyses strength, 
to account for the efficiency of a particular enzyme, the effect of introducing synthetic 
standards, reference material, as well as samples at predefined intervals and frequencies 
should be determined prior. During the procedure, special attention should be placed to 
aspects such as pH, temperature, ionic strength and the incorporation of impurities as they 
have an effect on the enzyme during immobilization.  Prior knowledge of the details of the 
experiment should be noted since the immobilization can affect the optimum pH, oxidation 
and reduction working range and the apparent Michaelis-Menten constant for the appropriate 
substrate of an immobilized enzyme (Worsfold et al. 1995).  
 
2.2 Transducers: 
The role of transducers in biosensor construction is to convert a biochemical signal to 
an electronic signal. Transducers allow biosensors to be more specific and more selective. 
Depending on the nature of the biocomponents interaction with the analyte of interest, 
suitable transducing systems can be adapted in the biosensor construction.  
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Table 2.3: Biological components and transduction methods used in biosensor designs 
 
Biological Compounds Transducer Reference 
Organisms Potentiometric Worsfold et al. 1995 
Tissues slices Amperometric Worsfold et al. 1995 
Whole microbial Cells Conductometric Worsfold et al. 1995 
Organelles Impedimetric Worsfold et al. 1995 
Membranes Optical Worsfold et al. 1995 
Enzymes Calorimetric Worsfold et al. 1995 
Enzyme components Acoustic Worsfold et al. 1995 
Receptors Mechanical Worsfold et al. 1995 
Antibodies Molecular electronic Worsfold et al. 1995 
 
Thus, depending on the transduction mechanism used, biosensors can be of different 
types such as; Optical, Resonant, Ion-Selective, Thermal and Electrochemical. Table 2.3 
illustrates some biological compounds along with their respective transduction systems.  
 
2.2.1 Optical Biosensors: 
For this type of biosensor, the transduction output measured is light which is either 
based on electrochemiluminescence or optical diffraction. In these types of biosensors, a 
silicon wafer is coated with a protein through covalent bonds and is later exposed to UV light 
through a photo-mask, thus inactivating the exposed antibodies. However, when the diced 
wafer chips are incubated in an analyte, the antigen (analyte molecule) - antibody (biological 
element) bindings are formed in the active regions, a diffracting grating is created. The result 
of this grating effect is a diffraction signal when illuminated with a light source such as laser. 
Therefore the resultant signal can be measured or amplified before measuring for improved 
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sensitivity. Optical biosensors have been used for the detection of O2, CO2 and pH etc 
(Gerard et al. 2002).  
 
2.2.2 Resonant Biosensors: 
Resonant biosensors couple acoustic wave transducers with antibodies. Attachment of 
the analyte molecule with the membrane changes the mass of the membrane thus changing 
the resonant frequency of the transducer which can then be measured (Paddle et al. 1996). 
 
2.3.3 Ion-selective Biosensors: 
These are semiconductor field effect transistors (FET) possessing ion-selective 
surfaces which undergo electrical changes once the ions and the semiconductor interact, and 
the potential change can be subsequently measured. By covering the sensor electrode with a 
polymer layer, an Ion Sensitive Field Effect Transistor (SFET) can be constructed. The 
polymeric layer is selectively permeable to analyte ions, since they diffuse through the 
polymeric layer, thus causing a change in the potential of the FET surface. This type of 
biosensor is also known as Enzyme Field Effect Transistor (ENFET) and is primarily used for 
pH detection (Paddle et al. 1996). 
 
2.2.4 Thermal Biosensors:  
These types of biosensors are developed by combining immobilized enzymes with 
temperature sensors. When the analyte of interest comes into contact with the enzyme, the 
heat reaction of the enzyme is measured and calibrated against the analyte concentration. The 
total heat absorbed or produced has been found to be proportional to the molar enthalpy as 
well as the total number of molecules involved in the reaction. The measurement of 
temperature is accomplished through the use of a thermistor, also known as an enzyme 
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thermistor. Thermistors are quite applicable in these types of applications as they are highly 
sensitive to thermal changes. The advantage associated with these types of biosensors is that 
they do not require recalibration and are insensitive to the optical and electrochemical 
properties of the sample. Thermal biosensors have found application towards the detection of 
pesticides and pathogenic bacteria (Paddle et al. 1996).  
 
2.2.5 Electrochemical Biosensors: 
The underlying principle governing this class of biosensors is that many chemicals 
produce or consume ions or electrons which result in changes in electrical properties of 
solutions which can be sensed and later used as measuring parameters. Therefore, the name 
electrochemical biosensor is applied to a molecular sensing device which couples biological 
recognition elements such as enzymes, antibodies, bacteria or tissues (Adhikari et al. 2004) to 
electrode transducers (Wang et al. 2006; Brennan et al. 1996; D ‘Orazio et al. 2003). The 
biological recognition element is immobilized in close proximity to a transducer that relays 
the interaction of the analyte and the bioactive substance into a measurable response which is 
often an electronic signal. This signal can result from the uptake and release of gases, the 
change in proton concentration or absorption light emission brought about by the metabolism 
of the target compound by the bioactive compound. This biological signal is then converted 
into a measurable response such as potential, current or absorption of light through 
electrochemical or optical means (Brennan et al. 1996; D ‘Orazio et al. 2003). 
Electrochemical biosensors can be classified based on their individual measuring parameters 
namely; Conductrimetric, Amperometric and Potentiometric. 
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2.2.5.1 Conductimetric Electrochemical Biosensors: 
Electric conductance or resistance is measured by these biosensors. This occurs when 
an electrochemical system either produces ions or electrons, during which the overall 
conductivity or resistivity changes. The observed change is measured and calibrated to a 
proper scale where it has been observed to have a relatively low sensitivity. A typical 
example of this type of biosensor was observed through the work by Chouteau et al. 2005 
where a conductrimetric biosensor was constructed for the detection of heavy metal ions and 
pesticides in water samples using immobilized Chlorella vulgaris microalgae as bioreceptors. 
The redox potential or pH changes associated with the microenvironment in the polymer 
matrix allowed changes in electronic conductivity to be effectively monitored.  
 
2.2.5.2 Amperometric Electrochemical Biosensors:  
This biosensor type is driven by an external constant potential, during which an 
electrochemical reaction takes place, and the resultant current is measured (Malhotra et al. 
2006; Chaubey et al. 2002). Most importantly, the function of amperometric biosensors is 
affected by the electron transfer between catalytic molecules and the electrode surface 
involving a mediation material. These types of biosensors commonly employ conducting 
polymers as their means of mediation is usually with enzymes either trapped within the 
polymer of covalently bound to functional groups (Gerard et al. 2002). An example of an 
amperometric biosensor can be observed in the work conducted by Yang et al. 2004 where 
horseradish peroxidise was self-assembled on hydroquinone during which the current 
response was measured at a fixed potential range.  
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2.2.5.3 Potentiometric Electrochemical Biosensors:  
These biosensors are based on ion-selective or gas sensing electrodes where a 
movement of ions into a membrane at a zero current allows for the monitoring of the cell 
potential (Malhotra et al. 2006; Chaubey et al. 2002). Potentiometry is rarely used in 
biosensing methods especially with enzymes immobilized on electrodeposited conducting 
polymers in which pH sensitivity of the conducting polymer is used. This interaction is 
clearly illustrated by Shin et al. 1998; where a thin hydrophilic polyurethane polymer film 
was combined with the enzyme urease for the determination of urea by monitoring changes in 
potential. 
 
2.3 Cytochrome P450 Enzymes: 
 
The main focus of this study was to employ Cytochrome P450-2E1 (abbreviated 
CYP2E1, EC 1.14.14.1), towards the construction of a biosensor responsible for the 
biotransformation of tuberculosis drugs. This section outlines the background on cytochrome 
enzymes with particular emphasis on CYP2E1. 
 
2.3.1 Occurrence of Cytochrome P450 Enzymes: 
 
Cytochrome P450 enzymes also known as Iron Porphyrin enzymes were first 
investigated by Warburg and at that time they were referred to as cell pigments. He 
discovered that in the dark carbon monoxide had an inhibitory factor on respiration cells, 
however upon illumination, respiration was resumed.  Knowing this fact, Warburg then 
suggested that in respiration a compound of iron was involved. Upon a close examination of 
the photo effect, it was discovered that a specific wavelength was involved with a 
characteristic absorption wavelength of iron hema-chromogen containing porphyrins. 
Warburg then came to the conclusion that the respiratory pigments were similar to these 
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compounds (Key et al. 1966). It was Keilen who revisited the work MacMunn continued 
from Warburg who discovered that at specific wavelengths a pigment was absorbed in 
several cells hence giving them the name cytochrome. Thereafter, all examined cells 
containing this pigment, could be readily observed on reduction due to a change in light 
absorption (Key et al. 1966; Hermeryck et al. 2002). 
 
2.3.2 Kinetic Reactions of Cytochrome P450 Enzymes: 
Cytochrome P450 enzymes belong to a multigene family of heme enzymes which 
catalyse the NADPH – dependant monoxygenase and reactions of different exobiotic and 
endobiotic liphophilic substrates. The unique ability of these enzymes is based on the fact 
that they can hydroxylate non-activated carbon atoms (C-H bonds). Metabolism of substrates 
produces products which serve as regulators in cells or are excreted from organisms. These 
enzymes are capable of metabolizing over 1,000,000 chemicals and involve about 60 distinct 
classes of biotrasformation reactions; N-, O-, or S-, demethylation, dealkylation, S- oxidation, 
epoxidation, aliphatic oxidation, reductive dehalogenation and sulfoxide formation 
(Shumyanteva et al. 2005;  Bistolas et al. 2005). They are also involved in mono-oxygenation 
reactions which are very useful as they are responsible for the hydroxylation of a number of 
compounds including steroids, fatty acids, drugs, food additives, fungi, bacteria, (Harris et al. 
2001) alkanes and polyaromatic and polychlorinated hydrocarbons.  
In man most of the cytochrome P450 enzymes are found in the liver with a 
remarkable amount also found in the small intestine, around the microsomal part of the 
cytoplasm, in the endoplasmic reticulum as well as in the mitochondria. Enzymes isolated 
from the mitochondria are known as steroidogenic cytochrome enzymes since they are 
situated in single cell organisms and are phylogenetically older.  Usually they consist of an 
iron-sulphur protein, NADPH and NADH-dependant reductase (on FAD-type flaovoprotein) 
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and cytochrome P450 enzyme. Steroidogenic enzymes are responsible for steroid synthesis as 
well as other substances which are required for maintaining the cell wall integrity. Another 
form of these enzymes evolved from steriodogenic enzymes over one billion years ago are 
known as xenobiotic enzymes. Xenobiotic enzymes are located in the smooth endoplasmic 
reticulum of cells, while some studies indicate that they have evolved during the period of 
plant-animal differentiation. They are constituted by NADPH: P450 reductase (FAD-and 
FMN- containing flavoprotein) and cytochrome P450 enzyme (Iwuoha et al. 2003). The 
strength of these enzymes lies in their ability to metabolise foreign biological substances.  
 
2.3.3 Kinetics of Catalytic Reaction: 
 
Cytochrome P450 enzymes consist of iron-protoporphyrin IX active sites with axial 
thiolate of cysteine residues as fifth ligands. Resting cytochrome P450 enzymes are in the 
ferric form (Fe3+), one electron reduction of a ferric form leads to a ferrous state (Fe2+). In 
most cases, these enzymes are octahedral and because of unpaired electrons in their 3d 
orbitals, they are practically all paramagnetic. Due to the presence of protoporphyrin IX, 
heme enzymes exhibit characteristic visible absorption spectra however, their spectra differ 
according to the identities of the lower axial ligands donated by the protein and the oxidation 
state of the iron, while the identities of the upper axial ligands are donated by the substrates 
(Harris et al. 2001). The source of electrons in this type of system is from flavoproteins, 
ferrodoxin like proteins, NADPH (Lewis et al. 2002), the mediator or an electrode.  
The mechanism for substrate hydroxylation by cytochrome enzymes, involves the following 
steps although there are still several details that still remain unsolved.  
 
 Step 1: When the substrate binds to the hexa-coordinated low-spin ferric enzyme, 
water is excluded from the active site resulting in a change in the 5-coordinate low 
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spin state. This causes a decrease in polarity which is accompanied by a positive shift 
(Bistolas et al. 2005) or lowering of the redox potential by 110 mV to 130 mV which 
makes the first electron transfer step thermodynamically favourable, from its redox 
partner NADH or NADPH (Shumyanteva et al. 2005).  
 
 Step 2: The transfer of the first electron from one of the redox partners reduces the 
ferric iron to the ferrous enzyme and this process is called reduction.  
 
 Step 3: This form of the enzyme can now bind molecular oxygen resulting in a 
ferrous-dioxygen (Fe2+- O2) complex.  
 
 Step 4: A second electron transfer takes place along with a proton gain forming an 
iron-hydroperoxo (Fe3+ - OOH) intermediate (Bistolas et al. 2005).  
 
 Step 5: The O22- reacts with two protons from the surrounding solvent, breaking the 
O-O bond to release a water molecule and a highly active iron-oxoferryl intermediate. 
One hydrogen atom is abstracted from the substrate by the intermediate to produce a 
one electron reduced ferryl species (FeIV- OH) and a substrate radical. On the other 
hand, the ferryl species reacts with the C – H bond of the substrate in a concerted 
reaction without the radical intermediate formation.  
 
 Step 6: The final step of the process is the formation of the enzyme product complex 
and the release of the product. The low-spin state of the enzyme is then regenerated 
(Bistolas et al. 2005).  
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The reaction mechanism of these enzymes is illustrated in the following scheme: 
 
 
 
Scheme 2.1: Mechanism pathway of CYP enzymes 
 
 
 
 
2.3.4 Classification of Cytochrome P450 Enzymes: 
The classification system of enzymes was developed based on certain similarities 
amongst different enzymes such as amino acid sequence homology. This system is based on 
the principle that the more similar the structure of the enzymes, the more closely are they 
both phylogenetically and functionally. Cytochrome P450 enzymes are grouped into families 
represented by the first number; example in cytochrome P450-2E1 (CYP2E1) the first 
number represented is 2. The idea behind this grouping is based on the fact that all the 
enzymes in the same family have at least 40% amino acid sequence homology. Furthermore, 
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these families are further grouped into subfamilies where at least 55% of the amino acid 
sequences are homologous among the enzymes. The subfamilies are denoted by an 
alphabetical letter which in cytochrome P450-2E1 (CYP2E1) is E. The last number which is 
1 represents the gene that codes for the enzyme (Ghosal et al. 2005).  
 
2.3.5 Cytochrome P450-2E1 (CYP 2E1): 
As a member of the cytochrome P450 mixed-function oxidase system, CYP2E1 is 
involved in the metabolism of xenobiotics in the human body. While it is involved in the 
oxidative metabolism of a small range of substrates, solvents and anesthetics there are many 
important drug interactions mediated by CYP2E1. The size of the active site is the smallest 
observed for a human cytochrome enzyme and is therefore consistent with the low molecular 
weights of the many substrates of CYP2E1.  Either directly or by facilitated excretion, CYP 
2E1 is able to deactivate most drugs or bioactive many substances to form active compounds 
(Spracklin et al. 1997).  
Among the available cytochrome P450 enzymes, CYP2E1 is notable for resulting in 
toxicity greatly affecting the liver. This is due to the fact that CYP2E1 comprises over 50 % 
of the hepatic cytochrome P450 mRNA and 7 % of the hepatic cytochrome P450 protein. On 
the other hand, CYP2E1 is expressed at lower levels in a variety of extra-hepatic tissues 
where it is thought to play a role in the metabolism of certain endogenous molecules. Levels 
of CYP2E1 together with resulting toxicity vary respectively in response to diabetes, alcohol 
consumption, fasting and obesity. Therefore, the action and behavior of CYP2E1 can have 
either a positive or negative influence on human health and drug metabolism (Porubsky et al. 
2008; de Groot et al. 2002). Table 2.4 indicates substrates, inducers and inhibitors of 
CYP2E1 while the structure of CYP 2E1 is illustrated in Figure 2.2 (Porubsky et al. 2008). 
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Figure 2.2: Distal face of CYP2E1 rainbow colored from N terminus (blue) to C terminus 
(red) also showing the active site of CYP2E1(Porubsky et al. 2008) 
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Table 2.4: Substrates, inducers and inhibitors of CYP2E1 
 
Substrates Inhibitors Inducers 
 
Anaesthetics: 
 Halothane 
 Enflurane 
 Isoflurane 
 
Strong: 
o diethyldithiocarbamate 
 
 
 acetone  
 ethanol  
 isoniazid  
 
 
Other: 
 paracetamol  
 dapsone 
 theophylline  
 ethanol 
 chlorzoxazone  
 toluene  
 Isoniazid 
 
Unspecified: 
 cimetidine 
 disulfiram  
 
 
2.4 Application of Cytochrome P450 Enzymes in Biosensors: 
Cytochrome P450 enzymes play a key role in detoxication of bioactive compounds 
and hydrophobic xenobiotics coming from both outside (drugs, medicines, environment 
pollutants and food supplements) and those formed inside cells (steriods, prostaglandins, 
cholesterol, saturated and unsaturated fatty acids and others) in living organisms. Computer 
assisted processes or enzymatic experimental systems are used to predict metabolic 
transformations of physiological active substances and to investigate possible metabolic 
pathways. As a result electrochemical systems based on recombinant forms of cytochrome 
P450 appear to be the most popular as they enable standardization of analysis formats 
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(Shumyantseva et al. 2007). Therefore, characterization of cytochrome P450 enzymes is a 
key issue in pharmacokinetics, toxicokinetics and in the regulation of some endogenous 
metabolic pathways.  
Currently, the activity of cytochrome P450 enzymes is determined from the rates of 
formation of metabolites while the metabolic concentration requires development and 
maintenance of methods for each metabolic pathway studied. Another possible applicable 
method irrespective of the substrate of interest and the individual cytochrome P450 enzyme 
under study is to measure the consumption of reaction co-factors such as oxygen and 
NADPH. These co-factors however need to be available in excess to avoid any influence on 
enzyme activity. Redox properties of cytochrome P450 enzymes have allowed the 
development of amperometric biosensors allowing individuals to follow their catalytic cycles 
and monitor electron transfers to the enzymes. This is resultant from the fact that 
electrochemical systems execute dual functions; by serving as a source of electrons and have 
the ability to substitute partner proteins. The success of an amperometric biosensor relies on 
the electrical communication between an electrode and an enzyme; however in most cases the 
bulk nature of the protein may impede the redox site from direct electron transfer. In addition 
to this, macromolecular impurities and enzyme denaturing may also impede electron transfer. 
On the other hand, specifically binding the enzyme to the electrode surface may overcome 
these problems. While various immobilization techniques have been reported to establish 
electrical communication in enzyme-electrode construction, methods must often be designed 
empirically for the specific enzyme under study (Joseph et al. 2003; Shumyantseva et al. 
2007; Bistolas et al. 2005). The ultimate approach is the direct or mediatorless electron 
transfer from the redox electrode to the redox active group of the CYP enzyme. Table 2.5 
illustrates a list of sensors based on direct electron transfer. 
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Table 2.5: A list of CYP biosensors based on direct transfer 
CYP Species Electrode Substrate tested Reference 
 
CYP102 
 
DDAB-EPG electrode. 
 
Catalysis with O2 and  
H2O2. 
 
Shumyantseva et al. 
2007 
 
CYP2E1 
 
Bare, thiol, DDAB-GC, 
Au. 
 
Catalysis with p-
nitrophenol. 
 
Shumyantseva et al. 
2007 
 
CYP101 
 
DMPC-PG, DDAB-PG. 
 
Catalysis seen with O2 
and TCA. 
 
Shumyantseva et al. 
2007 
 
Recombinant 
CYP101  
 
EPG. 
 
Binding of camphor. 
 
Shumyantseva et al. 
2007 
 
CYP101 
 
DAB-BSA-
glutaraldehyde-GCE. 
 
Catalysis with camphor, 
adamantanoneand 
fenchone. 
 
Shumyantseva et al. 
2007 
Alternatively to this approach, cytochrome enzymes are attached to electrodes by 
introducing electroactive bridges; also known as mediators covalently coupled to the enzyme. 
Such redox relays have been bound at specifically selected sites generated by protein 
engineering or randomly. Table 2.6 presents a list of cytochrome biosensors based on 
mediated electron transfers. These approaches are relevant since cytochrome P450 and 
enzyme based electrodes may be used as biosensors in patient point-of-care diagnostics, the 
investigation of drug interferences and high-throughput screening.  
This is clearly demonstrated by the study reported herein where CYP2E1 was used as 
a bioactive component coupled to a nanostructured silver nanoparticles-poly (8-anilino-1-
naphthalene sulphonic acid) nanocomposite. This nanobiosensor was successfully used in the 
determination of tuberculosis treatment drugs. 
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Table 2.6: List of CYP biosensors based on mediated direct transfer 
CYP species Electrode Substrate tested Reference 
 
CYP2D6 
 
Polyaniline doped 
GCE. 
 
Catalysis with 
fluoxetine. 
 
Shumyantseva et al. 
2007 
 
CYP2B4 
 
 
Clay/detergent-GCE. 
 
Catalysis with 
aminopyrine, 
benzphetamine. 
 
Shumyantseva et al. 
2007 
 
CYP101 
 
PEI multilayers-rough 
PG electrode. 
 
 
Catalysis with O2 and 
H2O2. 
 
Shumyantseva et al. 
2007 
 
CYP3A4 
 
Au-MPS-PDDA 
multilayers. 
 
Catalysis with verapamil 
and medazolam. 
 
 
Shumyantseva et al. 
2007 
 
CYP101 
 
Au-MPS-PDDA 
multilayers, DDAB, 
multilayers carbon 
cloth. 
 
 
Catalysis with styrene 
and cis-β-methylstyrene. 
 
Shumyantseva et al. 
2007 
 
CYP101 
 
Nano-crystalline Sb-
dobed tin oxide 
electrode. 
 
 
Catalysis with styrene 
and camphor. 
 
Shumyantseva et al. 
2007 
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2.5 Enzyme Kinetics: 
Enzymes are positive catalysts that dramatically increase the rate of a given reaction. 
Enzyme kinetics is principally concerned with the measurement and mathematical description 
of this reaction rate and its associated constants. The Michaelis–Menten equation as 
presented by Michaelis and Menten and further developed by Briggs and Haldane is 
fundamentally important to enzyme kinetics. Although derived from a simple, single-
substrate, irreversible reaction, the Michaelis–Menten equation also remains valid for more 
complex reactions. Since enzyme-catalyzed reactions reach saturation, their rate of catalysis 
does not show a linear response to increasing substrate. If the initial rate of the reaction is 
measured over a range of substrate concentrations (denoted as [S]), the reaction rate (V) 
increases as [S] increases, as illustrated in Figure 2.3. However, as [S] increases, the enzyme 
becomes saturated with substrate and the rate reaches VMAX, which is the enzyme's maximum 
rate (Fersht et al. 1984). 
Figure 2.3 shows the Michaelis-Menten kinetic model for a single-substrate reaction. 
Initially there is indication of a bimolecular reaction between the enzyme [E] and [S] to form 
the enzyme-substrate complex [ES]. Although the enzymatic mechanism is a uni-molecular 
reaction; Equation 2.1 can be quite complex. There is typically one rate-determining 
enzymatic step that allows this reaction to be modeled as a single catalytic step with an 
apparent uni-molecular rate constant KCAT. However, if the reaction path proceeds over one 
or several intermediates, KCAT will be a function of several elementary rate constants, 
whereas in the simplest case of a single elementary reaction (a reaction absent from 
intermediates) it will be identical to the elementary uni-molecular rate constant k2. The 
apparent uni-molecular rate constant, KCAT is also known as the turnover number and denotes 
the maximum number of enzymatic reactions catalysed per second (Fersht et al. 1984).  
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PEES CATK              Equ.(2.1) 
                                                           
The Michaelis-Menten Equation is as follows (Equation 2.2) and it describes how the 
initial reaction rate v0 depends on the position of the substrate-binding equilibrium and the 
rate constant k2. 
][
][
SK
SV
V
M
i
MAX
                        Equ. (2.2)                        
The above equation illustrates that the substrate concentration that produces exactly 
half of the maximum rate, the substrate concentration is equal to KM. The equation can be 
rearranged as follows: 
}1]/]{[[  iM VVSK MAX                  Equ. (2.3) 
Therefore since the substrate concentration is half that required to enhance the 
maximum rate of reaction, the observed rate, Vi, will be equal to VMAX divided by two. At 
this substrate concentration VMAX /Vi will be equal to two, with the result that [S] (1) = KM. A 
graphical representation of reaction rate (Vi) versus concentration [S] produces a hyperbolic 
rate plot as shown in Figure 2.3 (Fersht et al. 1984). Figure 2.3 has key features denoted as 
points A, B, and C. At high substrate concentrations, the rate of reaction denoted C is almost 
equal to VMAX with the difference almost negligible in nearby substrate concentrations. 
Extrapolating the plot at infinitely high substrate concentrations indicates the extrapolated 
rate being equal to VMAX. On the other hand, the rate of reaction becomes independent of the 
concentration of the substrate, and the rate is said to be zero order. The substrate 
concentration has a very small difference in reaction velocity around point C, meaning that at 
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these concentrations, almost all of the enzyme molecules are bound to the substrate and the 
rate is not dependent on the substrate (Duggleby et al. 1994). 
 
Figure 2.3: Illustration of Michaelis-Menten Kinetics 
Point A and B are the lower substrate concentrations and here the velocities are lower 
which indicates that at any moment, a portion of the enzyme molecules are bound to the 
substrate. In fact, at the substrate concentration denoted by point B, exactly half of the 
enzyme molecules are in the enzyme-substrate complex at any instant and the rate is exactly 
one half of VMAX. At substrate concentrations, near point A the rate appears to be directly 
proportional to substrate concentration, and the reaction rate is said to be first order (Fersht et 
al. 1984). 
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2.5.1 Enzyme Inhibition: 
Enzyme inhibitors are compounds that have the ability to reduce the rate of enzyme-
catalyzed reaction, by interacting with the enzyme, cofactor or the substrate. The enzyme-
inhibitor reaction is often complex. Upon inhibition, the enzyme is unable to bind the 
substrate and the catalytic ability of the enzyme is reduced hence KM and KCAT are affected. 
There are two types of inhibitors namely; reversible and irreversible.  
Irreversible inhibitors are unable to be physically separated from the enzyme and it 
had been observed that their degree of inhibition tends to increase with time. On the other 
hand, reversible inhibitors can be separated physically from the enzyme restoring the 
enzymatic activity it had prior to inhibition. Therefore a reversible inhibition process 
occurring for a single-intermediate enzymatic reaction can be described as competitive, 
uncompetitive, non-competitive, mixed effects and allosteric inhibition (Conn et al. 1987; 
Fersht et al. 1984). 
 
2.5.1.1 Reversible Inhibition: 
Competitive inhibitors slow reactions down as they have a similar structure to the 
normal substrate molecule and therefore compete with the substrate for the active site of the 
enzyme. The enzyme-bound inhibitor can either bind to an unfavourable position for the 
catalytic reaction to take place with potential substrate molecules or they can inactivate the 
enzyme’s ability. During a catalytic reaction, at a particular enzyme and substrate 
concentration, if the inhibitor concentration is higher than that of the substrate, then the 
inhibitor will favourably compete with the substrate for the enzyme binding site and the 
degree of inhibition is high. When the substrate concentration is high, this effect is reversed 
(Paddle et al.1996).  
Ks Kp 
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Scheme 2.1: Mechanism of Competitive Inhibition 
 
On the other hand, non-competitive inhibitors are quite different in structure to the 
substrate molecule and therefore do not fit into the active site of enzymes. Usually, inhibition 
occurs at other parts of the enzyme thus changing the shape of the entire enzyme, including 
the active site in such a manner that the substrates can no longer bind. In this case the degree 
of inhibition is dependent on the concentration of the inhibitor as well as its affinity for the 
enzyme or the enzyme-substrate complex. This mechanism is clearly demonstrated by Songa 
et al. 2009 in which glyphosate inhibited the activity of the enzyme horseradish peroxidase.  
Competitive and non-competitive inhibition affects enzyme kinetics differently. 
Competitive inhibitors increase KM but do not change VMAX; while non-competive inhibitors 
decrease VMAX leaving KM unchanged. These interactions are displayed in a Lineweaver-
Burk Plots as illustrated in Figure 2.4 (Yung-chi et al. 1973). 
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Scheme 2.3: Mechanism of Non-competitive Inhibition 
 
 
 
Figure 2.4: Illustration of Competitive and Non-competitive Inhibition 
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In the case of mixed-inhibition, the inhibitor binds the enzyme as well as the enzyme-
substrate complex with a different affinity. These systems do not show any characteristics 
that are in any way similar to competitive and non-competitive inhibition. Both KM and KCAT 
are affected by such systems (Fersht et al. 1984).  
 
 
 
             E  I + S                         E I S 
 
 
 
 
 
Scheme 2.4: Mechanism of Mixed Inhibition 
 
In uncompetitive inhibition, the inhibitor only binds upon the formation of the enzyme-
substrate complex. 
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Scheme 2.5: Mechanism of Uncompetitive Inhibition 
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2.5.1.2 Irreversible Inhibition: 
Irreversible inhibition is as a result of the formation of covalent bonds between the 
enzyme active centre and the inhibitor during enzyme-inhibitor interaction. The term 
irreversible means that the decomposition of the enzyme-inhibitor complex causes 
destruction of the enzyme (Yung-chi et al.1973). 
 
 
 
                              
 
 
             E 
 
 
Scheme 2.6: Mechanism of Irreversible Inhibition 
 
 
2.6 Metal Nanoparticles and Conducting Polymers in Biosensors: 
In recent years, nanostructured materials have received increasing attention due to 
their wide range of potential applications. Among these materials, composites of conducting 
polymers and inorganic nanoparticles in particular often exhibit improved physical and 
chemical properties over their single-component counterparts, and hence their use is highly 
recommended (Huang et al. 2009; Nabid et al. 2008). Metal nanoparticles, especially gold, 
silver and copper, have attracted much attention due to their interesting properties and 
potential applications in technical fields. On the other hand, chemical resistance and surface 
modification of these metal nanoparticles together with functional polymers are of significant 
importance, on which many research works have been developed (Sadik et al. 2009; Ahuja et 
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al. 2009). Furthermore, embedding these metal nanoparticles inside the core of conducting 
polymers such as polyaniline and polypyrrole has become a popular and interesting aspect of 
polymer/metal nanocomposites synthesis as a result of the possibilities of the development of 
materials for chemical sensors, micoelectronic devices and electrocatalysts. This is due to 
their highly conductive nature of these polymers coupled with their ease of preparation and 
good stable environment which effectively accommodates the small dimensioned 
nanoparticles, thus improving specific electronic and catalytic properties. Various approaches 
have been employed to prepare polymer/metal composites (Alqudami et al. 2007; Li et al. 
2005). The most popular method involves the electrodepostion of the monomer at electrode 
surfaces, followed by the electrodeposition of metal nanoparticles from a precursor salt using 
either a potential cyclic or a pulsed program. Another route of synthesis involves the 
polymerization of the monomer simultaneously with the formation of the metal nanoparticles 
using γ-irradiation or ultraviolet irradiation (Guascito et al. 2008). 
A new challenge in this area has been the manipulation of polymer/metal composites 
together with biological molecules. This has led to the development of a novel class of 
modified electrodes in which both the charge transfer and the preservation of biological 
activity is obtained through experimental techniques designed to manipulate metal 
nanoparticles and polymers, tissues, DNA fragments, enzymes and other biological 
molecules. Two main problematic aspects with regards to the development of enzyme-based 
biosensors are the incorporation of sensing components in suitable matrices and the 
monitoring of the interaction of these components with analytes. Another aspect in enzymatic 
devices is the control of enzyme, which is dependent on the interface between the enzyme 
and polymers/metal composite. Such control has led to immobilization techniques suitable for 
anchoring the enzyme in close proximity to the electrode surface, thus preserving the 
biological activity. Therefore, in electrochemical devices where preservation of biological 
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activity at the polymer/metal-enzyme interface is priority towards efficient electrode design, 
the charge transfer between the enzyme and the electrode is usually fast and reversible (Liu et 
al. 2009; Mu et al. 2009; Cresphilho et al. 2009; Wang et al. 2006). The following section 
describes the most popular metal nanoparticles namely; silver, gold and copper nanoparticles, 
their characteristics, applications and use in biosensor devices. 
 
2.6.1 Silver Nanoparticles 
Nanomaterials, an emerging sub-discipline in Chemistry, have been extensively 
investigated in recent years due to their contribution towards the development in 
ultrasensitive electrochemical biosensors (Sadik et al. 2009; Zhang et al. 2000). Among the 
noble metal nanoparticles, silver are perhaps the most widely studies due to its unique optical 
and intrinsic shape-dependant properties (Sarkar et al. 2009; Hong et al. 2009). Silver 
nanoparticles have important application in sensors, in bio-labelling, as intercalation 
materials for electrical batteries, as antimicrobials, as catalysts in chemical reactions and 
filters. These nanoparticles also have the ability to purify drinking water, degrade pesticides 
and kill human pathogenic bacteria (Kathiresan et al. 2009; Mokhtari et al. 2009). A variety 
of methods have been employed to synthesize silver nanopartcles such as, molecular beam 
epitaxy, thermal deposition in organic solvents, laser ablation, chemical and photo-induced 
reduction (Zhang et al. 2000; Mokhtari et al. 2009; Sarkar et al. 2009; Hong et al. 2009). 
There has been considerable interest in the use of silver nanoparticles immobilized on 
polymeric films in nanobiosensor construction. This is due to their quantum size and surface 
effects, which result in novel physical, chemical magnetic and structural properties (Reddy et 
al. 2009) which enhances the conductivity of conducting polymers (Sadik et al. 2009).  
This study reveals a novel method for the detection of TB drugs using an electroactive 
silver/polymer matrix on gold electrode surfaces. 
 
 
 
 
	
	
 
46	
 
2.6.2 Gold Nanoparticles: 
Much attention has been placed to gold nanoparticles as they have emerged as 
attractive nanomaterials for biological and biomedical applications. Their physical and 
chemical properties resulting from their inert core make them essentially non-toxic to cells.  
Upon excitation of their surface plasmon oscillation, these particles absorb and resonantly 
scatter visible and near-infrared light. The plasmon resonance band can be tuned over a wide 
spectral range by changing intrinsic parameters such as the size, shape or type of material. 
Gold nanoparticles are advantageous in single molecule imaging due to their intense and 
brighter light-scattering signals which do not photobleach or blink. For particles below 30 
nm, the absorption becomes dominant over scattering and can be used for detection by 
photothermal microscopy (Levy et al. 2010). 
Gold salts in the presence of stabilizing agents used to prevent nanoparticle 
agglomeration and control growth, are used in the preparation of gold nanoparticles with 
varying core sizes. Furthermore, gold nanoparticles can be easily functionalized by anchoring 
thiol linkers in their monolayers. Besides these a wide variety of functional 
bionanoconjugates has been obtained, which include nanoparticles modified with peptides, 
proteins, antibodies, oligosaccharides, and nucleic acids. This has allowed gold nanomaterials 
to act as multifunctional platforms for both therapeutic and diagnostic purposes which  
include bio-imaging, single molecule tracking, drug delivery, transfection, and diagnostic 
(Levy et al. 2010). Because of their high effective surface area, catalysis and biocompatibility, 
gold nanoparticles are also used in biosensing due to their ability to adsorb redox enzymes 
without loss of their biological activities. 
 Norouzi et al. 2010; designed a new glucose electrochemical biosensor using a flow 
injection system. Glucose oxidase was used as the sensing material, immobilized on to the 
surfaces of gold nanoparticles and multiwall cabon nanotubes on glassy carbon electrode. 
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Fast Fourier transformation continuous cyclic voltammetry (FFTCCV) as the detection 
method showed acceptable reproducibility, good stability and low interferences for the 
biosensor developed in this study. Guo et al. 2007 reported an improved method for the 
detection of Concanavalin A (Con A) with a label-free optical biosensor. Success of the 
biosensor was based on self-assembling 1-Dodecanethiol (DDT) onto gold nanoparticles 
which were deposited on glass slides, with the insertion of glycolipid molecules into 
dodecanethiol by physical interactions. The recognition between Con A and carbohydrate 
was observed by Ultra-Visible spectrophotometry. The self-assembled bilayer on nanogold 
substrates had very high sensitivity for Con A, illustrating a low concentration detection 
limit. In addition to the ultra sensitivity for investigating interaction, the self-assembled 
bilayer structure, is expected to replace many receptors which require time-consuming 
organic syntheses for the fixation to the transducer. Therefore the simplicity and sensitivity of 
this biosensor architecture once again show the prospect of gold nanoparticles application in 
biosensor. 
 
2.6.3 Copper Nanoparticles:  
Over the years silver nanoparticles have been used in conductive inks which are 
mainly used in inkjet technology. However their high cost has limited their application in 
certain fields even though they are considered to possess high conductivity. Since copper is 
much cheaper, and also possesses very high conductivity (and which only 6% less than that 
of silver), copper nanoparticles can be considered as a replacement for silver nanoparticles in 
some fields of study (Magdassi et al. 2010). Many attempts have been made since the 1990’s 
to synthesize copper nanoparticles by wet Chemistry as well as by gas or solid phase 
methods. These methods include, thermal reduction, polyol processes, and vacuum vapor 
deposition, radiation methods, and sonochemical methods, microemulsion techniques, 
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reducing flame synthesis, metal vapor synthesis and chemical reduction in solution (Magdassi 
et al. 2010). Recently, copper nanoparticles are used as an additive in lubricants, 
polymers/plastics, metallic coating and inks.  Due to their excellent mending effect copper 
nanoparticles are added into lubricant oil as additives to effectively reduce friction and 
wearing, or to repair worn-out surfaces. When deposited on graphite surfaces, copper 
nanoparticles improve the charge discharge properties such as coulombic efficiency, cycle 
characteristics, and high rate performances and are commonly used as anode materials for 
lithium ion batteries. The unique chemical and physical properties of copper nanoparticles 
makes them extremely suitable for designing new and improved sensing devices, especially 
electrochemical sensors and biosensors. Important functions provided by copper 
nanoparticles include immobilization of biological components, labeling of biomolecules, 
catalysis of electrochemical reactions, enhancement of electron transfer between electrode 
surfaces and proteins and even acting as reactants (Luo et al. 2006). 
A study by Heli et al. 2009; revealed the successful electrocatalytic oxidation of 
acetylcholine using copper microparticles modified carbon paste electrodes and copper 
nanoparticles modified carbon paste electrodes. Voltammograms recorded for the former 
electrode illustrated a single anodic peak related to the oxidation of acetylcholine while the 
latter showed two overlapped anodic peaks.  The presence of copper nanoparticles facilitated 
the constructed of a nonenzymatic amperometric biosensor with a simple analysis procedure 
for the determination of acetylcholine. Another example of the importance of copper 
nanoparticles towards the construction of biosensor is seen in the work by Wang et al. 2008. 
An amperometric glucose biosensor was developed based on immobilization of glucose 
oxidase on a copper nanoparticles/chitosan/carbon nanotube modified glassy carbon electrode 
for the determination of hydrogen peroxidase. With the synergistic effect of both copper and 
carbon nanotubes towards the reduction of hydrogen peroxide in the chitosan matrix, an 
 
 
 
 
	
	
 
49	
 
amplified reduction current of hydrogen peroxide was observed. The developed biosensor 
exhibited excellent sensitivity, a lower detection limit, a fast response time, a wide linear 
range and perfect selectivity. 
 
2.6.4 Polymers: 
Traditional polymers take charge as conductors with a range of novel applications. 
Various experts are now in the process of combining expertise to study organic solids that 
exhibit remarkable conducting properties. A large proportion of organic compounds which 
effectively transport charge are divided into three groups such as; organometallic species, 
charge transfer complexes or ion radical salts and conjugated organic polymers. Recently a 
new class of intrinsically conducting polymers or electroactive conjugated polymers has just 
emerged. These materials exhibit interesting optical and electrical properties which were 
previously only found in inorganic systems. The key requirement for a polymer to become 
intrinsically electrically conductive is that there should be an overlap of molecular orbitals to 
allow the formation of delocalized molecular wave function. These molecular orbitals should 
be partially filled so that there is a free movement of electrons throughout the lattice (Gerard 
et al. 2002).   
 
2.6.5.1 Conducting Polymers: 
Conducting polymers contain π-electron backbones exerting charge mobility along 
the backbone which is responsible for their unusual electronic properties such as low energy 
optical transitions, electrical conductivity and high electron affinity (Gerard et al. 2002). The 
chemical bonding in conducting polymers is such that one unpaired electron is produced per 
carbon atom in the backbone of the polymer. The carbon atoms are π bonded in a sp2pz 
configuration where the orbital of successive carbon atoms overlap providing delocalization 
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of the electrons along the backbone of the polymer. The π bonds however are also highly 
susceptible to chemical, electrochemical oxidation or reduction processes. The formations of 
non-linear defects such as solitons, polarons and bipolarons produced during doping 
polymerization of a polymer, have made a contribution to the electrical conduction in these 
polymer materials. An increase in electrode modification as a result of these polymers has 
provided new and interesting properties, which have contributed to the wide application of 
conducting polymers. They have been applied in electrocatalysis, rechargeable batteries, 
membrane separation, optoelectronic, chromatography; solar cells (Ahuja et al. 2007; 
Malholtra et al. 2006) and most recently they have found great application in electrochemical 
biosensors. This is due to their mechanical flexibility, chemical specificities, tunable 
conductivities, high surface areas and easy processing (Zhu et al. 2006). 
 
2.6.5.2 Synthesis of Conducting Polymers: 
There are various available methods for the synthesis of conducting polymers, with 
oxidative coupling of the monomer being the most widely used technique. This technique 
involves the formation of a cation radical followed by another coupling to produce a di-cation 
and the repetition then leads to the polymer (Malholtra et al. 2006). With the advantage of 
simplicity and reproducibility, electrochemical synthesis has rapidly become the preferred 
method of synthesizing conducting polymers (Trivedi et al. 1996).  
Electropolymerization is normally carried out in a single cell compartment where a 
three-electrode configuration is employed subjected to an electrochemical solution consisting 
of a monomer and a supporting electrolyte (in some case) all dissolved in an appropriate 
solvent which in most cases is an acidic. The polymerization can be carried out either 
potentiostatically where the potential is kept constant with a variation of the current with 
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time, or galvanostatically by keeping the current constant thereby monitoring the electrode 
potential. A three-electrode system employed during the polymerization comprises of a 
working electrode, a counter electrode and a reference electrode. Metals such a gold, 
platinum, carbon, nickel, titanium, palladium and most recently microelectrodes are used as 
working electrode and function as support systems for the polymer films. Counter electrodes 
on the other hand, supply the current required by the working electrode. A few commonly 
used counter electrodes include metallic foils of nickel, platinum and gold. Reference 
electrodes such as SCE, NCE, silver and mercurous sulfate establish stable potentials in 
electrochemical reactions and are used immersed in aqueous media (Ahuja et al. 2007). 
Advantages associated with electrochemical polymerization reactions is that reactions 
can be carried out at room temperature by varying either the potential or the current with 
time, and the thickness of the film can be controlled.  Free standing, homogenous and self 
doped films can be prepared through electrochemical synthesis. This method of polymer 
synthesis is an electro-organic process rather than an organic electrochemical one with great 
emphasis on the electrochemical process rather than organic synthesis. Electrochemical 
techniques employed in the polymerization of conducting polymers on the electrode surface 
are; pulse, galvanostatic, potentiostatic or sweeping techniques, with potentiodynamic 
techniques being more preferred because of their homogenous film production and strong 
adherence of the film to the electrode surface. Conductivity of the polymer is influenced by a 
number of factors including polaron length, the conjugation length, and the overall chain 
length and by the charge transfer to adjacent molecules (Gerard et al. 2002; Ahuja et al. 
2007; Malholtra et al. 2006; Grennan et al. 2006; Trivedi et al. 1996).  
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2.6.5 Types of Conducting Polymers:  
2.6.5.1 Polyaniline (PANI): 
Polyaniline (PANI) is a conducting polymer of the semi-flexible rod polymer family 
that is electrically synthesized in the presence of an acidic medium by anionic oxidation of 
the aniline polymer onto an electrode surface. This attachment of PANI on the electrode 
surface can be done either by chemical or electrochemical means. Electrochemical 
polymerization is though galvanostatic, potentiostatic or potentiodynamic means, offering the 
potential to incorporate a wider range of dopant ions, since the reaction can be carried out in 
the presence of an appropriate electrolyte rather than a chemical oxidant.  This procedure 
allows for film property control such as morphology and thickness allowing this polymer to 
be the most commonly used in biosensor preparation. For the polymer to retain its conductive 
property in the presence of non-acid media, it should be electrically neutral in the oxidized 
form of the polymer (Grennan et al. 2006; Naudin et al. 1998). 
PANI is known for its very strong pH sensitivity existing between the half-oxidized 
emeraldine base (EB) and the emeraldine salt (ES) form of PANI, which is a reversible acid – 
base reaction. Therefore it is generally accepted that polyaniline has been observed to exist in 
three oxidation states namely: the half oxidized ES, the fully reduced leucoemeraldine (LEB) 
and the fully oxidized pernigraniline (PNB). In biosensor development, polyaniline serves as 
a point of attachment of bioactive compound such as enzymes, antibodies etc. as well as a 
means of electron transport between the electrode and the active site of the bioactive 
compound (Grennan et al. 2006; Lindfors et al. 2002; Slim et al. 2008).  
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Figure 2.5: Structure of Polyaniline 
 
 
2.6.6.2 Polypyrrole (PPY): 
Polypyrrole is a conducting polymer which can be synthesized either chemically or 
electrochemically. Electrochemical sysnthesis of PPY is advantageous as the polymer 
produced is better conducting and the conductivity is stabilized for a long period of time 
(Lakard et al. 2007). Parameters such as the applied current or voltage can control the 
location, morphology, thickness and chemical composition of PPY. On the other hand, 
chemical synthesis involves the use of particular dopants during the synthesis. These dopants 
include heparin and heparin sulphate and their use is based on the fact that they have an 
ability to increase the conductivity of the polymer to a level of 103 S cm-1. PPY 
polymerisation mainly occurs on platinum electrodes where a wide variety of enzymes are 
immobilized where the  mechanism takes place at potentials above + 600 mV.  There are a 
number of factors affecting the film including the crystallographic structure of the underlying 
electrode, the nature of the electrolyte, the speed of the potential of deposition of the polymer 
known as the scan rate, the concentration of the monomer, the presence of anions and 
polyanions or in some instances surfactants and finally the pH of the solution.  
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Figure 2.6: Structure of Polypyrrole 
 
2.6.6.3 Polyindole (PND): 
PND is another electroactive polymer, which is synthesized by anionic oxidation of 
indole in various electrolytes. Electrochemical oxidation of indole in LiClO4 containing 
acetonitrile produces an electrochromic polymer film with good air stability (Pandey et al. 
1998). PND is green in colour in its doped state and possesses an electrical conductivity in 
the range of 10-2 to 10-1 S cm-1 depending on the nature of counter anion. The polymer is 
closely structured to polypyrrole and polyaniline however its conductivity is much lower 
although it has a better thermal stability than them. Derivatives of indole are found 
abundantly in natural plants and possess various physiological properties which are potential 
bioactive components. 
n
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Figure 2.7: Structure of Polyindole 
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2.6.6.4 Polycarbozole (PCZ): 
As opposed to the former discussed polymers, polycarbazoles are less studied. Their 
ability to exhibit some photoconductivity and electrochromic properties somehow makes 
them to be of particular interest. These polymers are synthesized by two main procedures. 
The first route is the most commonly used and involves the electrochemical or chemical 
oxidation of carbazole derivatives in solution (Fernandes et al. 1999). The second method 
employs the activation of the carbon-halogen bond of 3, 6-dihalogenated of the carbazole 
monomer in the presence of a zero valent nickel complex. The dehalogenative 
polycondensation can be carried either chemically or electrochemically and leads to well 
defined polymers with 3, 6-linkages. The electrochemical stability of this polymer has been 
observed to be less when compared to those of other conducting polymers however, this 
property can be enhanced by decreasing the poly disparity of the material (Tran-Van et al. 
2002). 
N
CH3  
Figure 2.8: Structure of Polycarbozole 
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2.6.6.5 Poly(8-anilino-1-naphthalene sulphonic acid) (PANSA): 
In this study 8-aninilo-1-naphthalene sulfonic acid (ANSA) was polymerized in the 
presence of sullfuric acid to produce poly (8-anilino-1-naphthalene sulfonic acid) (PANSA) 
incorporating the enzyme cytochrome P450-2E1 (CYP2E1) for the detection of TB treatment 
drugs. ANSA belongs to a family of substituted naphthalene’s which are normally used as 
fluorescent probes in the study of biologically active molecule structures. These compounds 
are moderately soluble in water but in most cases they prefer a more hydrophobic 
environment (Catena et al. 1989). Since ANSA is viewed as aniline substituted naphthalene 
we have successfully polymerised the aniline substituent with the assistance of the sulphuric 
substituent attached on gold electrode.  Even though conducting polymers show admirable 
qualities towards the construction of nanobiosensors, we have also observed the role of silver 
nanoparticles coupled with PANSA towards the nanobiosensor construction. 
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Figure 2.9: Structure of Poly(8-anilino-1-napthalene sulphonic acid) 
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2.7 Tuberculosis: 
 
Tuberculosis (TB) is a common and infectious disease caused by mycobacterium, 
mainly Mycobacterium tuberculosis (Wang et al. 2009). The infection is  spread as exhaled 
drops in coughs, spits or sneezes from infected individuals, where the contagion may be 
caused by even a single bacterium ingested (Schweon et al. 2009).  Primarily TB attacks the 
lungs as pulmonary TB but it can also affect the lymphatic system, central nervous system, 
the genitourinary system, the circulatory system, the gastrointestinal system, joints, bones and 
even the skin. This disease is said to be a slow-growing pathogen which has the unusual 
propensity to shut down its metabolism during adverse conditions such as, starvation or 
immune stress (Wang et al. 2009; Hernandez et al. 2008). 
Treatment for TB uses antibiotics to kill the bacteria. These drugs are administered as 
part of the directly observed treatment short course (DOTS) therapy which is a multiple drug 
regimen given over a long duration of time.  This regime employs an initial phase which is 
usually 2 months, with at least three drugs (Isoniazid (INH), Rifampin (RIF), and 
Pyrazinamide (PZA)) to reduce the bacterial load as rapidly as possible. This is followed by a 
continuation phase employing only two drugs (INH and RIF) given for 4 months (Eoh et al. 
2009).  
 
2.7.1 The Bacterial Cell:  
 
The effectiveness and success antibacterial agents; which in this case are 
antituberculous drugs, owes much to the fact that these agents can act selectively against 
bacterial cells as opposed to animal cells. This is attributed to the fact that bacterial cells and 
animal cells differ both in structure as well as in their biosynthetic pathways. The following 
are some of the differences between bacterial and animal, also illustrated in Figure 2.10. 
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 Animal cells have defined nuclei while bacterial cells have none. 
 Bacterial cells are quite simple while animal cells contain a variety of structures such 
as mitochondria, endoplasmic reticulum; called organelles. 
 The biochemistry between these two cells is also very different. For instance bacterial 
cells are required to synthesize essential vitamins which animal cells are able to 
acquire intact from food. Bacterial cells therefore should have enzymes to catalyse 
these reactions but animal cells should not since the reactions are not required. 
 The bacterial cell has a cell membrane and a cell wall while an animal cell only has a 
cell membrane. The cell wall is crucial to the survival of bacterial cells as they have to 
survive a wide range of environments and osmotic pressures, whereas animal cells do 
not (Patrick et al. 2005).    
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Figure 2.10: Structures of (A) bacterial cell 
(http://rpscportal2010.blogspot.com/2010/09/component-of-bacterial-cell.htmland) (B) 
animal cell (http://www.animalport.com/animal-cells.html) 
 
A 
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2.7.2 Principles of Anti-tuberculous Therapy:  
 
 To kill a large number of actively multiplying bacilli. Isoniazid achieves this 
successfully. 
 They treat persisters; which are semi-dormant bacilli that metabolize slowly or 
intermittently. Rifampicin and pyrazinamide are the most efficacious. 
 To prevent the emergence of drug resistance by multiple therapies to suppress single-
drug-resistant mutants that may exist de nova or emerge during therapy. Isonaizid and 
rifampicin are the best in these cases. 
 Combined formulations are used to ensure that poor compliance does not result in 
monotherapy with consequent drug resistance. 
After extensive clinical trials, the following 3 facts have been found satisfactory: 
 An unsupervised regime of daily dosage which comprise of isoniazid and rifampicin 
for 6 months including pyrazinamide for the first 2 months. 
 A supervised (DOTS) regime for patients who cannot be relied on to complete 
treatment. This comprises of three weekly doses of isonaizid and rifampicin for 6 
months, and pyrizinamide for the first two months. As opposed to the unsupervised 
regime, isoniazid and pyrizinamide are given in high dosages. However, with both 
regimes, ethambutol or streptomycin is also added for the first 2 months to prevent the 
likelihood of drug resistance or if the patient is severely ill with extensive active 
lesions. 
 A low cost and even free (in developing countries), yet effective, regime favoured by 
most if not all affected countries comprises the supervised regime; daily 
administration of isoniazid, rifampicin, pyrazinamide and either ethambutol or 
streptomycin. 
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Although the DOTS regime has contributed significantly towards the falling 
incidences of TB, incomplete implementation of the campaign has also been a major cause of 
the high occurrences of the drug resistant strains of Mycobacterium tuberculosis coupled with 
the spread of HIV/Aids in tuberculosis-endemic regions (Wallis et al. 2009; Zvavamwe et al.  
2009). This stems from the fact that patients with fully susceptible TB develop secondary 
resistance during the TB therapy as a result of inappropriate dosing of treatment, inadequate 
treatment, not taking the prescribed regimen appropriately or using low quality medication. 
Multidrug-resistant TB (MDR-TB) defined as an isolate showing resistance to the two most 
effective first-line TB drugs INH and RIF and the extensively drug resistant (XRD-TB) 
defined as an isolate showing resistance to INH, RIF and three or more of the six classes of 
second line drugs, are phenomena threatening to destabilize TB control (Eoh et al. 2009, 
Castagnolo et al. 2009, Balganesh et al. 2008). MRD-TB and XRD-TB are more difficult to 
treat than sensitive TB since they require the administration of expensive and less effective 
second-line TB drugs for longer treatment duration than first line drugs (Eoh et al. 2009). A 
few second-line TB drugs are listed in Table 2.7. It is therefore acknowledged that new 
approaches are required in order to promptly address the issue of patients falling ill as a result 
of inappropriate dosing of treatment and inadequate treatment administration. 
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Table 2.7: List of first and second-line antimicrobials used in the treatment of 
tuberculosis 
 
Drug Typical Adult-Daily Dosage 
First-line Drugs (In appropriate order of preference) 
Isoniazid 300 mg/d 
Rifampicin 600 mg/d 
Pyrazinamide 25 mg/kg/d 
Ethambutol 15-25 mg/kg/d 
Steptomycin 15 mg/kg/d 
Second-line Drugs (In appropriate order of preference) 
Amikacin 15 mg/kg/d 
Aminosalicylic acid 8-12 g/d 
Capreomycin 15 mg/kg/d 
Ciprofloxacin 1500 mg/d, divided 
Clofazimine 200 mg/d 
Cycloserine 500-1000 mg/d, divided 
Ethionamide 500-750 mg/d 
Ofloxacin 600-800 mg/d 
Rifabutin 300 mg/d 
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2.7.3 Isoniazid (INH): 
 
Isoniazid (Figure 2.11) was introduced in 1952, and is the most active tuberculostatic 
drug against susceptible strains. INH is a hydrazide of isonicotinic acid and is a small simple 
molecule (molecular weight 137 g/mol), a white crystalline powder that is freely soluble in 
water. Commercially this drug is known as Laniazid or Nydrazid depending on the country of 
purchase. The structure of isoniazid is shown below. 
 
NHO
NH2
 
Figure 2.11: Structure of Isoniazid. 
 
2.7.3.1 Mechanism of Action and Basis of Resistance: 
Research has shown that INH inhibits most tubercle bacilli in a concentration of 
µg/mL or less and is bactericidal for effective in actively growing tubercle bacilli. INH 
inhibits the synthesis of mycolic acids, which are essential components of mycobacterial cell 
walls. The mechanism of action of INH is not yet known. INH apparently combines with an 
enzyme that is peculiar to INH-susceptible strains of Mycobacterium Tuberculosis, 
displaying a pigment precursor molecule and leading to a variety of disorders in cellular 
metabolism. 
Resistance is associated with overproduction of the inhA gene and with mutation of 
katG, which encodes mycobacterial catalase. The loss of catalyse activity which is the result 
of INH resistance is not yet completely understood, but is assumed that catalase maybe 
important for an activation step permitting INH to interact with its target protein. On the other 
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hand, inhA overproducers express low level resistance and cross-resistance to other 
antituberculous drugs such as rifampicin and ethambutol, while KatG mutants express high-
levels INH resistance and are not cross-resistant to other antituberculous drugs. The 
simultaneous use of any 2 of these drugs markedly delays the emergence of resistance to one 
of them (Meyer et al. 1980; Craig et al. 1990). Resistant mutants tend to occur in susceptible 
mycobacterial populations and tend to be selected out both in vitro and in vivo in the 
presence of INH with a frequency of 1 bacillus in 106. Since tuberculous lesions often contain 
more than 108 tubercle bacilli, with resistant mutants readily selected out if INH is 
administered solely. However, administration of a second independently acting drug, to 
which resistance also merges at a frequency of 1 in 106 to 108 , is effective. The odds that a 
bacillus is resistant to both drugs approximately 1 in 106 x 106, or 1 in 1012, which is several 
orders of magnitude more than the number of infecting organism. Singular drug therapy with 
INH and failure to use INH in combination with other drugs to which the strains are 
susceptible has lead to the 20-30 % prevelance of INH resistance in South Africa (Meyer et 
al. 1980; Craig et al. 1990). 
 
2.7.3.2 Pharmacokinetics: 
 
INH is readily absorbed from the gastrointestinal tract. The administration of a 300 
mg oral dose; with 5 mg/kg in children; results in peak concentrations of 3 - 5 µg/mL within 
1 - 2 hours. INH diffuses readily into all body fluids and tissues, including the central nervous 
system and cerebrospinal fluid with ranging between 20 % and 100 % of simultaneous serum 
concentration.  
Metabolism of INH, particularly the acetylation by the liver is under genetic control. 
Two groups of people are recognized through acelaytion; the ‘slow’ and the ‘rapid’ 
acetylators of the drug. The ‘slow’ acetylators appear to possess autosomal homozygous 
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recessive hereditary traits, while ‘rapid’ acetylators show intermediate dominance.  
Therefore, the average concentration of INH in the plasma of ‘rapid’ acetylators is about one-
third to one half of that in ‘slow’ acetylators with average half-lives of less than 1 hour and 3 
hours, respectively. More rapid clearance of INH by rapid acetylators is of no therapeutic 
consequence when the drug is administered daily, but sub-therapeutic concentrations may 
occur if the drug is administered as a once-daily dose. INH is excreted mainly in the urine, 
partly as unchanged drug and partly as the acetylated form and partly as other conjugates. 
The percentage of unchanged INH in urine of ‘slow’ acetylators is higher; while the 
percentage of the acetylated form is higher in the ‘rapid’ acetylators. The dose need not be 
adjusted in cases of renal failure, but a third to a half of the normal dose is recommended in 
severe hepatic insufficiency (Meyer et al. 1980; Craig et al. 1990).  
 
2.7.3.3 Clinical Uses: 
INH is probably the most widely useful drug in tuberculosis. The usual dosage of INH 
is 5- 10 mg/kg/d, with a typical adult dose being 300 mg given once daily. In cases of serious 
infections up to 10 mg/kg/d may be used. However, where cases of malabsorption develop, or 
in children, a 15 mg/kg dose, or 900 mg may be used in a twice weekly regime in 
combination with a second anti-tuberculous drug. INH is usually given by mouth but can be 
given parentally in the same dosage (Meyer et al. 1980; Craig et al. 1990). 
 
2.7.3.4 Adverse Reactions 
Severity and incidences of untoward reactions to INH are related to dosage and the 
duration of administration (Meyer et al. 1980; Craig et al. 1990). 
 
 
 
 
 
 
	
	
 
66	
 
2.7.3.5 Allergic Reactions  
Fever and skin rashes are seen occasionally but drug-induced systematic lupus 
erythematosus have also been reported (Meyer et al. 1980; Craig et al. 1990). 
 
2.7.3.6 Direct Toxicity 
The most common toxic effects attributed to INH are on the peripheral and central 
nervous system; also known as peripheral neuropathy. These toxic reactions include 
insomnia, peripheral neuritis, muscle twitching, restlessness, convulsions, urinary retention 
and psychotic episodes. Peripheral neuropathy is observed in 10 – 20% of patients 
administered 5 mg/kg/d but is infrequently seen with the standard 300 mg adult dose. This 
condition is more likely to occur in ‘slow’ acetylators and patients with predisposing 
conditions such as malnutrition, alcoholism, AIDS, uraemia and diabetes (Meyer et al. 1980; 
Craig et al. 1990).  INH-induced hepatitis has however been found to be the most frequent 
major toxic effect. Clinical hepatitis with loss of appetite, vomiting, nausea, jaundice occurs 
in 1 % of INH recipients and can be fatal, especially if the drug is not discontinued. The risk 
of hepatitis depends on age. It occurs rarely under age 20, in 0.3 % of those from aged 21 – 
35, 1.2 % of those aged 36 – 50, and 2.3 % for those aged 50 and above. The risk of hepatisis 
has been seen to be much higher among alcoholic, post partum period and possibly during 
pregnancy (Meyer et al. 1980; Craig et al. 1990).  
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2.7.4 Rifampicin (RIF): 
Rifampicin (Figure 2.12) commercially known as either Rifadin, Rimactane or 
Riadin; is a large complex (with Molecular weight 823 g/mol) semisynthetic derivative of 
rifamycin, which is an antibiotic produced by Streptomyces mediterranei. In vitro this drug is 
active against gama-positive and gama-negative cocci, some enteric bacteria, mycobacteria 
and Clamydia. Susceptible organisms are inhibited by less than 1 µg/mL but resistant mutants 
are present in all microbial populations at a frequency of approximately 1: 106. The 
administration of rifampicin as a single drug is responsible for the selection for these highly 
resistant organisms. There is no documented evidence to suggest any cross-resistance to RNA 
other to other classes of antimicrobial drugs, but there is cross-resistance to other rifamycin 
derivatives such as rifabutin (Bennet et al. 2007; Meyer et al. 1980; Craig et al. 1990). 
 
OH OH
OH
NH
N
N
N
CH3
O
CH3
O
O
O
OH
CH3
O
CH3
CH3
O
CH3
O
H
CH3
OH
CH3
 
Figure 2.12: Structure of Rifampicin 
 
2.7.4.1 Mechanism of Action, Resistance and Pharmacokinetics: 
RIF forms strong bonds with the β subunits of bacterial DNA-dependant polymerase 
and thereby inhibits RNA synthesis. Resistance results from one of several possible point 
mutations that prevent binding of RIF to RNA polymerase. Human RNA polymerase does 
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not bind rifampicin and is not inhibited by it. Therefore since RIF is bactericidal for 
mycobacteria, it readily penetrates most tissues and into phagocytic cells. This drug is 
capable of killing organisms that are poorly accessible to many other drugs, such as 
intracellular organisms and those sequestered in abscesses and lung cavities. 
RIF is well absorbed in the body after oral administration and excreted mainly 
through the liver into bile. It then undergoes enterohepatic recirculation, with the bulk 
excreted as a deacylated metabolite in faeces and a small amount in the urine. With oral doses 
of 600 mg daily serum levels exceed 5 µg/mL for 4 – 6 hours and urine levels may be 10 – 
100 times higher. In tuberculosis, a single oral dose of RIF, usually 600 mg daily (10 – 20 
mg/kg), is administered together with INH, ethambutol and another antituberculous in order 
to delay the emergence of rifampicin-resistant mycobacteria (Bennet et al. 2007; Meyer et al. 
1980; Craig et al. 1990). 
 
2.7.4.2: Mycobacterial Infections: 
In some short-course therapies, 600 mg of RIF is given twice weekly. RIF is also 
effective in some atypical mycobacterial infections as well as in leprosy when used together 
with sulfone. This drug is sometimes used as an alternative to INH prophylaxis for patients 
who are unable to take INH or who have been in close contact with a case of active 
tuberculosis caused by an INH-resistant, rifampicin susceptible strain (Bennet et al. 2007; 
Meyer et al. 1980; Craig et al. 1990). 
 
2.7.4.3 Other Indications: 
RIF is used in a number of other clinical situations. RIF, 20 mg/kg/d for 4 days is 
used as prophylaxis in contacts of children with Haemophilus influenza type b disease. Also, 
an oral dosage of 600 mg twice daily for 2 days can eliminate meningococcal carriers. RIF 
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together with a second-line drug is used to eradicate staphylococcal carriers. This 
combination therapy is also used in the treatment of serious staphyloccal infections such as 
osteomyelitis and prosthetic valve endocarditis (Bennet et al. 2007; Meyer et al. 1980; Craig 
et al. 1990). 
 
2.7.4.4 Adverse Reactions: 
RIF manifests as a harmless orange colour in urine, tears and contact lenses. 
Occasional adverse effects also include rashes, nephritis and thrombocytopenia. This drug 
commonly causes light chain proteinuria. If RIF is administered less often than twice weekly, 
RIF causes flu-like symptoms characterized by chills, fever, anaemia, and thrombocytopenia 
and sometimes associated with acute tubular necrosis. RIF induces microsomal enzymes 
(cytochrome P450), which increases the elimination of numerous other drugs including 
methadone, anticoagulants, contraceptives and some anticonvulsants (Bennet et al. 2007; 
Meyer et al. 1980; Craig et al. 1990). 
 
2.7.5 Ethambutol (ETH): 
This is a synthetic, water-soluble, heat-stable compound, the dextro isomer of the 
structure shown below (Figure 2.13), is dispensed as the dihydrochloric salt (Bennet et al. 
2007; Meyer et al. 1980; Craig et al. 1990). Commercially, ethambutol is referred to as 
Myambutol. 
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Figure 2.13: Structure of Ethambutol 
 
2.7.5.1 Mechanism of Action, Resistance and Pharmacokinetics: 
Susceptible strains of mycobacterium tuberculosis and other mycobacteria are 
inhibited in vitro by ETH with concentration 1 - 5 µg/mL. ETH functions by inhibiting the 
synthesis of arabinogalactan, an essential component of the mycobacterial cell wall. It 
enhances the activity of lipophilic drugs such as RIF that cross the cell wall primarily in lipid 
domain of this structure. 
ETH is well absorbed the gut following ingestion of 25 mg/kg. A blood level peak of 
2 – 5 µg/mL is reached in 2 – 4 hours with about 20 % of the drug excreted in faeces and 50 
% in urine in unchanged form. In cases of renal failure, ETH accumulates and therefore drug 
dose should be reduced in half if creatine clearance is less than 10 mL/min. ETH is able to 
cross the blood-brain barrier only if the meninges are inflamed. Cerebrospinal fluid is highly 
variable, ranging from 4 – 64 % of serum levels in the setting of meningeal inflammation. 
Similarly to all antituberculous drugs, resistance to ETH emerges at a very rapid rate when 
the drug is administered alone. Therefore, ETH is always administered in combination with 
other antituberculous drugs. As of date, there is no known documentation about the 
mechanism of resistance (Bennet et al. 2007; Meyer et al. 1980; Craig et al. 1990; Clayton et 
al. 2001). 
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2.7.5.2 Clinical Uses: 
ETH hydrochloride, 15 – 25 mg/kg, is usually given as a single daily dose in 
combination with rifampicin and INH. Higher doses are however required for the treatment 
of tuberculosis meningitis. The dose of ETH is 50 mg/kg when a twice-weekly dose schedule 
is used (Bennet et al. 2007; Meyer et al. 1980; Craig et al. 1990). 
 
2.7.5.3 Adverse Reactions:  
The most common serious adverse event associated with ETH is retro-bulbar neuritis 
resulting in loss of visual acuity and red-green blindness. This is a dosage-related side effect 
and is more likely to occur at a dosage of 25 mg/kg/d which is continued for several months. 
With doses of 15 mg/kg/d or less, visual disturbance are very rare. ETH is relatively 
contraindicated in children too young to permit assessment of visual acuity and red-green 
colour discrimination (Bennet et al. 2007; Meyer et al. 1980; Craig et al. 1990). 
 
2.7.6 Pyrazinamide (PYR): 
This compound is a relative of nicotinamide (Figure 2.14), stable, slightly soluble in 
water and quite inexpensive and whose brand name is Rifter.  At neutral pH, PYR is inactive 
in vitro, but at pH 5.5 it strongly inhibits the growth of tubercle bacilli within cells in 
concentrations of 20 µg/mL. The drug is taken up by macrophages and kills bacilli residing 
within this acid environment (Bennet et al. 2007, Craig et al. 1990; Clayton et al. 2001). 
N
N
NH2
O
 
Figure 2.14: Structure of Pyrazinamide 
 
 
 
 
	
	
 
72	
 
2.7.6.1 Clinical Uses:  
PYR is well absorbed from the gastrointestinal tract and widely distributed in body 
fluids as well as inflamed meninges with serum concentrations of 30 – 50 µg/mL achieved 
with dosages of 25 mg/kg/d. The half-life of 12 - 24 hours permits once-daily dosing, while a 
50 -70 mg/kg dose is used for twice or thrice-weekly treatment regimes. Tubercle bacilli 
develop resistance to PYR readily, but there is no evidence of cross-resistance with INH or 
other antituberculous drugs. As a result of this, PYR is used in combination with other drugs 
such as ciplofloxacin or ofloxacin for the treatment of active disease and exposure to 
multidrug- resistant bacilli (Bennet et al. 2007, Craig et al. 1990). 
 
2.7.6.2 Adverse Reactions: 
Major adverse effects of PYR include hepatotoxicity (1 – 5 % of patients), drug fever, 
vomiting, hyperuricemia and nausea. PYR should always be considered only as part of a 
combined drug regimen in patients harbouring tubercle bacilli resistant to first choice drugs 
(Bennet et al. 2007, Craig et al. 1990).  
 
2.8 Detection of Tuberculosis Treatment Drugs: 
Owing to the widespread and therapeutic importance of tuberculosis treatment drugs, 
considerable attention has been paid to construct rapid and sensitive analytical techniques for 
their determination either in pharmaceutical preparation, biological fluids or in their 
respective pure forms. Among these techniques, the most cited are those involving titrimetry, 
fluorimetry, chemiluminescence, high performance liquid chromatography, capillary 
electrophoresis and electroanalytical methods (Jena et al. 2010; Bergamini et al. 2010).   
Electroanalytical techniques are of particular advantage because of their simplicity, 
low-cost, good sensitivity, precision and rapidity of real time detection. Literature suggests 
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that there a few biosensors available for the analytical detection of the TB drugs 
pyrazinamide, ethambutol and rifampicin. An example is a crayfish walking leg neuronal 
biosensor which was constructed by Leech and Rechnitz, 1993 for the selective determination 
of pyrazinamide and selected anesthetics. 
In a study by Lomillo et al. 2003, a rifampicin biosensor was developed on platinum 
electrode using pyrrole and horseradish peroxidise (HRP) in the presence of LiO4 at constant 
H2O2 concentration. This biosensor was applied to the determination of rifampicin in 
pharmaceutical preparations and biological samples. A study by Girousi et al. 2004 also 
reports a rifampicin biosensor. A DNA modified carbon paste electrode was applied in the 
study of the interaction of rifampicin and DNA in solution and at the electrode surface. A β-
cyclodextrin (β-CD)-based sensor was also developed a simple and sensitive determination of 
rifampicin.  β-CD was immobilized onto a Pt electrode by means of pyrrol 
electropolymerization. RIF was also deposited on the surface of the modified electrode 
through complex formations and quantified amperometrically (Lomillo et al. 2005). 
  Interestingly enough, particular interest has been placed on isoniazid allowing it to be 
the most, extensively studied drug among all the other TB drugs. This is due to the fact that in 
most cases isoniazid can be quantified without the use of any special reagents (Jena et al, 
2010). Ghomeim et al. 2003 explored this phenomenon where he studied the polarographic 
reduction of isoniazid using square wave adsorptive cathodic stripping method where two 
irreversible cathodic waves were observed at two different solutions. This interaction 
suggested the possibility of applying this method for the determination of isoniazid in 
pharmaceutical formulations and human body fluids. In a study carried out by Hamman et al. 
2004, the electrochemical oxidation of isoniazid by cyclic and square wave voltammetry was 
investigated at a carbon paste electrode. One irreversible anodic peak was observed which 
was attributed to the oxidation of the amide group of isoniazid. Co-workers M.S.M. Quintino 
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and L. Agnes, 2006, presented a direct determination of isoniazid based on the 
electrochemical oxidation of the substrate at a glassy carbon electrode in an alkaline medium 
using a batch injection analysis procedure. 
A major concern with electrochemical techniques is the high overpotential required 
for the oxidation of isoniazid associated with unmodified electrodes. Traditionally, mediator 
and polymer based electrodes have been used to decrease the over-potential; however the 
lack of long-term stability is one of the disadvantages associated with mediator modified 
electrodes. The use of metal nanoparticles on electrode surfaces for the oxidation of isoniazid 
have also been explored however, they require high over-potentials as large as 1 V and 
voltammetric responses are not well-defined (Jena et al. 2010). To curb this problem, 
scientists have developed techniques capable of manipulating nanomaterials and biopolymers 
to allow for better oxidation processes and the attachment of biological components 
(Crespilho et al. 2009).   
A nafion-ordered mesoporous carbon modified electrode with a low over-potential for 
the electrochemical oxidation of isoniazid was successfully developed by Yan et al. 2011. 
The method suggested the modified electrode to be a potential candidate for a stable and 
efficient electrochemical sensor for the determination of isonaizid in tablets. A high 
sensitivity of 3.1 A/µM, a low detection limit of 8.4 x 10-8 µM and a wide linear range was 
provided by the biosensor. Yang et al. 2008 successfully demonstrated a poly (amidosulfonic 
acid) modified glassy carbon electrode for the determination of isoniazid in pharmaceuticals. 
The modified electrode showed excellent electrocatalytic effect of injection and tablet 
isoniazid. The proposed procedure showed that the good properties associated with modified 
electrodes such as easy of fabrication, reproducibility, stability and high sensitivity are 
promising for the measurement of isoniazid in vivo and in vitro.  
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Composites of conducting polymers and inorganic nanoparticles in particular often 
exhibit improved physical and chemical properties over their single-component counterparts, 
and hence their use is highly recommended (Huang et al. 2009; Nabid et al. 2008). In 
electrochemical devices where preservation of biological activity at these polymer/metal 
interfaces is priority towards the efficient electrode design, the charge transfer between the 
electrode and enzyme is usually fast and reversible (Liu et al. 2009; Mu et al. 2009; 
Cresphilho et al. 2009; Wang et al. 2006). This makes the concept of modified electrodes 
very popular in the electroanalytical area as there has been a gradual improvement in 
sensitivity, selectivity and reactivity of electrode reactions in many applications (Yan et al. 
2011). 
 For the first time, this study reports the use of polymer/metal enzyme biosensor for 
the analytical determination of the TB drugs; ethambutol, isoniazid, pyrazinamide and 
rifampicin. 
 
2.8 Electrochemical Techniques: 
Electrochemistry is the study of chemical and physical events as a result of electrons 
through oxidation and reduction reactions. Not only is electrochemistry a cheap and efficient 
way of dealing with some of the most common extant pollutants, it is also showing itself to 
be a greener alternative to several other forms of cleanup now available. Advantages 
associated with using electrochemistry include versatility, energy efficiency, safety, 
selectivity, environmental compatibility, cost effectiveness and amenability to automation. 
Although there is a tremendous interest in using electrochemistry to develop novel and 
healthier ways of manufacturing and using chemical products, there is a broader need to 
address pollution, waste and deteriorating health issues produced by non-green processes of 
the past. Because electrochemistry can generate charged species; whether through oxidation 
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or reduction at will, and can deal with solid, liquid, or gaseous pollutants, it only takes a 
scientists imagination to develop new methods of use (Lesney et al. 2002). 
Electrochemical techniques are among the most widely used current applications in 
waste treatment, environmental protection and medical diagnostics devices. The following 
section describes a few commonly used electrochemical techniques. 
 
2.9.1 Sweep Techniques: 
Potential sweep techniques such as cyclic voltammetry (CV) have been applied to an 
increasing range of systems over the past couple of decades. The mathematical descriptions 
of these techniques have been sufficiently developed to enable kinetic parameters to be 
determined for variety of reaction and mechanisms. This technique indicates the potentials at 
which processes occur while from the sweep rate dependence, the involvements of coupled 
homogeneous reactions are identified and complications of absorption are detected. Because 
of these capabilities, CV is nearly always the technique of choice when studying a system for 
the first time (Greef et al. 1990; Monk et al. 2002). 
Voltammetry is a microanalysis technique analyzing only small proportions of a given 
solution at solid working electrodes. In Linear Sweep Voltammetry (LSV); which is the 
simplest of these techniques, the potential is swept from an initial potential E1, to a final 
potential E2 at a known scan rate before halting the potential. Figure 2.15 
(http://www.cartage.org.lb/en/themes/sciences/Chemistry/Electrochemis/Electrochemical/Cy
clicVoltammetry/CyclicVoltammetry.htm) shows a linear sweep voltammogram for the 
reduction of a solution phase analyte illustrated as a function of scan rate (Greef et al. 1990; 
Monk et al. 2002). 
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Figure 2.15: Linear sweep voltammogram for the reduction O + ne- → R, at a solid 
electrode, shown as a function of the scan rate 
(http://www.cartage.org.lb/en/themes/sciences/Chemistry/Electrochemis/Electrochemical/Cy
clicVoltammetry/CyclicVoltammetry.htm) 
 
A more useful technique is CV where the potential is similarly swept from initial 
potential E1, however at the end of the linear sweep, the potential scan is reversed rather than 
terminated. The potential sweep may be reversed again, halted or continued further to another 
value, E3. In an experiment where a reverse in the potential occur, then the potential at which 
the reverse occurs is known as the switch potential (Eλ). The scan rate between E1 and Eλ is 
the same as that between Eλ and E1 while the values of the scan rate νforward and νreverse are 
always written as positive values.  
When studying a system for the first time using CV, it is common to start by carrying 
out quantitative experiments so as to get a feel for the system before proceeding semi-
quantitative and finally quantitative ones. In a study voltammograms are recorded over a 
wide range of sweep rates and various values of potential; as seen in Figure 2.16 
(http://www.thefullwiki.org/Cyclic_voltammetry). Commonly there are several peaks of 
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similar shape on either sides of the voltammogram, however if fully reversible, their 
magnitudes can be identified. These peaks indicate either oxidation or reduction taking place  
at the forward or reverse scan. Just as other forms of voltammetry, the magnitude of the 
current (I) is proportional to the concentration and this parameter is usually the most 
commonly observed. 
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Figure 2.16: Schematic cyclic voltammogram for the reduction of an analyte at a solid 
electrode (http://www.thefullwiki.org/Cyclic_voltammetry). 
 
 
2.9.2 Pulse Voltammetry: 
Pulse voltammetric techniques have been developed largely to provide enhanced 
sensitivity in analytical application. Pulse methods were developed in the 1950s to improve 
the sensitivity of polarographic measurements made by pharmaceutical companies.  Presently 
two techniques dominate the analytical field; Differential and Normal Pulse Voltammetry. 
Pulse techniques are based on rate decay differences of the charging and the faradaic currents 
following a potential step (or "pulse"). The rate of decay of the charging current is 
considerably faster than the decay of the faradaic current (Greef et al. 1990; Monk et al. 
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2002). What happens is that the charging current decays exponentially, while the faradaic 
current (usually for a diffusion-controlled current) decays as a function of 1/(time)½. At a 
time of 5RuCdl after the potential step, the charging current is negligible. RuCdl is known as 
the time constant for the electrochemical cell, and it ranges from µs to ms.  After this time, 
the measured current consists solely of the faradaic current; that is, measuring the current at 
the end of a potential pulse allows discrimination between the faradaic and charging currents 
(Greef et al. 1990; Monk et al. 2002).  
 The important parameters for pulse techniques are as follows:  
 The height of the potential pulse is known as the pulse amplitude which may or may 
not be constant depending upon the technique in question.  
 The duration of the potential pulse is also known as the pulse width.  
 The sample period is the time at the end of the pulse during which the current is 
measured.  
 The pulse period or drop time must also be specified depending on the pulse 
technique used. This parameter defines the time required for one potential cycle, and 
is particularly significant for pulse voltammetry.  
Differential Pulse Voltammetry (DPV); Figure 2.17 
(http://www.basinc.com/mans/EC_epsilon/Techniques/Pulse/pulse.html) can be considered as 
a derivative of linear sweep LSV with a series of regular potential pulses superimposed on 
the potential sweep or stair steps. The current is measured immediately before every change 
in the potential, while the current difference is plotted as a function of potential (Greef et al. 
1990; Monk et al. 2002). 
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Figure 2.17: Potential wave form for Normal and Differential Pulse Voltammetry 
(http://www.basinc.com/mans/EC_epsilon/Techniques/Pulse/pulse.html) 
 
On the other hand, in Normal Pulse Voltammetry (NPV) the current resulting from a 
series of ever larger potential pulses is compared with the current at a constant baseline 
potential and is chosen to be sufficiently anodic for currents to be zero (Greef et al. 1990; 
Monk et al. 2002). 
 
 
2.9.3 Square wave voltammetry (SWV): 
Just like DPV, Square Wave voltammetry (SWV) is a derivative of linear sweep 
voltammetry. As mentioned before LSV involves the measurement of the current at a 
working electrode while the potential between the working electrode and a reference 
electrode is swept linearly with time. In SWV, a potential waveform is applied to the working 
electrode while pairs of current are measured for each wave cycle.  The oxidation or 
reduction of involved species is observed as peaks in these current signals at potentials where 
the species began to be oxidized or reduced (Chang et al. 2010; Shumyantseva et al. 2005). A 
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SWV votammogram illustrates the difference between these two currents as a function of the 
applied potential as illustrated in Figure 2.18 
(http://www.basinc.com/mans/EC_epsilon/Techniques/Pulse/pulse.html) 
 
 
Figure 2.18: Potential wave form for Square Wave Voltammetry 
(http://www.basinc.com/mans/EC_epsilon/Techniques/Pulse/pulse.html) 
 
 
2.9.4 Electrochemical Impedance Spectroscopy (EIS): 
Electrochemical impedance spectroscopy (EIS) has been part of the electrochemistry 
community for more than a century and is one of the most effective techniques for studying 
the properties at the electrode/electrolyte interface. In an electrochemical system the 
electrode/electrolyte interface is fully characterized when impedance measurements have 
been made in a whole range of frequencies. Unfortunately, to make such measurements takes 
relatively long, somewhere between about 30 min and a few hours, depending on the 
frequency range and the stability of the electrochemical system because the frequency needs 
to be scanned for the measurements. Often by the time the impedance measurements are 
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made the electrochemical system has been changed completely in the full frequency range, 
particularly at a given potential. Therefore in EIS, the system under study is exposed to a 
sinusoidal voltage of small amplitudes (5 - 10 mV) with variable frequency (0.1 Hz - 100 
kHz), and the resulting change in impedance (Z) is measured. The imaginary impedance (ZIm) 
and the real impedance (ZRe) are recorded as a function of the applied frequency with the 
result that the Nyquist plots (ZIm vs ZRe) is fitted to simple electrical equivalent circuits 
(EECs). By fitting EECs, important information of the interface such as solution resistance 
(Rs), electron transfer resistance (Rct), Warburg element (Rw) and double layer capacitance 
(Cdl), are measured (Chang et al. 2010; Shumyantseva et al. 2005).  
 No matter how well the measurement is made, the current flowing at an 
electrode/electrolyte interface always contains nonfaradaic components. Electrons are 
tranfered across the interface as illustrated in Figure 2.19 (Chang et al. 2010) with the charge 
transfer resulting in both faradiac and nonfaradaic components. The faradaic component 
arises from the electron transfer through a reaction across the interface by overcoming an 
appropriate activation barrier, also known as the polarization resistance (Rp), along with (Rct) 
while the nonfaradaic currents results from charging the double layer capacitor (Cd) (Siddiqui 
et al. 2010).  
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Figure 2.19: An electrified interface in which the electrode is negatively charged and where 
counter anions are aligned along the surface. Below that are the electrical circuit 
corresponding to each interface component (Siddiqui et al. 2010) 
 
 
Typically, in electrochemical systems three types of Nyquist plots are observed:  
(1) A straight line, which illustrates a diffusion-limited process with facile electron transfer; 
(2) A semicircle that is accompanied by a straight line at low frequencies of the spectrum; 
and  
(3) A semicircle, which represents an electron transfer-limited process with its diameter (x-
axis) corresponding to the Rct at the electrode (Yoo et al. 2003).  
 
For biosensor applications, a semicircle spectrum with negligible noise from an 
unmodified electrode is preferable as it provides higher sensitivity. This was clearly 
demonstrated by the work of Sun et al. 1998 where a single-stranded deoxyribonucleic acid 
was immobilized on gold electrode with self-assembled aminoethanethiol monolayer for 
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DNA electrochemical sensor applications. The success of the DNA electrochemical sensor 
was based on hybridization with a complementary DNA and the intercalation of daunomycin 
as a hybridization indicator to form a dsDNA: daunomycin system on the gold electrode 
surface. The DNA sensor was shown to be highly stable and sensitive. 
 
2.10 Other Characterization Techniques: 
For this study techniques such Ultraviolet Visible Spectroscopy (UV-vis), Transmission 
Electron Microscopy (TEM), Atomic Force Microscopy (AFM) and Scanning Electron 
Microscopy (SEM) were used to study the morphology of PVP-AgNP, PANSA/PVP-AgNPs 
nanocomposite, PANSA film and PANSA/PVP-AgNP/CYP2E1 nanobiosensor. This section 
describes the principles behind some of these techniques as well their applications. 
 
2.10.1 Ultraviolet Visible Spectroscopy (UV-vis): 
Ultraviolet-visible spectroscopy sometimes known as ultraviolet-visible 
spectrophotometry refers to absorption spectroscopy or reflectance spectroscopy in the 
ultraviolet-visible region of the spectrum. This ultimately means that light in the visible and 
adjacent (near-UV and near-infrared ) ranges is used resulting in absorption or reflectance of 
any chemical involved. Molecules undergo electronic transitions in this region of the 
spectrum. UV-vis is a complementary technique to fluorescence spectroscopy, since 
fluorescence deals with transitions from the excited state to the ground state, while absorption 
measures transitions from the ground state to the excited state. UV/Vis spectroscopy is 
applied in analytical chemistry for the quantitative determination of different analytes, such 
as highly conjugated organic compounds, transition metal ions and biological 
macromolecules with analyses usually carried out in solutions (Skoog et al. 1992; Jenkel et 
al. 1994). 
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 The solutions of transition metal ions may be coloured so as to absorb visible light 
because d electrons within the metal atoms can be excited from one electronic state to 
another. The presence of other species such as ligands or certain anion, are capable of 
affecting the colour of metal ion solutions. 
 Highly conjugated organic compounds absorb light in the UV or visible regions of the 
electromagnetic spectrum. The solvents for these determinations are often water for 
water soluble compounds, or ethanol for organic-soluble compounds. The absorption 
spectrum of organic compounds may be highly affected by solvent polarity and pH.  
 While charge transfer complexes also give rise to colours, the colours are often too 
intense to be used for quantitative measurement (Skoog et al. 1992; Kenkel et al. 
1994). Figure 2.20 illustrates how a UV-vis spectrometer functions. 
(http://pulse.yahoo.com/_6HVLWLKIRHDJDG2Q2QSUFAH7RU/blog/articles/32113
1) 
 
Figure 2.20: Illustration of how a UV-vis spectrometer functions 
(http://pulse.yahoo.com/_6HVLWLKIRHDJDG2Q2QSUFAH7RU/blog/articles/321131) 
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Our study successfully utilized UV-vis to characterize PVP-AgNPs, PANSA/PVP-
AgNPs nanocomposite, PANSA and PANSA/PVP-AgNP/CYP2E1 dissolved respectively in 
phosphate buffer.  The resultant spectra illustrated absorbance peaks for each compound with 
a strong soret band for CYP2E1 suggesting successful attachment of the enzyme on the 
/PVP-AgNPs nanocomposite. 
In a study by Arshi et al. 2011; silver/polyvinylpyrrolidone synthesized respectively 
in water and ethylene glycol were compared using UV-vis resulting in plasmon absorption 
peaks at 435 and 445 nm respectively. Similar results were observed in our study for PVP-
AgNPs synthesized in the presence of methanol.  In another study by Hagedoorn et al. 2002 
ferrous enzymes studied using UV-vis showed strong soret bands at approximately 409 nm. 
This value is characteristic of most heme enzymes such as CYP2E1. Our study revealed a 
strong soret band at 410 nm indicating the oxidation of CYP2E1. 
 
2.10.2 Transmission Electron Microscopy (TEM): 
Transmission electron microscopy (TEM) is a microscopic technique operational 
when a beam of electrons is transmitted through an ultra thin sample material, interacting 
with the sample as it passes through. The electrons behave as a light source with much lower 
wavelengths making it possible to obtain resolutions a thousand times better than using light 
microscopes. Depending on the density of the material present, some of the electrons are 
scattered and disappear from the beam, while at the bottom of the microscope the unscattered 
electrons hit a fluorescent screen, which gives rise to a "shadow image" of the sample in 
question with its different parts displayed in varied darkness according to their respective 
densities. The interaction of the electrons with  the sample create an image which is 
magnified and focused onto an imaging device, such as a layer of photographic film, a 
fluorescent screen or to be detected by a sensor such as a CCD camera (is a device for the 
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movement of electrical charge, usually from within the device to an area where the charge 
can be manipulated (Skoog et al. 1992; Jenkel et al. 1994). 
As a result of this, instrument users are able to exam fine details, even as small as a 
single column of atoms, which is tens of thousands times smaller than the smallest resolvable 
object in a light microscope. TEM is one of the important major analysis methods in physical 
and biological sciences finding application in virology, material science, and pollution, 
cancer and semiconductor research (Skoog et al. 1992; Jenkel et al. 1994). The orientation of 
the instrument and its way of function is depicted below, in Figure 2.21 (A) 
(http://edu.glogster.com/glog.php?glog_id=17548229&scale=54&isprofile=true) (B) 
(http://www.ifn.upr.edu/people/8-carlos-cabrera-martinez).  
 
 
Figure 2.21: (A) Schematic presentation of transmission electron microscope (TEM) 
(http://edu.glogster.com/glog.php?glog_id=17548229&scale=54&isprofile=true) and (B) An 
example of a TEM image (http://www.ifn.upr.edu/people/8-carlos-cabrera-martinez) 
 
 
A B
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In this study TEM was used to study the morphology, shape, distribution and size of 
PVP-AgNP, PANSA/PVP-AgNPs nanocomposite, PANSA film and PANSA/PVP-
AgNP/CYP2E1 nanosensor. In a similar study carried out by Reddy et al. 2008; TEM was 
used to characterize poly (o-toluidine) - silver nanocomposite synthesized by chemically 
oxidizing o-toluidine in the presence of negatively charged silver nanocolloids. Just like our 
study, the TEM images in this study revealed that silver nanoparticles of approximately 20 
nm sizes were dispersed in the poly (o-toluidine) matrix. Most importantly, this 
nanocomposite exhibited a higher electrical conductivity than that of the poly (o-toluidine). 
 
2.10.4 Atomic Force Microscopy (AFM): 
The Atomic Force Microscope is an instrument that can analyze and characterize 
samples at the microscope level. Surface characteristics can be studied with very accurate 
resolution ranging from 100 μm to less than 1μm. Operating AFM involves an extremely fine 
sharp tip coming in contact or in very close proximity to the sample of interest. Usually this 
tip is a couple of microns long and often less than 100Å in diameter and is located at the free 
end of a cantilever (which one may think of as a spring) that is 100 to 200μm long. Different 
forces either attract or repeal the tip allowing the sample to be scanned beneath the tip. 
Imaging softwares record and process these deflections producing a topographical 
representation of the sample that was imaged as illustrated in Figure 2.22 
(http://asdlib.org/onlineArticles/ecourseware/Bullen/SPMModule_BasicTheoryAFM.pdf). 
One may also be able to know other features about the sample rather than just a view of its 
surface using different imaging modes for different types of analysis (Binnig et al.1986). 
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Figure 2.22: (A) An illustration of AFM probing a sample surface with a sharp tip 
(B) An example of an AFM image showing sharp, randomly-oriented peaks 
(http://asdlib.org/onlineArticles/ecourseware/Bullen/SPMModule_BasicTheoryAFM.pdf) 
 
AFM provides a number of advantages over conventional microscopy techniques.  
AFMs make measurements in three dimensions, x, y, and z, producing three-dimensional 
images of a sample surface. With good samples resolution in the x-y plane ranges from 0.1 to 
1.0 nm and in the z direction is 0.01 nm. Neither a vacuum environment nor any special 
preparations are required for AFM since an ambient or liquid environment is always suitable. 
With these advantages AFM has significantly impacted the fields of chemistry, materials 
science, physics and biology (Blanchard et al. 1996; Binnig et al.1986). 
 Work by Crespilho et al. 2009 give an account of using AFM towards the 
construction of a urea biosensor. The surface of the biosensor displayed a globular 
morphology and large roughness than the electrode without enzyme. A similar profile of 
events was also observed for the study in question. 
 
The following chapter gives detailed experimental methods involved in this study. 
 
A B 
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CHAPTER 3 
 
 
 
 
Experimental Method 
 
 
 
 
Summary 
 
 
 
 
This section provides detailed experimental methods involved in this study. Outlined here are 
the procedures involved in the synthesis of poly (8-anilino-1-naphthalene sulphonic acid) and 
silver nanopartcles, their characterization and their application in this study. Also included 
in this section is the enzyme immobilization technique used towards the development of the 
nanobiosensors as well as the description of the characterization methods employed for the 
success of the nanobiosensors. Finally, the methods used towards the detection of 
Tuberculosis treatment drugs by the nanobiosensors are also described. Techniques 
employed in this study were steady state amperometry, CV, DPV, SWV, EIS, TEM, AFM and 
SEM. 
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3.1 Reagents: 
Analytical grade methanol, silver nitrate (AgNO3) and polyvinylpyrrolidone (PVP) 
were purchased from Sigma-Aldrich and used for the synthesis of the silver nanoparticles. 
Electropolymerization was achieved by the use of 8-anilino-1-naphthalene sulfonic acid, 
ammonium hydrate salt 97% (ANSA) (Sigma-Aldrich) in the polymerization medium, 
sulphuric acid (Fluka). The nanobiosensors were prepared using, Cytochrome P450-2E1 
Isozyme (CYP 2E1) or 4-nitrophenol 2-hydroxylase; EC 1.14.14.1 (Sigma-Aldrich).  One 
unit of CYP2E1 is said to be the required amount to convert 1 picomole of p-nitrophenol to 
4-nitrocatechol per minute at a pH of 7.4 and at temperature of 37 ºC. The enzyme 
modification reagents, such as; disuccinimidyl octanedioate [suberic acid bis (N-
hydroxysuccimide ester) (SA-NHS)] and ethylene glycol bis(succinimidyl succinate) 
[ethylene glycol bis(succinic acid N-hydroxysuccinimide ester) (EG-NHS)] were products of 
Sigma-Aldrich South Africa and stored at  -4 ºC under anhydrous conditions when not in use. 
The reaction medium, pH 7.4, 0.1 M phosphate buffer was prepared from 
dihydrogenorthophosphate dehydrate, anhydrous and disodium hydrogenorthophosphate all 
purchased from Sigma-Aldrich. The nanobiosensor substrates, ethambutol [(2S, 2′S)-2, 2′-
(ethane-1, 2-diyldiimino) dibutan-1-ol) - C10H20N2O2], isoniazid [4-pyridinecarboxylic acid -
C6H7N3O], rifampicin [3 - [ [(4-methyl-1 -piperazinyl) imino] -methyl] -rifamycin; or 
5,6,9,17,19,21 -hexahydroxy-23methoxy-2,4,12,16,18,20,22 heptamethyl-8-[N-(4-methyl-l-
piperazinyl)formimidoyl]-2,7-(epoxypentadeca [1,1 l,13] trienimino)naphtha [2,l-b] furan-l, 1 
l (2H)-dione 21-acetate - C43H5gN4Oi2] and pyrazinamide [pyrazinecarboxamide - C5H5N3O] 
capsules were supplied by the University of Western Cape Health Centre courtesy of 
Kaaselsvlei Clinic in Bellville South, Cape Town. All these drugs were used without further 
purification dissolved in pH 7.4, 0.1 M phosphate buffer solution.  De-ionized ultra-purified 
water used throughout these experiments was prepared with a Milli-Q water purification 
	
	
 
101	
 
system. Analytical grade argon obtained from Afrox, SA was used for degassing the cell 
solutions and all the solutions were kept refrigerated at -4 ºC when not in used. 
 
3.2 Apparatus and Measurement: 
All electrochemical experiments were carried out using a BAS 100W integrated 
automated electrochemical workstation BioAnalytical Systems (BAS, West Lafayette, IN) 
controlled by a computer and a conventional three-electrode system with a 0.0201 cm2 gold 
(Au) disk or screen printed gold electrode (SPAuE) as the working electrode, a platinum (Pt) 
wire auxillary electrode and Ag/AgCl reference electrode with a 3 M NaCl salt bridge 
solution, all purchased from (BAS, West Lafayette, IN). All the results obtained for the 
PANSA, PANSA/PVP-AgNPs and [PANSA/PVP-AgNPs/CYP2E1; PANSA/PVP-
AgNPs/SA-CYP2E1 or PANSA/PVP-AgNPs/EG-CYP2E1] modified electrodes using cyclic 
(CV), differential pulse (DPV) square wave (SWV) voltammograms and steady state 
amperometry (constant potential amperometry) were recorded with a computer interfaced to 
the electrochemical workstation.  Alumina micropolish (1.0, 0.3 and 0.05 mm alumina 
slurries) and polishing pads (Buehler, IL, USA) were used for polishing the electrode. 
Electrochemical impedance spectroscopy (EIS) of the PANSA, PANSA/PVP-AgNPs 
and [PANSA/PVP-AgNPS/CYP2E1; PANSA/PVP-AgNPs/SA-CYP2E1 or PANSA/PVP-
AgNPs/EG-CYP2E1] modified electrodes was measured with a Voltalab instrument 
(Radiometer Analytical, France). Impedance measurements were performed in the frequency 
range from 105 to 50−1 Hz at 0 V, which was found to have the least impedance after potential 
step from 0 to 800 mV with AC amplitude of 5 mV. Cyclic voltammetry (CV) 
characterization of the PANSA, PANSA/PVP-AgNP and [PANSA/PVP-AgNPS/CYP2E1; 
PANSA/PVP-AgNPS/SA-CYP2E1 or PANSA/PVP-AgNPS/EG-CYP2E1] modified 
electrodes were carried out at a potential window of -300 mV (initial potential, Ei) to +1100 
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mV (switch potential, Eλ), sensitivity of 10 μA/V and at different scan rates (10 – 200 mV/s). 
The modified electrodes were also investigated using Differential Pulse Voltammetry (DPV). 
The DPV experimental conditions were: potential window of +1000 mV to -300 mV, 
sensitivity of 10 A/V, pulse amplitude of 50 mV, current sampling width of 17 msec, pulse 
width of 50 msec and at different scan rates (10 – 200 mV/s). Characterization of the 
modified electrodes was also carried out using Square Wave voltammetry (SWV). SWV 
experimental conditions were: potential window of +1100 mV to -300 mV, sensitivity of 10 
A/V, SWV amplitude of 25 mV, Step potential of 4 mV and at different SWV frequencies 
(10 – 200 Hz). Ultraviolet-Visible (UV-Vis) spectra of PANSA, PANSA/PVP-AgNP and 
[PANSA/PVP-AgNP/CYP2E1; PANSA/PVP-AgNP/SA-CYP2E1 or PANSA/PVP-
AgNP/EG-CYP2E1] were recorded on a Nicolet Evolution 100 (Thermo Electron 
Cooperation, UK). After electrodeposition of PANSA, PANSA/PVP-AgNPs and 
immobilization of CYP2E1, SA-CYP2E1 and EG-CYP2E1 onto the PANSA/PVP-AgNP 
electrode, the samples were immobilized on ITO and their UV-Vis spectra recorded. Free 
CYP2E1 and SA-CYP2E1 and EG-CYP2E1 samples were dissolved in buffer and their 
spectra recorded. 
The modified SPAuE were used for scanning electron microscopy (SEM) studies 
while the modified Au electrodes were used for the detection of TB drugs, using the same 
reference electrode and counter electrode. SEM images were taken with a Hitachi S3000N 
scanning electron microscope at an acceleration voltage of 20 kV at various magnifications. 
Gold sputtering of the SEM samples was done using a SC7640 Auto/ Manual high resolution 
super coater (Quorum Technology Ltd., England) at a voltage of 2 kV and plasma current of 
25 mA for one minute. Morphological studies of PANSA, PANSA/PVP-AgNPs and 
[PANSA/PVP-AgNPs/CYP2E1; PANSA/PVP-AgNPs/SA-CYP2E1 or PANSA/PVP-
AgNPs/EG-CYP2E1] were carried out using transmission electron microscopy (TEM). After 
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electrodeposition of PANSA, PANSA/PVP-AgNPs and immobilization of CYP2E1, SA-
CYP2E1 and EG-CYP2E1 onto the PANSA/PVP-AgNPs electrode, the samples were all 
dissolved in ethanol. A drop of each sample was placed over carbon copper grids and allowed 
to dry prior to measurements. TEM images were acquired on Philips Technai-FE 12 TEM 
instrument operated at an accelerating voltage of 120 kV. The instrument was equipped with 
an Energy dispersive X-ray (EDAX) detector (Oxford LINK-ISIS 300) for elemental 
composition analysis and the EDAX spectra were measured at an accelerating voltage of 10 
kV. Further confirmation studies to study the film morphology and thickness were 
investigated with Multimode atomic force microscope controlled by a Digital Instruments 
Nanoscope III controller (Vee Instruments, USA). 
 
3.3 Synthesis of Silver Nanoparticles (PVP-AgNPs): 
Silver nanoparticles were prepared by a soft solution technique starting with a 
solution of AgNO3 and an aqueous solution of PVP. In a typical synthesis; 30 mg AgNO3 
was dissolved in 140 mL of methanol and brought to a boil. A second solution was prepared 
by dissolving 200 mg PVP in hot deionized water and 10 mL of this second solution was then 
added dropwise to the AgNO3 solution under vigorous stirring. The colour of the mixture 
became pale red several minutes after methanol began to boil. Addition of the PVP solution 
caused the mixture to become increasingly darker until a red-orange colour was reached 
signifying completion of the silver nanoparticles synthesis. 20 μL of AgNP were drop casted 
onto Au electrode and allowed to dry for 3hrs after which the Au/PVP-Ag electrode was 
characterized at various scan rates using CV, DPV and SWV at +1100 mV to -300 mV at 
various scan rates in pH 7.4, 0.1 M phosphate buffer. 
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3.4 Synthesis of Poly (8-anilino-1-naphthalene sulphonic acid) PANSA: 
The electropolymerization of ANSA was performed in a cell solution containing 0.01 
M of the ANSA monomer in 20 mL 0.5 M H2SO4 solution degassed with argon for 15 min. 
The potential was cycled from -300 mV to +1100 mV, at a potential scan rate of 50 mV/s. An 
argon blanket was maintained on top of the cell solution during the polymerization process 
which was stopped after 5 voltammetric cycle.  Poly (8-anilino-1-naphthalene sufonic acid) 
PANSA was conditioned for biosensor application by rinsing out superficial acid and un-
reacted monomer and then incubated in buffer. This electrode will be referred to as 
Au/PANSA electrode. To develop the Au/PANSA/PVP-AgNP electrode, 20 μL of PVP 
AgNP were drop casted onto the Au/PANSA and allowed to dry at room temperature for 1 h 
after which it was characterized using CV, DPV and SWV at +1100 to -300 mV at various 
scan rates in pH 7.4, 0.1 M  phosphate buffer. 
 
3.5 Preparation of TB Drugs Nanobiosensors: 
3.5.1 Modification of CYP2E1:  
SA-NHS and EG-NHS were used in the modification of CYP2E1. 15 mg of SA-NHS 
or 18 mg of EG-NHS was dissolved in 250 µL of 5% DMSO. A 10 µL sample of the solution 
was reacted with 4 µL of CYP2E1 dissolved in 100 µL of, pH 7.4, 0.1 M phosphate buffer. 
The reaction was allowed to proceed for 60 min in room temperature and terminated by 
adding 100 µL of 0.1 M cold Tris –HCl buffer pH 7.0. The modified CYP2E1 solutions were 
stored in the refrigerator at 4 ºC and used within 3 days of preparation.  
 
3.5.2 Preparation of Au/PANSA/PVP-AgNP/CYP2E1 Nanobiosensors: 
To develop the Au/PANSA/PVP-AgNP electrode, 20 μL of PVP-AgNP were drop 
casted onto the Au/PANSA and allowed to dry at room temperature for 1 h. A freshly 
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prepared PANSA/PVP-AgNPs electrode was reduced at a constant potential of -600 mV 
under an argon blanket in a 5 mL solution of buffer until a steady state current was attained 
which took 5 min to attain.  20 μL of CYP2E1, SA-CYP2E1 or EG-CYP2E1 were added 
respectively to a 5 mL solution of buffer, and the Au/ PANSA/PVP-AgNPs nanocomposite 
was oxidized at a potential of +700 mV for 10 min during which the PANSA/PVP-AgNPs 
nanocomposite was electrostatically attached with CYP2E1, A-CYP2E1 or EG-CYP2E1. The 
resultant PANSA/PVP-AgNPs/CYP2E1; PANSA/PVP-AgNPs/SA-CYP2E1 or 
PANSA/PVP-AgNPs/EG-CYP 2E1/nanobiosensors were rinsed in buffer and stored 
refrigerated at -4 ºC when not in use. 
 
3.5.3 Application of PANSA/PVP-AgNP/CYP2E1 Modified Gold Electrodes as 
Amperometric TB Drug Nanobiosensors: 
 
All experiments were carried out at room temperature. All modified electrodes;  
Au/PANSA, Au/PANSA/PVP-AgNPs and [Au/PANSA/PVP-AgNPs/CYP2E1; 
Au/PANSA/PVP-AgNPs/SA-CYP 2E1 or Au/PANSA/PVP-AgNPs/EG-CYP 2E1] were 
tested for the amperometric sensing of the TB drugs namely; Isonaizid (INH), ethambutol 
(ETH), rifampicin (RIF) and pyrazinamide (PYR). Standard solutions were prepared daily by 
dissolving a capsule of each drug type in 50 mL phosphate buffer resulting in final 
concentrations of INH = 0.015 M ; ETH = 0.08 M ETH; RIF = 0.015 M and PYR = 0.08 M.  
Different concentrations of each drug were varied independently in 20 mL of phosphate 
buffer solutions. INH and ETH were monitored using the Au/PANSA/PVP-AgNPs/CYP2E1 
nanobiosensor; RIF was monitored using Au/PANSA/PVP-AgNPs/EG-CYP2E1 
nanobiosensor and PYR was monitored using Au/PANSA/PVP-AgNPs/SA-CYP2E1 
nanobiosensor. The volumetric determination of these drugs was carried out in 20 mL 
phosphate buffer under the following parameters. 
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CV experiments were carried out at a potential window of +300 mV to -800 mV, 
sensitivity of 10 μA/V and at 20 mV/s at different concentrations of each drugs; and the DPV 
experimental conditions were: potential window of +300 mV to -800 mV, sensitivity of 10 
A/V, pulse amplitude of 50 mV, current sampling width of 17 msec, pulse width of 50 msec 
and at 50 mV/s at different concentrations of each drug; while the SWV experimental 
conditions were: potential window of +300 mV to -800 mV, sensitivity of 10 A/V, SWV 
amplitude of 25 mV, Step potential of 4 mV and at 15 Hz and at different concentrations of 
each drug. Data obtained from these detection experiments were not included as the data was 
not consistent even after several trials of changing the working parameters. Steady state 
amperometric determination of the drugs was carried out at an applied potential of -250 mV 
with stirring maintained at 500rpm in buffer solution as the supporting electrolyte. The 
background current was allowed to reach a steady value before aliquots of standard drug 
solutions were successively added into the supporting electrolyte while steady-state current 
values were recorded as the response.  
 
3.6 Stability, Reproducibility and Interference Studies: 
The stability and reproducibility of the Au/PANSA/PVP-AgNPs/CYP2E1, 
Au/PANSA/PVP-AgNPs/SA-CYP2E1 and Au/PANSA/PVP-AgNPs/EG-CYP2E1 
nanobiosensor was investigated in pH 7.4, 0.1 M phosphate buffer solution for two weeks 
and the modified bioelectrodes were stored at 4 0C when not in use. Ten successive 
measurements of either 2 µM ETH, 2 µM INH, 2 µM RIF or 2 µM RIF was carried out 
independently for two weeks. For the interference studies, K+, Mg2+, Na+, NH4+, Cl-, SO42- 
and NO3- ions were dissolved in distilled water and each was added independently to 2 µM of 
each TB drug solution. The resultant solutions were then analysed without any further pre-
treatment by amperometry at 20 mV.  
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CHAPTER 4 
 
 
Results and Discussion: Part 1 
 
 
Summary 
 
 
This is the first of three chapters outlining and discussing the results obtained from this 
study. This chapter deals specifically with the characterization of poly(8-anilino-1-
napthalene sulphonic acid), silver nanoparticles as well as the PANSA/Silver nanoparticulate 
composite used for the development of the nanobiosensor. Physical and electrochemical 
properties of these materials were interrogated using techniques such as CV, DPV, SWV, 
TEM, SEM and AFM. Therefore, this chapter clearly illustrates the success of using these 
techniques to study these nanomaterials and illustrates their potential towards the 
development of nanobiosensors for the detection of tuberculosis treatment drugs. 
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4.1 Morphology Characterization of PANSA, PVP-AgNPs and PANSA/PVP-AgNPs: 
4.1.1 PVP-AgNPs: 
In this study TEM was utilized to study the fine details of PANSA, PVP-AgNPs and 
PVP-AgNPs/PANSA nanocomposite. Figure 4.1 shows the TEM images of PVP-AgNPs 
dispersed in ethanol. The nanoparticles formed were predominately spherical and 
polydispersed with average diameter of 20 – 50 nm as indicated in Figure 4.1 A. The particle 
size was calculated by using approximately 100 randomly selected individual nanoparticles 
from the TEM micrograph giving a range of values (Arshi et al. 2011). Besides the above 
mentioned characteristics, some of the nanoparticles are seen to lay one above the other. Dark 
nanoparticles in Figure 4.1 B illustrate these under laying nanoparticles and in some areas on 
the image; these silver nanoparticles are clearly visible from beneath.  
 
  
 
A 
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Figure 4.1: TEM images (A) indicating spherical and polydispersed PVP-AgNPs (B) Layer 
by layer orientation of some nanoparticles 
 
The EDAX analysis (Figure 4.2) revealed the elemental composition of the synthesized 
nanoparticles suggesting silver as the predominant element. An optical absorption peak near 
3 keV indicates the presence of metallic nano-sized silver. Other elemental signals were also 
recorded namely; carbon and oxygen and copper. Carbon and oxygen are due to presence of 
PVP in the nanoparticles while copper is a result of the copper grid onto which the 
nanoparticles were immobilization for TEM analysis (Kumar et al. 2011).  
B 
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Figure 4.2: Energy dispersive X-ray spectrum of PVP-AgNPs 
 
These silver nanoparticles are credited with producing the absorbance band at 450 nm, as 
observed in the UV-vis spectrum, Figure 4.3. The broadness of the peak is a further 
indication of the spheroid nature of the nanoparticles. Looking closely at the spectrum, one 
might notice that there is an undeveloped peak at around 410 nm which is due to transverse 
plasmon vibrations in the PVP-AgNPs, whereas the former is due to the excitation of 
longitudinal plasmon vibrations (Sathishkumar et al. 2009). Literature suggests that 
absorption spectra of spherical silver nanoparticles show maximum between 420 nm and 450 
nm with a blue or red shift when silver nanoparticles either diminish or increase. As a result 
of this, the PVP-AgNPs synthesized in this study indicate a plasmon which is red shifted 
(Arshi et al. 2011). 
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Figure 4.3: UV-vis spectrum of silver nanoparticles 
 
The PVP-AgNPs synthesized in this study were almost identical to those produced from sun 
dried leaf powder of Cinnamomum camphora resulted from a reducing agent present in the 
plant (Huang et al. 2007). In a study by Basavaraja et al.2008, spherical and polydispersed 
silver nanoparticles were also synthesized by an extracelluar biosynthesis method using the 
fungus Fusarium semitectum. The results obtained in this study were also in agreement with 
those reported by Mukherjee et al. 2008; where silver nanoparticles were synthesized via a 
green synthesis process involving a non-pathogenic and agriculturally important fungus, T. 
asperellum. 
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4.1.2 PANSA: 
The morphology of PANSA was also studies using TEM, however the structure was 
not clearly observed as seen in Figure 4.4. The polymeric material was observed from the 
image with no information on the orientation of PANSA. SEM was found to be the best 
technique to study PANSA because the distinct structure of the polymeric material was 
observed as seen in Figure 4.7. Therefore, the surface morphology of PANSA 
nanocomposites was observed with SEM. 
 
Figure 4.4: TEM image of PANSA 
 
EDX analyses (Figure 4.5) gave the components of PANSA which are C-O-N-S from low to 
high energy respectively with energy scale of maximum approximately 3 kev. The O atom is 
due to the ITO glass substrate components while the observed S atom is contributed by the 
suphonic substituent on PANSA. The N atom is as a result of the aniline substituent which 
forms part of the repetitive backbone of the polymer. 
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Figure 4.5: Energy dispersive X-ray spectrum of PANSA 
 
Figure 4.6 shows the SEM morphology of PANSA film obtained in a solution containing 
0.01 M ANSA and 0.50 M H2SO4 where regular and uniform PANSA nanotubes are 
observed. Their network structure increased the effective surface area of the electrode. The 
layer-by-layer nanotubes observed for the morphology of PANSA was seen to cover the 
electrode surface allowing the adsorption of both silver nanoparticles and enzymes as 
discussed in the next chapter. PANSA was also evaluated using UV-vis spectroscopy (Figure 
4.7) where two distinct peaks where observed at 265 nm and 370 nm. These peaks are 
attributed to π – π* transition of benzoid rings and are indicative that nanostructed PANSA 
showed the formation or the presence of the stable pernigraniline salt. Because of the self-
limiting nature of PANSA, there are no peaks observed between 600 nm and 800 nm which 
are normally observed in PANI. Depending on their specific location, the presence of these 
peaks is either associated with charge transfer excitons of the quinoid structure or are due to 
the doping level (Iwuoha et al. 2006).  
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Figure 4.6:  SEM image of electropolymerized PANSA 
 
 
 
Figure 4.7: UV-vis spectrum of PANSA 
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4.1.3 PANSA/PVP-AgNPs: 
After drop coating PVP-AgNPs onto PANSA, the resultant nanocomposite was 
evaluated using TEM. Figure 4.8 gives the TEM image of the PANSA/PVP-AgNPs 
nanocomposite. One can find that the PVP-AgNPs with a mean diameter of 20 nm – 50 nm 
are the core of the nanocomposite and the PANSA (as seen by the blob like structure) as the 
shell wrap of the PVP-AgNPs while some PVP-AgNPs are dispersed on the surface of 
PANSA. Agglomerated particles as large as 100 nm were also observed since the 
nanoparticles were deposited after the polymerization of PANSA.  
 
 
Figure 4.8: TEM image of PANSA/PVP-AgNPs nanocomposite 
  
EDX analyses (Figure 4.9) gave the components of PANSA which are C-O-Si-S from low to 
high energy respectively with energy scale of maximum approximately 2.5kev. O-Si is due to 
the ITO glass substrate components while S is contributed by the sulphonic substituent of 
PANSA. On the other hand, the presences of PVP-AgNPs are indicated by an optical 
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absorption peak near 3keV which was also observed for the individual PVP-AgNPs reported 
previously. 
 
Figure 4.9: Energy dispersive X-ray spectrum of PANSA/PVP-AgNPs 
 
The PANSA/PVP-AgNP nanocomposite was also studied using UV-vis. The resultant 
spectrum (Figure 4.10), illustrated two absorbance broad peaks at 425 nm and 535 nm and an 
undeveloped peak at approximately 410 nm. As indicated previously, the peak at 425 nm is 
due to excitation of longitudinal plasmon vibrations of PVP-AgNPs while that at around 410 
nm is due to transverse plasmon vibrations in the PVP-AgNPs (Sathishkumar et al. 2009). 
The peak at 535 nm is as a result of π – π* transition of benzoid rings and that nanostructed 
PANSA indicated the presence of the stable pernigraniline salt. A study by Jing et al. 2007 
involving the synthesis and characterization of Ag/polyaniline core-shell nanocomposites 
also showed a similar behaviour for the nanocomposite.  
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Figure 4.10: UV-vis spectrum of PANSA/PVP-AgNPs 
 
4.1.4 EIS analysis: 
4.1.4.1 Nyquist plot characterization: 
Scheme 4.2 gives the stepwise fabrication procedure of the enzyme electrode. To 
monitor the self assembly process and in some cases, the electrochemical attachments, EIS 
was used to get information between each step. EIS is an effective method that is often used 
for probing the changes of surface-modified electrodes. Figure 4.11 shows curves of each 
modified step presented as Nyquist plot (Z∞im versus Z0re) where significant differences in 
EIS were observed during the assembly process. The total impedance was determined by 
several parameters such as solution resistance Rs; double layer capacitance Cdl; charge 
transfer resistance Rct; and Warburg impedance W; among which Cdl and Rct depend on the 
dielectric and insulating features at the electrode/electrolyte interface. On the other hand the 
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electron transfer kinetics of the redox-probe at the electrode interfaces being greatly affected 
by Rct.  
In this study, EIS measurements were carried out in pH 7.4, 0.1 M phosphate buffer at 
the  potential window +1100 mV to -300 mV where bare Au, Au/PVP-AgNPs, Au/PANSA 
and Au/PVP-AgNP/PANSA where investigated. The change in electron transfer resistance 
arising after each surface modification step was investigated and represented as Nyquist 
diagrams as indicated in Figure 4.11. After the electrodeposition of PANSA on Au electrode, 
the semi-circle increased dramatically (curve a) compared to that of the bare Au electrode 
(curve c) indicating that the layer of PANSA functioned as a barrier making interfacial charge 
transfer more difficult. This semi-circle was found to be much larger than that observed for 
(curve d) Au/PVP-AgNPs indicating that PVP-AgNPs have a much higher conductivity than 
PANSA.  
Drop-coating PVP-AgNPs on the PANSA film resulted in a further decrease in the 
semi-circle (curve b). Since PVP-AgNPs have a much higher conductivity than PANSA, this 
interaction allowed a much easier electron transfer process to occur between the electrode 
surface and the nanocomposite. The nanocomposite indicated to possess increased 
conductivity as opposed to PVP-AgNPs and PANSA individually. Therefore, the smaller the 
impedance as illustrated by the reduced semi-circles, the higher the conductivity. The PVP-
AgNPs nanocomposite was then ready for the immobilization of the CYP2E1 to form the 
nanobiosensor whose impedance was also studied (Yin et al.2010; Arotiba et al.2010; Ding 
et al.2003). 
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Figure 4.11: EIS Nyquist plot of PANSA, PVP-AgNPs and PANSA/PVP-AgNPs modified 
electrodes 
 
4.2.4.2  Bode plot characterization: 
 
Bode plot analysis (Figure 4.12) for the Au/PANSA/PVP-AgNP nanocomposite 
showed a higher conductivity than bare Au electrode with a lower change transfer resistance 
when compared to the Au/PVP-AgNP and Au/PANSA electrodes. This is indicative of a fast 
electron transfer between the Au electrode and the nanocomposite. The direct interaction of 
the electrons with the bare Au electrode resulted in a high Rct value of 89.27 KOhm while 
values for Au/PVP-AgNP (118 KOhm), Au/PANSA (217.6 KOhm) and Au/PANSA/PVP-
AgNP (35.51 KOhm) where observed. These values revealed the hindering ability of PANSA 
and PVP-AgNP on the electrode thus impeding electron transfer. The exchange current value 
obtained for the bare electrode further confirmed its ability to transfer electron fast when 
compared to modified electrodes. The bode plot in Figure 4.12 confirmed this behaviour by a 
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huge increase in impedance after the electrode was modified with either PANSA, PVP-
AgNPs or PVP-AgNPs  with  observable shifts in phase angles for the bare, PANSA, PVP-
AgNPs and PANSA/PVP-AgNPs modified electrodes (Yin et al.2010; Arotiba et al.2010; 
Ding et al.2003). 
 
Figure 4.12: Bode plot of PANSA, PVP-AgNPs and PANSA/PVP-AgNPs modified electrodes 
 
 Table 4.1 gives a list of all the parameters; Rs, Cdl, Rct and Warburg element, Zw, 
resulting from the EIS study. The parameters where used to calculate the time constant using 
equation 4.1 a and 4.1 b (where Time constant = τ) and the exchange current (io) by using 
equation 4.2. Where Cdl = double layer capacitance; τ = time constant; Rct = charge transfer 
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resistance. K et , the homogeneous rate constant was determined by using equation 4.3.  The 
resulted parameters are clearly illustrated in Table 4.2. 
 
Table 4.1: EIS parameters attained from the circuit fitting of plots in Figure 4.15 for 
bare Au, PANSA, PVP-AgNPs and PANSA/PVP-AgNP modified Au electrode 
Parameter Bare Au Au/PANSA Au/PVP-
AgNP 
Au/PANSA/
PVP-AgNP 
Electrolyte resistance (Rs) (Ohms) 159.1 134.4 461.4 222 
Charge transfer resistance (Rct) 
(KOhms) 
89.27 217.6 118 35.51 
Warburg impedance (W) (kDW) 2.905 26.63 16.83 13.82 
Double layer capacity (Cdl) (uF) 2.888 845.7 880.1 1.417 
 
dlctCR
1
max           Equ. 4.1(a) 
dlct CR                    Equ. 4.1(b) 
ct
o nFR
RTi               Equ.4.2 
*CnFAKi et                                  Equ. 4.3 
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Table 4.2: Results for time constant, exchange current and homogeneous rate constant 
for bare Au, PANSA, PVP-AgNPs and PANSA/PVP-AgNPs modified Au electrode 
Element Bare AuE PANSA PVP-AgNPs PANSA/PVP-
AgNPs 
Time Constant τ (s rad-1) 8.54x10-3 4.70x10-2 1.59x10-3 1.49x10-3
Exchange current ίo (A) 1.43x10-4 5.00x10-5 1.09x10-4 3.61x10-4 
Ket (cm s-1) 3.68x10-4 1.52x10-4 2.80x10-4 9.31x10-4
 
4.2.4.3 AFM Analysis: 
AFM analyses were carried out for PANSA, PVP-AgNPs and PANSA/PVP-AgNP to 
investigate the differences in their surface morphology. Figure 4.13 exhibits the AFM images 
of the bare screen printed gold electrode (SPAuE) (Figure 4.13 A) and the substrate modified 
with different nanomaterials; PANSA film, PVP-AgNPs and PANSA/PVP-AgNP 
nanocomposite, respectively. As can be seen from Figure 4.13 B, silver nanoparticles are 
obviously assembled on the gold substrate. The size of the formed silver nanoparticles is 
about 20 nm - 50 nm, and the roughness of the formed silver nanoparticles layer is about 10 
nm. Similar to SEM, the electrodeposited PANSA film (Figure 4.13 C) shows a porous 
structure, indicating the tubular nature of PANSA with a roughness of 10 nm. It can be seen 
that for the PANSA/PVP-AgNPs nanocomposite in Figure 4.13 D, the produced silver 
nanoparticles are almost homogenously distributed within the electrodeposited PANSA film.  
Of interest is the fact that the surface of the nanocomposite is rougher than both of the 
PANSA and silver nanoparticles film independently. The reason for the difference can be 
attributed to the highly hydrophilic nature of the polymer which is able to adsorb metal 
particles and forms rigid nanocomposites. In the presence of PANSA, the assembled silver 
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nanoparticles are covered by PANSA evenly and thus prevent it from growing bigger. 
Moreover, PANSA adsorbed onto silver nanoparticles can also stabilize the formed silver 
nanoparticles, and with the electrodeposition of PANSA, silver nanoparticles can be 
entrapped into the PANSA film. 
 
 
 
 
 
B 
A 
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Figure 4.13: AFM images of (A) bare SPAuE (B) SPAuE/PVP-AgNPs (C) SPAuE/PANSA 
and (D) SPAuE/PANSA/PVP-AgNPs 
 
 
 
 
 
 
 
C 
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4.2. CV Characterization of PANSA: 
PANSA was prepared from 0.01 M ANSA in 0.5 M H2SO4 by electropolymerization 
on a 0.0201 cm2 diameter Au disk working electrode using CV at 50 mV/s  from –300 to 
+1100 mV. Figure 4.14 A shows a typical cyclic voltammogram of the nanotubular 
polymeric film on Au produced after 5 voltammetric cycles with Scheme 4.1 clearly 
illustrating the polymerization process. It can be seen that, PANSA possesses one redox 
couple illustrating an anodic shift in the polymerisation peak potential with the result that the 
formal potential; E0 values increased from +425 mV for the first polymerisation cycle to 
+440 mV with an average of 433 mV and error of 8.89.  This indicates that the oxidation of 
ANSA on already deposited polymer involves charge transportation across the polymer film 
and is therefore energetically more demanding, whereas the reduction of the accumulated 
polymer film becomes easier. The observed increased anodic peak currents and decreased 
cathodic peak currents are attributed to the influence of the naphthalene sulphonic acid 
moiety which makes the aniline substitute self-limiting upon polymerization. This differs 
from the electropolymerization of aniline alone which is well known to be of a self-
accelerating character. This behaviour of PANSA was found to be closely related to that 
observed in a study carried out by Mazeikiene et al. 2006 in which one redox couple was also 
observed when aminonaphthalene sulphonates were polymerized in the presence of 0.1 M 
sulphuric acid where  a E0 = +415  mV was obtained. One redox couple was also observed in 
another study in which PANI was polymerized in the presence and absence of sodium 
dodecyl sulphate where an E0 value was estimated to be +410 mV (Mazeikiene et al.2006).  
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Figure 4.14:  Cyclic voltammograms of (A) electrochemical synthesis of PANSA  at 50 mV/s 
and electrochemical characterization of PANSA using (B) CV and (C) SWV of Au/ PANSA 
electrode in 0.5 M H2SO4 at different scan rates 
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Scheme 4.1: Schematic representation of ANSA polymerization on Au electrode to produce 
PANSA 
 
Using the CV of polyaniline (PANI) as a reference point, the redox couple observed 
in the synthesis of PANSA is indicative of the most stable form of PANI, the emeraldine 
radical cation/emeraldine transition. CV characterizations at different scan rates (10, 20, 30, 
40, 50, 50, 70, 80, 90 and 100 mV/s) of both PANSA and PANI in the presence of their 
respective polymerization acidic media show similar electrochemistry as denoted by the 
configuration of their peaks. Evidence of this can be seen in Figure 4.14 B where the 
characterization of PANSA shows a similar electrochemistry to that of PANI in the work 
done by Lindofors et al.2002. This interaction is also reflected in the accompanying square 
wave (Figure 4.14 C). The redox couples A'/A and B'/B are attributed to intrinsic redox 
processes of the polymer.  Similar voltammograms have been reported for polyaniline 
confirming that aniline in anilinonapthalene sulfonic acid can be polymerized. The redox 
couple; A'/A is as a result of the transformation of aniline in ANSA from the reduced 
polyleucoemeraldine state to the partly oxidized polyemeraldine state. The second redox 
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peak;  B'/B is due to the transition of polyleucoemeraldine state to the pernigraniline state, 
which is accompanied by oxidation of ANSA monomer (Lindofors et al. 2002; Iwuoha et 
al.2006; Mathebe et al.2004; Pu et al.2007). At low scan rates, there is an observed third 
anodic peak attributed to the electrochemistry of p-benzoquinone formed in the 
polymerization process (Iwuoha et al.2007).  Of interest is the fact that at high scan rates, two 
anodic peaks which appeared at the initial stage of polymerization where seen to merge into 
one peak. This explains the broadness of the outer anodic peak confirming the self-limiting 
character of PANSA. 
The multiscan voltammograms of the PANSA film modified Au electrode in 0.50 M 
H2SO4 solution shown in Figure 4.14 B indicates that the peak potentials as well as the peak 
currents were seen to vary with scan rate. Slopes of plots of log scan rate versus log current 
are commonly used to identify diffusion controlled or adsorption controlled peaks or even a 
mixture of the two. In such plots, a slope of 1 is indicative of an adsorption controlled peak 
while 0.5 indicates a diffusion controlled peak with intermediate values indicating mixed 
diffusion/adsorption controlled peaks.  In this study, all plots of log scan rate versus log 
current gave values in the range of approximately 1 as indicated in Figure 4.15. This indicates 
an adsorbed electroactive polymer with electron diffusion taking place along the polymer 
chain (Kanungo et al. 2002; Mu et al. 1997; Bistolas et al.2005). Therefore, the role of the 
PANSA film in the nanobiosensor construction was to shuttle electrons between the Au disk 
electrode and the active site of the immobilized enzyme and served as a point of attachment 
for the enzyme CYP2E1 and silver nanoparticles. This interaction is clearly illustrated in 
Scheme 4.2. 
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Figure 4.15: Plots of log scan rate versus log current 
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Scheme 4.2: Schematic representation of PANSA on Au electrode and the illustration of the 
immobilization of PVP-AgNPs and CYP2E1 
 
 
Also illustrated in Figure 4.14 B, is the linear dependency of the current on the scan 
rate for the main redox couple B'/B. This is indicative of a thin surface bound conducting 
electro-active polymer film undergoing a rapid reversible electron transfer reaction along the 
polymer backbone possibly through the conjugated benzene ring units making up the chain. 
Ip,c (peak B') / Ip,a (Peak B) which was obtained to be  ~1.1  confirming that the polymer 
behaved as a stable redox species adsorbed on the electrode surface undergoing reversible 
electrochemistry. A similar behaviour was also observed in the work carried out by Brahim et 
al. 2003 and Mu et al. 1997.  ∆Ep [Ep,a (Peak B') – Ep,c (Peak B) ] was calculated for the 
polymer film grown at different scan rates but the film grown at 50 mV/s resulted in a value 
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of ∆Ep lower than 65 mV, which was also seen from the work of Bistolas et al.2005. This 
suggested that the polymer grown at this scan rate exhibited a reversible and a fast 
electrochemistry as compared to polymer grown at other scan rates which are suggestive of 
slow electron transfer rates. Using the Brown-Anson method (Equation 4.4), the surface 
concentration of the polymer was estimated to be 1.0257 x 10-6 mol cm-2 (0.6 ± 0.1). 
 
RT
AFnI PANSAp
4
*22 
         Equ. (4.4) 
 
Where n represents the number of electrons involved in the reaction, F the Faraday constant, 
96,584 C/mol, Г*PANSA is the surface concentration of the PANSA film in mol cm2, ν the scan 
rate in mV/s, A is the electrode area of the electrode (0.0201 cm2), R the universal gas 
constant, 8.314 J mol K-1 and T is the temperature of the system, 298 K. The magnitude of 
the peak currents was seen to increase upon increment of the scan rate suggesting that the 
peak currents are diffusion controlled. De, the electron charge transport coefficient, also 
known as the rate of electron charge propagation along the polymer chain and is determined 
using the Randel-Sevcik method (Equation 4.5). For this study, this coefficient was estimated 
to be 3.8225 x 10 2 cm s-1. Accuracy of this calculation is based on non-variation of the 
potential with scan rate, with variation in scan rate being the essential parameter. An 
increased value was obtained in this study as compared to that of 8.68 x 10-9 cm s-1 observed 
in PANI studies reported by Iwuoha et al. 2004 and a value of 6.46 x 10-8 cm s-1 (0.6 ± 0.1) 
reported by Iwuoha et al. 1997. 
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2/1
*2/3
2/1 )(
)(4463.0
RTL
ADnFI PANSAep                                                   Equ. (4.5)
 
Where L represents the polymer thickness. 
 
4.3 CV Characterization of PVP-AgNPs and PANSA/PVP-AgNPs: 
A layer of the PVP-AgNPs was deposited by drop-coating on the Au/PANSA 
electrode after polymerization of PANSA.  The effect of the PVP-AgNPs on the 
electroactivity of PANSA was evaluated by comparing the profile of the three electrodes 
namely; Au/PANSA (Figure 4.14 B), Au/PVP-AgNPs (Figure 4.16 A) and Au/PANSA/PVP-
AgNPs (Figure 4.16 B). For the Au/PVP-AgNPs electrode, a pair of quasi-reversible redox 
peaks was obtained at +490 mV and +180 mV resulting from the Ag(0) to Ag(I) transition. 
With increasing scan rate, the PVP-AgNPs oxidation peak was seen to be shifted oxidatively, 
from +180 mV (peak A in Figure 4.16 A) to +195 mV (peak C in Figure 4.16 B) and the 
reduction peak  cathodically from +490 mV (peak B in Figure 4.16 A) to +395 mV (peak D 
in Figure 4.16 B).  
The shift in potential is accompanied by a large background current, indicating that 
the electroactive area of Au electrode has been increased due to the high special surface area 
of PVP-AgNPs. Of great interest is the fact that for the Au/PANSA/PVP-AgNPs electrode, 
both PANSA (as observed from the Au/PANSA electrode) and the PVP-AgNPs redox peaks 
are clearly evident in the voltammograms illustrated in (Figure 4.16 B) and further illustrated 
by SWV as indicated in Figure 4.16 C indicating a strong interaction between PANSA and 
PVP-AgNPs.  Li and co-workers also reported a similar pattern illustrating more negative 
peaks on glassy carbon electrode. In another study where glassy carbon electrode was used 
(Li et al. 2005), the oxidation peak was observed at +700 mV and the reduction peak at +330 
mV. A decrease in peak current was observed for the Au/PANSA/PVP-AgNPs electrode 
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compared to the Au/PVP-AgNPs electrode. This is attributed to further modification of 
PANSA by PVP-AgNPs on the electrode surface, with the resultant nanocomposite blocking 
mass transfer of electroactive probe. The reduced current did not affect the electroactivity of 
PANSA since there was no significant shift or change in the PANSA peaks as demonstrated 
by the peak at around +120 mV resulting from the transformation of aniline in ANSA from 
the reduced polyleucoemeraldine state to the partly oxidized polyemeraldine state (Guasicito 
et al. 2008; Wang et al. 2006; Owino et al. 2008; Lin et al. 2008).  
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Figure 4.16: (A) CVs of Au/PVP-AgNPs electrodes, (B) CVs of Au/PANSA/PVP-AgNPs and 
(C) SWV of Au/PANSA/PVP-AgNPs at different scan rates in pH 7.4, 0.1 M phosphate buffer 
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CHAPTER 5 
 
 
Results and Discussion: Part 2 
 
 
Summary 
 
 
This chapter provides a detailed account of the development of nanobiosensors used for the 
detection of tuberculosis treatment drugs. Herein the morphological studies of the developed 
PANSA/PVP-AgNPs/CYP2E1 bioelectrode using TEM, AFM and EIS will be discussed. 
Furthermore an in-depth discussion of the electrochemical properties of the developed 
nanocomposite is also given from results obtained from amperometric studies. The most 
important aspect of this section of the study was to see whether the fundamental properties of 
CYP2E1 were retained after chemical modification and after being immobilization onto 
PANSA/PVP-AgNPs nanocomposites. 
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5.1 Morphology Characterization of PANSA/PVP-AgNPs/CYP2E1 Nanobioelectrode: 
5.1.1 TEM Analysis: 
As mentioned in Chapter 3, CYP2E1 was chemically modified using suberic acid bis 
(N-hydroxysuccinimide ester) (SA-NHS) and ethylene glycol bis(succinic acid N-
hydroxysuccinimide ester) (EG-NHS). SA-NHS and EG-NHS reacted with the primary 
amino acids such as the ϵ-amino functions of lysine residues or even available N-termini to 
form stable amide bonds (Iwuoha et al.1997). Part of this study was to study CYP2E1 and the 
modified forms of CYP2E1; SA-CYP2E1 and EG-CYP2E1 after being electrochemically 
immobilized onto PANSA/PVP-AgNPs using TEM. 
Figure 5.1 indicates TEM images of PANSA/PVP-AgNPs/CYP2E1, PANSA/PVP-
AgNPs/SA-CYP2E1 and PANSA/PVP-AgNPs/EG-CYP2E1 all disperded in ethanol with no 
observable morphological differences. Spherical and polydispersed silver nanoparticles with 
average diameter of  20 nm – 50 nm are seen attached onto the polymeric film seen as 
colourless while CYP2E1, SA-CYP2E1 and EG-CYP2E1 the white crystalline layers in the 
images are seen to be attached onto both the polymeric film and silver nanoparticles. EDX 
analyses (Figure 5.2) gave the components of PANSA/PVP-AgNPs/CYP2E1 which are C-O-
Fe-S-Ag from low to high energy respectively with energy scale of maximum approximately 
7.5 keV. O is due to the ITO glass substrate components while S is contributed by the 
sulphonic substituent of PANSA. The presence of PVP-AgNPs is indicated by an optical 
absorption peak near 3keV which was also observed for the individual PVP-AgNPs reported 
previously. The active site of CYP2E1 is indicated by the presence of Fe as seen by optical 
peaks near 7.5 keV. Very similar if not the same EDX patterns were observed for the 
PANSA/AgNPs/NHS-CYP2E1 and PANSA/PVP-AgNPs/SA-CYP2E1 nanobioelectrodes 
therefore, their patterns were excluded. 
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Figure 5.1: TEM images of (A) PANSA/PVP-AgNPs/CYP2E1 (B) PANSA/PVP-
AgNPs/EG-CYP2E1 and (C) PANSA/PVP-AgNPs/SA-CYP2E1 
 
A 
C 
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Figure 5.2: Energy dispersive X-ray spectrum of PANSA/PVP-AgNPs/CYP2E1 
 
5.1.2 Uv-Visible Spectroscopic Analysis: 
UV-visible spectroscopy is a useful tool for monitoring the possible changes in the 
Soret absorption band which exists in heme group regions. Band shifts provide information of 
possible denaturation of heme proteins particularly that of conformational changes. 
Therefore, in this study this technique was employed to investigate the interaction between 
CYP2E1 and PANSA/PVP-AgNPs (Salimi et al. 2009; Lui et al. 2007). Figure 5.3 shows the 
spectra of CYP2E1 in buffer and CYP2E1 immobilized onto PANSA/PVP-AgNP 
electrodeposited on ITO electrode. As seen from Figure 5.3, a strong soret was observed at 
449 nm for pure CYP2E1, while lower peaks at 451 nm for PVP-AgNP/CYP2E1 and 353 nm 
for Au/PANSA/PVP-AgNP/CYP2E1. The slight shift of 4 nm in the Soret band is due to the 
interaction between CYP2E1 and the PANSA/PVP-AgNP nanocomposite. Such an 
interaction neither destroyed the protein structure nor changed the fundamental 
microenvironment of the protein and its conformation. This result indicates no observable 
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denaturation of CYP2E1 occurred on the PANSA/PVP-AgNP film. A similar interaction has 
also been observed by the work carried out by Yu and co-worker.2010 where haemoglobin 
was immobilized on colloid silver nanoparticles-chitosan film.  
The spectrum observed for PANSA/PVP-AgNP illustrates two absorbance peaks at 
around 425 nm and 535 nm and an undeveloped peak at approximately 410 nm. As indicated 
previously, the peak at 535 nm is as a result of π – π* transition of benzoid rings with the 
nanostructed PANSA indicating the presence of the stable pernigraniline salt. The peak at 
425 nm is due to excitation of longitudinal plasmon vibrations of PVP-AgNPs while that at 
around 410 nm is due to transverse plasmon vibrations in the PVP-AgNPs (Sathishkumar et 
al. 2009). The same behaviour was observed in a study by Jing et al. 2007 involving the 
synthesis and characterization of Ag/polyaniline core-shell nanocomposites.  
 
Figure 5.3: UV - visible spectra of (A) CYP2E1 (B) PVP-AgNPs/ CYP2E1 (C) PANSA/PVP-
AgNPs composite and (D) PANSA/PVP-AgNPs/CYP2E1 
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5.1.3 EIS Analysis: 
5.1.3.1 Nyquist Plot Characterization: 
EIS measurements were carried out in pH 7.4, 0.1 M phosphate buffer at the potential 
window;  -300 mV to +1100 mV where bare Au electrode, Au/PVP-AgNPs, Au/PANSA, 
Au/PVP-AgNP/PANSA and PANSA/PVP-AgNPs/CYP2E1 nanobioelectrode where 
investigated. The change in electron transfer resistance arising after each surface modification 
step was investigated and represented as Nyquist diagrams as indicated in Figure 5.4. As 
discussed in the previous chapter, EIS studies indicated that PVP-AgNPs is more conductive 
than PANSA as seen by the different sizes of the semi-circles. Immobilization of PVP-
AgNPs onto the PANSA film resulted in a further decrease in the semi-circle (curve a). The 
nanocomposite was found to be more conductive than PVP-AgNPs and PANSA individually 
thus allowing a much faster electron movement between Au electrode and the 
nanocomposite. Immobilization of and (b) SA-CY2E1, (c) EG-CYP2E1 and (d) CYP2E1 
onto PANSA/PVP-AgNPs resulted in increased semi-circles. This illustrated a slight 
restriction in electron transfer between the Au electrode (curve e) and the PANSA/PVP-
AgNPs/CYP2E1 nanobioelectrode. The same impedance profile was observed for EG-
CYP2E1 and SA-CY2E1 nanobiosensors (Yin et al.2010; Arotiba et al.2010; Ding et 
al.2003).  
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Figure 5.4: EIS Nyquist plot of Au/PVP-AgNPs, Au/PANSA and Au/PVP-
AgNPs/PANSA and PANSA/PVP-AgNPs/CYP2E1 nanobioelectrode 
 
5.1.4.2 Bode Plot Characterization: 
 
Bode plot analysis (Figure 5.5) for the Au/PANSA/PVP-AgNPs/CYP2E1 
nanobioelectrodes showed a lower conductivities than bare Au electrode with a slightly 
higher charge transfer resistance when compared to the Au/PANSAPVP-AgNPs electrode 
indicating  a slower electron transfer between the Au electrode and the nanocomposite.  As 
indicated in the previous chapter, Rct values for PVP-AgNP, PANSA and PANSA/PVP-
AgNP modified gold electrodes where obtained as 118 KOhm, 217.6 KOhm and 35.51 
KOhm respectively.  For the Au/PANSA/PVP-AgNP/CYP2E1 nanobioelectrode a Rct value 
of 335 KOhm was found and for (Au/PANSA/PVP-AgNP/SA-CYP2E1 = 119.6 KOhm) and 
(Au/PANSA/PVP-AgNP/EG-CYP2E1 = 275 KOhm) which reveal the hindering ability of 
PANSA/PVP-AgNPs and CYP2E1 on the electrode surface thus, impeding electron transfer. 
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An increase in impedance was observed from the Bode plot (Figure 5.5) for the 
PANSA/PVP-AgNP/CYP2E1 nanobioelectrode as compared to the PANSA, PVP-AgNP and 
PANSA/PVP-AgNPs modified gold electrodes with corresponding shifts in phase angles 
respectively (Yin et al.2010; Arotiba et al.2010; Ding et al.2003). As seen from the diagram 
the angle shift of the Au/PANSA/PVP-AgNP/CYP2E1 nanobioelectrode was found to be 
similar to that of Au/PANSA/PVP-AgNP/SA-CYP2E1 and Au/PANSA/PVP-AgNP/EG-
CYP2E1 nanobioelectrodes (not shown since bode plots are the same as the 
Au/PANSA/PVP-AgNP/CYP2E1 nanobioelectrode).  
 
 
Figure 5.5: Bode plot of Au/PVP-AgNPs, Au/PANSA and Au/PVP-AgNPs/PANSA 
and PANSA/PVP-AgNPs/CYP2E1 nanobioelectrode 
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Table 5.1 gives a list of all calculated EIS parameters; Rs, Cdl, Rct and Warburg 
element, Zw, resulting from the EIS study. The parameters where used to calculate the time 
constant using equation 4.1 a and 4.1 b (where Time constant = τ) and the exchange current 
(io) by using equation 4.2 (Yin et al.2010; Arotiba et al.2010; Ding et al.2003). Where Cdl = 
double layer capacitance; τ = time constant; Rct = charge transfer resistance. Ket, the 
homogeneous rate constant was determined by using equation 4.3.  The resulted parameters 
are clearly illustrated in Table 5.2 
 
Table 5.1: EIS parameters attained from the circuit fitting of plots in Figure 4.15 for 
PANSA, PVP-AgNPs and PANSA/PVP-AgNPs and PANSA/PVP-AgNPs/CY2E1 
modified Au electrode 
Parameter Au/PANSA Au/PVP-
AgNPs 
Au/PANSA/
PVP-AgNP 
Au/PANSA/PVP
-AgNP/CYP2E1 
Electrolyte resistance (Rs) 
(Ohms) 
159.1 461.4 222 176.7 
Charge transfer resistance 
(Rct) (KOhms) 
89.27 118 35.51 275 
Warburg impedance (W) 
(kDW) 
2.905 16.83 13.82 33.53 
Double layer capacity (Cdl) 
(uF) 
2.888 880.1 1.417 706.5 
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Table 5.2: Results for time constant, exchange current and homogeneous rate constant 
for bare PANSA, PVP-AgNPs and PANSA/PVP-AgNPs and PANSA/PVP-
AgNPs/CYP2E1 modified Au electrode 
Element PANSA PVP-AgNPs PANSA/PVP/AgNPs/CYP2E1 
Time Constant τ (s rad-1) 4.70x10-2 1.59x10-3 8.90 x10-1 
Exchange current ίo (A) 5.00x10-5 1.09x10-4 4.67x10-5 
Ket (cm s-1) 1.52x10-4 2.80x10-4 2.29 x10-4 
 
5.1.5 AFM Analysis: 
1D and 3D AFM images are shown in Figure 5.6. The surface of 
SPAuE/PANSA/PVP-AgNPs/CYP2E1 (Figure 5.6 B) nanobioelectrode displayed a globular 
morphology and larger roughness than the electrode without enzyme (Figure 5.6 A). The 
latter is consistent with the close packing of enzymes onto solid surfaces as reported by 
Crespilho et al. 2009 and Wang et al. 2009. Globular and increased roughness was also 
observed for the SPAuE/PANSA/AgNPs/EG-CYP2E1 and SPAuE/PANSA/PVP-AgNPs/SA-
CYP2E1 nanobioelectrodes (not shown since images are the same as SPAuE/PANSA/PVP-
AgNPs/CYP2E1). This is indicative of the fact that the chemical modification of CYP2E1 did 
not drastically alter the morphology of the enzyme. 
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Figure 5.6: 1D and 3D AFM images of (A) SPAuE/PANSA/PVP-AgNPs and (B) 
SPAuE/PANSA/PVP-AgNPs/CYP2E1 
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5.1.4 Amperometric characterization of PANSA/PVP-AgNPs/CYP2E1 
nanobioelectrode: 
CYP2E1, EG-CYP2E1 and SA-CYP2E1 were individually electrostatically attached 
onto PANSA/PVP-AgNPs nanocomposites by applying a potential of +700 mV in anaerobic 
pH 7.4, 0.1 M Phosphate buffer solution. After immobilization it was crucial to access 
whether the enzymes were attached onto the nanocomposites. CV was used for this study at a 
potential window of -300 mV to +1100 mV at vaying scan rates. Figure 5.7 shows the CV 
voltammogram of the characterization at 10, 20, 30, 40, 60, 80 and 100 mV/s where one 
redox couple was observed for CYP2E1’s heme (Fe3+/Fe2+) electron transition (Figure 5.7 A) 
while for the EG-CYP2E1 (Figure 5.7 B) and SA-CYP2E1 bioelectrodes, (Figure 5.7 C) two 
redox peaks were observed. The redox peak towards the more positive potentials is attributed 
to the enzymes (Fe3+/Fe2+) transition while the other is due to the PVP-AgNPs (Ag(0)/Ag(1)) 
transition.   
 
A
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Figure 5.7: CV characterization of (A) PANSA/PVP-AgNPs/CYP2E1, PANSA/PVP-
AgNPs/EG-CYP2E1 and (C) PANSA/PVP-AgNPs/SA-CYP2E1in pH 7.4, 0.1 M, phosphate 
buffer at 10, 20, 30, 40, 60, 80 and 100 mV/s 
B
C
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As seen from the voltammograms in Figure 5.7, as the scan rates increased the peak 
amplitudes also increased confirming immobilization of the enzymes. On the other hand, a 
slight shift in both the current and the potential was observed illustrating that the 
PANSA/PVP-AgNPs nanocomposite had not lost its conductivity and electro-activity upon 
enzyme immobilization (Iwuoha et al. 1998; Iwuoha et al.1997; Qu et al. 2005). This is 
clearly indicated by the second redox peak illustrated for the PANSA/PVP-AgNPs/EG-
CYP2E1 and PANSA/PVP-AgNPs/SA-CYP2E1 nanobioelectrode. The same interaction 
observed in CV for the bioelectrode was also observed in DPV (Figure 5.8) and SWV (Figure 
5.9) analyses.  DPV and SWV reveal another redox peak at approximately -200 mV which is 
confirmation of immobilization of PANSA. The DPV and SWV profiles of the PANSA/PVP-
AgNPs/EG-CYP2E1 and PANSA/PVP-AgNPs/SA-CYP2E1 bioelectrodes are not shown 
since they resemble that of PANSA/PVP-AgNPs/CYP2E1. 
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Figure 5.8: DPV characterization of PANSA/PVP-AgNPs/CYP2E1 pH 7.4, 0.1 M, 
phosphate buffer at 10, 20, 30, 40, 60, 80 and 100 mV/s.  
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Figure 5.9: SWV characterization of PANSA/PVP-AgNPs/CYP2E1 in pH 7.4, 0.1 M, 
phosphate buffer at 10, 20, 30, 40, 60, 80 and 100 mV/s 
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In order to effectively investigate the electrochemical properties of the Au/ PANSA 
PVP-AgNPs/CYP2E1 nanobioelectrode, CV of different electrodes in buffer were recorded, 
as shown in Figure 5.10. No peaks were observed at bare gold electrode (green curve A,) 
while peaks were observed for the PANSA/PVP-AgNPs modified electrode (black curve B), 
with the (red curve C) obtained after injection of 20 µL CYP2E1 in pH7.4, 0.1 M phosphate 
buffer under anaerobic conditions and PANSA (blue curve A) modified electrode.  
 
Figure 5.10 CVs of (A) bare Au electrode (green line) (B) of Au/PANSA/PVP-AgNPs 
(black line) and (C) Au/PANSA/PVP-AgNPs after CYP2E1 immobilization (red line) and (D) 
of PANSA at 50 mV/s in pH 7.4, 0.1 M phosphate buffer  
 
The pair of redox peaks arose from the redox of the heme Fe centre of CYP2E1 
embedded in the PANSA/PVP-AgNPs nanocomposite attributed to the (Fe2+/Fe3+) transition 
(Ashe et al. 2007; Cerqueira et al. 2000). Thus, PANSA/PVP-AgNPs must have a great effect 
on the kinetics of electrode reaction providing a suitable environment for CYP2E1 to transfer 
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electrons with the underlying electrode. It was found that the peak currents of the CYP2E1 
enzyme at the PANSA/PVP-AgNPs modified electrode were larger than those of at the bare 
gold electrode with a clear defined redox pair at +790 (oxidation peak) and +150 mV 
(reduction peak) with the separation of peak potential (∆Ep) of +640 mV and formal potential 
(defined as the average of the anodic and cathodic peak potential) or E0’ =Ep,a + Ep,c /2 = +450 
mV (Iwuoha et al.2003). A similar profile was also seen for the Au/ PANSA PVP-
AgNPs/EG-CYP2E1 and Au/ PANSA PVP-AgNPs/SA-CYP2E1 hence, all discussions will 
be referred in terms of Au/ PANSA PVP-AgNPs/CYP2E1. 
Heme proteins exhibit different formal potentials which are attributed to the effect of 
different system configurations and different microenvironments on the direct electron 
transfer (Guascito et al. 2008).  Zong et al. 2005 obtained a formal potential of -36 mV for 
the direct electron transfer hemogloblin immobilized in multi-walled carbon nanotubes 
enhanced grafted collagen. On the other hand, Yang et al. 2006 immobilized myoglobin and 
gold nanoparticles on a glassy carbon electron by a nafion film, where a pair of reversible 
redox peaks appeared with a formal potential of -373 mV. Varying the scan rates for the Au/ 
PANSA PVP-AgNPs/CYP2E1 electrode illustrated an increase in the peaks current with 
increasing scan rates, indicating that the electrochemical behaviour of CYP2E1 immobilized 
on Au/PANSA/PVP-AgNPs nanocomposite was a surface controlled process.  It was also 
found that the peak potentials varied with an increase in scan rate, while the formal potential 
was kept almost unchanged, showing that CYP2E1 does not hinder charge transport across 
the PANSA/PVP-AgNPs film but enhances electron transportation between the CYP2E1 
active site and the electrode surface (Zhang et al. 2007).  
  According to Laviron equation (Equ. 5.1); 
 
RTAFnIp 4/*22  RTnFQ 4/                     Equ.(5.1) 
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Where Γ* is the electroactive CYP2E1 amount (mol cm-2) and Q is the quantity of charge (C) 
with the symbols n, Ip, R, F and T bearing their usual meaning.  From the slope of Ip,c versus 
ν plot (Figure 5.11),  n was calculated to be 2.21 indicating a two electron reaction of 
CYP2E1 on PANSA/PVP-AgNPs. The average coverage of CYP2E1 on the surface of the 
modified electrode was estimated to be 8.25 x 10-5 mol cm-2 and 4.56 x 10-5 mol cm-2 for the 
Au/PANSA/AgNP electrode. Since ∆Ep ≥ 200 mV/n, the heterogeneous rate constant (ks) 
was estimated using the revised Laviron equation; Equation 5.2. 
 
Figure 5.11: Plot of Ip,c versus ν plot used to calculate n, the number of electrons transferred 
in the reaction 
 
 
RTEpnFnFRTks 3.2/)1()/log(log)1()1log(log  
                              (5.2) 
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Taking the electron transfer coefficient α of 0.52, calculated from a plot of Ep versus 
log ν (Figure 5.12), a scan rate of 100 mV/s and ∆Ep  of +640 mV, the heterogenous rate 
constant was estimated to be 1.75 s-1. The estimated value is in the controlled range of the 
surface-controlled quasi-reversible process, and is in agreement with the values (0.41 s-1, 0.71 
s-1 and 0.62 s-1 respectively) reported by Laviron and co for heme proteins suggesting that the 
active centre (Fe3+/Fe2+) of CYP2E1 underwent a quasi reversible process (Zhang et al. 2005; 
Laviron et al. 1979a; Laviron et al. 1979b). 
 
Figure 5.12: Plot of Ep versus log υ used to calculate α, electron transfer coefficient 
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CHAPTER 6 
 
 
Results and Discussion: Part 3 
 
 
Summary 
 
 
 
This chapter gives details on the detection of the tuberculosis drugs namely; Isoniazid (INH), 
Ethambutol (ETH), Rifampicin (RIF) and Pyrazinamide (PYR) using PANSA/PVP-
AgNPs/PANSA/CYP2E1, PANSA/PVP-AgNPs/PANSA/SA-CYP2E1 and PANSA/PVP-
AgNPs/PANSA/EG-CYP2E1 nanobiosensors on gold electrodes. Detection of these drugs 
was achieved by using techniques such as CV, DPV, SWV and steady state amperometry. 
Thorough discussions based on the interaction of CYP2E1 and the individual drugs are 
provided in sections below. 
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6.1 PANSA/PVP-AgNPs -mediated Electrocatalytic Reduction of TB Drugs: 
Amongst the TB drugs INH is a known substrate inhibitor of CYP2E1 whose 
metabolism is via a hydroxylation process.  RIF and ETH are also metabolism by CYP2E1 
but too a much lesser extent than INH while PYR is known to be metabolised to 5-
hydroxypyrazinamide by the molybdenum iron-sulphur flavin hydroxylase enzyme, xanthine 
oxidase/xanthine dehydrogenase (Yamamoto et al. 2001; Rasoulzadeh et al. 2009). For the 
first time, this study introduces a new biotransformation method by studying the metabolism 
of these drugs using the enzyme CYP2E1 coupled to a nanocomposite of silver 
nanoparticles/poly (8-anilino-1-naphthalene sulphonic acid). The initial stage of this study 
involved the detection of all four drugs using PANSA/PVP-AgNPs/CYP2E1 nanobiosensors 
however; these nanobiosensors were found to be more selective for only INH and ETH. 
Therefore, modifying CYP2E1 with [suberic acid bis (N-hydroxysuccimide ester) (SA-NHS)] 
and [ethylene glycol bis (succinic acid N-hydroxysuccinimide ester) (EG-NHS)] allowed for 
the successful detection of PYR and RIF.  Thus, the next step of the study was the detection 
of these drugs using PANSA/PVP-AgNPs/SA-CYP2E1 nanobiosensors which were found to 
be more selective for PYR and finally, these drugs were detected using PANSA/PVP-
AgNPs/EG-CYP2E1 nanobiosensors which were found to be more selective for RIF.   
In the sections below the CV, DPV or SWV and steady state amperomeric results of 
the compounds namely; INH, ETH, PYR and RIF obtained from their respective 
nanobiosensors are discussed. By plotting calibration curves; which are plots of current 
against analyte concentrations (above mentioned TB drugs), parameters such as KM, KMapp 
and IMAX where determined from the linear ranges of the nanobiosensor systems. From the 
calibration curves the sensitivity (determined as the slope of the plot) and the detection limits 
of the individual nanobiosensors were also determined.  Detection limits are dependent on the 
background current exhibited by the nanocomposite and the importance of their estimation is 
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to know the least amount a particular nanobiosensor can detect (Grennan et al. 2006). The 
nanobiosensors showed increased sensitivities resulting from the presence of CYP2E1 
embedded in the electron transfer mediator PANSA/PVP-AgNPs (Svobodova et al. 2002). 
The sensitivity and detection limit values are stipulated in Table 6.1 were a clear comparison 
among the nanobiosensor systems is made.  
 
6.1.1 Electrocatalytic Reduction of Isonaizid and Ethambutol using PANSA/PVP-
AgNPs/CYP2E1 Nanobiosensors: 
Of all the TB drugs studied, the Au/PANSA/PVP-AgNPs/CYP2E1 nanobiosensor 
was found to be greatly selective for INH and ETH. Interestingly enough, the 
electrochemistry of ETH (Figure 6.2 A) and INH (Figure 6.5 A) was seen to be very similar. 
Illustrated in the following sections are the voltammetric responses of the Au/PANSA/PVP-
AgNPs/CYP2E1 nanobiosensors under aerobic and anaerobic conditions in the presence of 
pH 7.4, 0.1 M phosphate buffer solution.  
 
6.1.1.1. Electrocatalytic Reduction of Ethambutol: 
The electrocatalytic activity of CYP2E1 in the PANSA/PVP-AgNPs nanocomposite 
was evaluated by SWV, DPV, CV and chronoamperometric methods.  Au/PANSA/PVP-
AgNPs/CYP2E1 was employed as the working electrode and its electrochemical response 
towards ethambutol was investigated in pH 7.4, 0.1 M phosphate buffer under aerobic 
conditions at 20 mV/s. Figure 6.1  illustrates the chronoamperometric analysis at different 
ETH concentrations (2 µM - 22 µM) , where the current as a function of time was monitored.  
The steady state amperometry experiments were performed at –250 mV in an air saturated 
cell solution with stirring maintained at 500 rpm. The first addition of ETH caused an 
increase in the current and the amperometric response of the nanobiosensor was allowed to 
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attain steady state value which took about 20 s to acquire, showing that the nanobiosensor can 
achieve real time responses. Using SWV, DPV and CV with only CV and DPV shown in 
(Figure 6.2 A and B), a well-defined reduction peak was observed for the Au/PANSA/PVP-
AgNP/CYP2E1 nanobiosensor in deoxygenated buffer. However, when ETH was injected 
into the buffer reaction medium, the reduction peak increased with no corresponding 
oxidation peak observable.  In anaerobic conditions we only have the electrochemistry of 
Au/PVP-PANSA/CYP2E1 which is essential for the oxidation and reduction of PANSA and 
PVP-AgNPs respectively.  
 
Figure 6.1: Steady state responses at applied potential of -250 mV with response time of 20 s 
 
With reference to Scheme 6.1, the reduction peak observed in aerobic conditions 
suggests the one electron electrochemical reduction of the hexa-coordinated low-spin ferric 
enzyme (Fe3+) to the high spin ferrous enzyme (Fe2+). This form of the enzyme has a high 
affinity for oxygen and thus binds molecular oxygen present in the solution forming the 
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CYP2E1 (Fe2+) O2 complex. This interaction results in the development of an aldehyde 
intermediate followed by the release of a water molecule. The result is a highly active iron-
oxoferryl intermediate CYP2E1 (Fe4+) during which a dicarboxylic acid form of ETH is 
produced upon reduction (Spracklin et al.1997; von Moltke et al.1997). 
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Figure 6.2: (A) CV and (B) DPV responses at different ethambutol concentrations for the 
Au/PVP-AgNPs/PANSA/CYP2E1 nanobiosensor 
 
 
As expected for enzymatic processes, the response upon ETH addition led to a 
Michaelis-Menten profile, with a linear response up to 16 µM, a sensitivity of 1.13 µA/ µM 
and a detection limit of 0.7 µM (Figure 6.3).  Compared to a study by Wu et al. 2011 where 
ETH was determined using a sensitive fluorescent probe; this nanobiosensor system showed 
to be more sensitive and effective. Thus, the Au/PANSA/PVP-AgNPs/CYP2E1 electrode 
provided a comfortable and friendly environment for the biocatalytic reaction to take place, 
which was more evident by the determination of the Michaelis-Menten constant (KM). The 
enzymatic reaction at the PANSA/ PVP-AgNPs electrode surface can be considered as 
follows: 
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CYP2E1 + Ethambutol → CYP2E1 – Ethambutol         K1 
CYP2E1 – Ethambutol → CYP2E1 + Ethambutol Aldehyde + H2O                     K2 
 
Therefore, based on the Michaelis-Menten reaction, the enzymatic kinetics of CYP2E1 as 
shown in Equation 6.1 is written as follows: 
 
     ETHAMBUTOLKETHAMBUTOLECYPKV M  /122     Equ. (6.1) 
 
               
Where V is the rate, K2 the equilibrium constant, KM the Michaelis-Menten constant, 
[CYP2E1] the concentration of CYP2E1 and [ETHAMBUTOL] is the concentration of 
ethambutol. Naturally, lower KM and higher V values are preferred since they indicate a high 
enzyme biocatalytic activity. These parameters were studied from Figure 6.3, where the 
entire enzymatic reaction is represented by the hyperbolic graph. At lower ETH 
concentrations, the rate of reaction is directly proportional to the ETH concentration 
illustrated in the linear range of Figure 6.3.  Therefore, when V = VMAX (the maximum rate, 
represented as IMAX in our calculations), then KM is numerically equal to half the ETH 
concentration. The value of KM was therefore determined and found to be 6.30 µM (Bai et al. 
2007; Cornish-Bowden et al. 1974; AL-Thabaiti et al. 2008). The electrochemical 
Lineweaver-Burk equation (Equation 6.2) was used to evaluate KMapp of the biosensor. In this 
case, the x-intercept of the graph represents -1/KM and the y-intercept is equivalent to the 
inverse of VMAX. 
 
MAX
app
M
MAXSS I
K
II
 11 [S]        Equ. (6.2) 
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Here ISS is the measured steady state current, IMAX the maximum current under 
saturated substrate concentration, KMapp the apparent Michaelis-Menten constant and [S] is 
the concentration of ethambutol. According to the intercept and slope of the above equation, 
the value for KMapp was estimated to be 1,01 µM, whereas the value for the maximum IMAX 
was calculated to be 2.1 x 10-6 µA. The KMapp is lower than previously reported for HRP 
immobilized in sol-gel-derived ceramic-carbon nanotubes composite film (Bai et al. 2007; 
Cornish-Bowden et al. 1974; AL-Thabaiti et al.2008). The smaller value of KMapp indicated 
for the present nanobiosensor indicates that CYP2E1 embedded in the PANSA/ PVP-Ag 
nanocomposite has better affinity towards ETH and that this new electrode configuration is 
promising for building enzymatic devices with improved biocatalytic properties. 
Of great interest is the fact that the blood peak level of ethambutol (1 – 5 µg/mL) or 6 
– 18 µM occurring between 4 - 8 hr post a daily dosage of 200 mg, is within the dynamic 
linear response range (2 – 16 µM). With an upper dynamic linear range of 16 µM it means 
that the nanobiosensors are effective and can be applied to systems where concentrations are 
0.7 µM - 16 µM.  
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Figure 6.3: Calibration curve of ethambutol showing the linear range (inset) for the 
Au/PVP-AgNPs/PANSA/CYP2E1 nanobiosensor  
 
 
 
	
	
 
171	
 
 
 
 
KEY 
CYP4+, 3+, 2+ - Different oxidation states of Cytochrome P450-2E1 
PANSA/Ag - poly (8-anilino-1-naphthalene sulphonic acid)/ silver nanoparticle 
nanocomposite 
 
 
RCH2OH – Ethambutol                        RCOH – Ethambutol aldehyde intermediate 
NH
CH3NH
CH3
OH
OH
                     
NH
CH3NH
CH3
COH
COH
 
 
RCOOH – Dicarboxylic acid ethambutol 
NH
CH3NH
CH3
CO
OC
OH
OH
 
 
 
Scheme 6.1: Reaction scheme showing the metabolism of ethambutol using the 
Au/PANSA/PVP-AgNPs/CYP2E1 nanobiosensor  
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6.1.1.2. Electrocatalytic Reduction of Isoniazid: 
The Au/ PANSA/PVP-AgNPs/CYP2E1 nanobiosensor responses towards INH were 
investigated using SWV, DPV, CV and chronoamperometric methods in pH 7.4, 0.1 M 
phosphate buffer solution under aerobic conditions at 20 mV/s. Comparing results from this 
study, DPV and CV conditions were chosen for the analytical application with steady state 
amperometry used as further confirmation of the results obtained. The current as a function of 
time was monitored at different INH concentrations (2 µM – 30 µM), as illustrated by the 
steady state amperometry responses in Figure 6.4. The first addition of INH caused an 
increase in the current and the amperometric response of the nanobiosensor was allowed to 
attain steady state value which took about 20 s to acquire. However, as can be readily seen 
from Figure 6.5 A and B, a well-defined reduction peak was observed for the reduction of 
INH by the Au/PANSA/PVP-AgNP/CYP2E1 nanobiosensor in deoxygenated buffer while a 
different electrochemistry was observed in anaerobic conditions.It should be noted that the 
electrochemistry of Au/PANSA/PVP-AgNP/CYP2E1 was studied at the potential window of 
+1100 mV to -300 mV.  Increasing the concentration of INH increased the reduction peak 
however, for the CV responses which were observed at +300 mV to -800 mV, no 
corresponding oxidation peak was observed.  
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Figure 6.4: Steady state responses of isonaizid at applied potential of -250 mV with response 
time of 20 s 
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Figure 6.5: (A) CV and (B) DPV responses at different isoniazid concentrations for the 
Au/PVP-Ag-PANSA/CYP2E1 nanobiosensor 
 
As illustrated in Scheme 6.2, these responses are resultant from a reaction initiated by 
the one electron reduction of the hexa-coordinated low-spin ferric enzyme (Fe3+) to the high 
spin ferrous enzyme (Fe2+) during which INH is reduced to an alcohol form.  This form of 
CYP2E1 attracts molecular oxygen subjected to the solution forming the CYP2E1 (Fe2+) O2 
complex introducing coupled an –OH group to the INH alcohol via a hydroxylation process 
followed by the release of a water molecule. A highly active iron-oxoferryl intermediate 
CYP2E1 (Fe4+) was the result with a nitro form of INH produced upon reduction which was 
then released (Spracklin et al.1997; von Moltke et al.1997). 
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KEY: 
CYP4+, 3+, 2+ - Different oxidation states of Cytochrome P450-2E1 
PANSA/Ag - poly (8-anilino-1-naphthalene sulphonic acid)/ silver nanoparticle nanocomposite 
 
RCONHNH2 - Isoniazid                                             RCOH2NHNH2 - alcohol form of Isoniazid 
NH NH2O
  
NH NH2OH
H
 
RC(OH)2NHNH2 - Intermediate isoniazid complex           RC(OH)2NHNO2  -  Nitro Isoniazid
 
NH NH2OH
OH
    
NH NO2OH
OH
 
 
 
Scheme 6.2: Reaction scheme showing the metabolism of isoniazid using the Au/PVP-AgNPs/ 
PANSA CYP2E1 nanobiosensor 
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The response upon INH addition led to a Michaelis-Menten profile, with a linear 
response up to 14 µM, a sensitivity of 1.25 µA/ µM and a detection limit of 0.65 µM (Figure 
6.7). This shows that a friendly and comfortable environment was created by the 
Au/PANSA/PVP-AgNP/CYP2E1 nanobiosensor for the successfull biocatalytic reaction to 
take place. This resulted in the determination of KM, KMapp and IMAX. The enzymatic reaction 
at the PANSA/ PVP-AgNPs electrode surface can be considered as follows: 
 
CYP2E1 + Isoniazid → CYP2E1 – Isonaizid         K1 
CYP2E1 – Isoniazid → CYP2E1 + Isoniazid Alcohol + H2O                K2 
 
Therefore, based on the Michaelis-Menten reaction, the enzymatic kinetics of CYP2E1 as 
shown in Equation 6.3 is written as follows: 
 
    ISONIAZIDKISONIAZIDECYPKV M  /122                 Equ. (6.3) 
 
With V, K1, K2, KM and [CYP2E1] have their usual definitions and [ISONIAZID] 
being the concentration of isoniazid. As indicated in Figure 6.6, the rate of reaction at lower 
concentrations of INH is directly proportional to the INH concentrations. The values of IMAX,  
KMapp and KM were determined from the hyperbolic region of the plot with the aid of 
Equation 6.3 and estimated to be 1.9 x 10-6 µA, 1,34 µM and 5.8 µM, respectively. The 
reduced KM and higher IMAX values are indicative of high enzyme biocatalytic activity taking 
place at the electrode surface (Bai et al. 2007; Cornish-Bowden et al. 1974; AL-Thabaiti et 
al. 2008). A more sensitive and efficient sensor system is reported here compared to 
previously reported sensor systems such as that developed by Haghighi et al. 2010; where a 
flow injection chemiluminescence sensor was developed for the determination of INH. The 
efficiency of the nanobiosensor is based on the fact that the blood peak concentration of INH, 
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3 µg/mL or (22 µM) which occurs 4 – 8 hr after administration of a 200 mg INH dose, is 
within the dynamic linear response range of the nanobiosensor (2 µM – 20 µM). Finally, with 
an upper dynamic linear range of 30 µM, it means that the nanobiosensor can be applied to 
systems where the concentration range is 0.65 µM – 30 µM.  
 
Figure 6.6: Calibration curve of isoniazid showing the linear range (inset) for the 
Au/PVP-AgNPs/PANSA/CYP2E1 nanobiosensor  
 
6.1.1.3 Electrocatalytic Reduction of Pyrazinamide (PYR): 
Figure 6.7 A illustrates the cyclic voltammetric responses of the Au/PVP-
AgNPs/PANSA/SA-CYP2E1 nanobiosensor in the absence and presence of PYR at low 
potential scan rate of 20 mV/s. Voltammograms obtained in the absence of PYR were 
performed in anaerobic and aerobic solutions. In anaerobic solutions, only the 
electrochemistry of Au/PVP-AgNPs/PANSA essential for the oxidation and reduction of 
PVP-AgNPs and PANSA is observed. Under anaerobic conditions the CV of Au/PVP-
AgNPs/PANSA/SA-CYP2E1 electrode is at the potential window of +1100 mV to -300 mV. 
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However, upon immobilization of SA-CYP2E1 under aerobic conditions, the CV gave a 
catalytic voltammetric wave at the potential window of +300 mV to -800 mV. This response 
is due to the binding of PYR to SA-CYP2E1 catalysing the low to high spin transition of iron 
increasing the rate of reduction of the ferric haem to ferro haem. As indicated in Scheme 6.3 
the ferro haem state of the enzyme binds molecular oxygen during which PYR is  
hydroxylated to 5-hydroxypyrazinamide. This is followed by the cleaving of the O-O bond 
resultant by the introduction of the second electron producing a highly active iron-oxoferryl 
intermediate CYP2E1 (Fe4+) with 5-hydroxypyrazinoic acid as the product which is released 
(Mehmedagic et al. 1997; Yamamoto et al. 1986). Indicated in Figure 6.7 B the responses of 
the Au/PVP-AgNPs/PANSA/SA-CYP2E1 nanobiosensor to PYR are also recorded. The 
figure shows that the DPV peak current increases as the concentration of PYR increases from 
2 µM to 24 µM. A calibration curve was derived from this data from which a sensitivity of 
1.38 µA/µM was determined.  
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KEY: 
CYP4+, 3+, 2+ - Different oxidation states of Cytochrome P450-2E1 
PANSA/Ag - poly (8-anilino-1-naphthalene sulphonic acid)/ silver nanoparticle nanocomposite 
 
RONH2 - Pyrazinamide                                                             R-O-OH-NH2 – 5-hydroxypyrazinamide           
N
N
NH2
O
                                                                       
N
N
NH2
O
OH  
                 R-OH-O-OH - 5-hydroxypyrazinoic acid 
     
N
N
OH
O
OH  
Scheme 6.3: Reaction scheme showing the metabolism of pyrazinamide using the Au/PVP-
AgNPs/PANSA/SA-CYP2E1 nanobiosensor 
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Figure 6.7: (A) CV and (B) DPV responses at different pyrazinamide concentrations for the 
Au/PVP-AgNPs/PANSA/SA-CYP2E1 nanobiosensor 
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The nanobiosensor response time was evaluated from steady state amperometry 
experiments performed at -250 mV (Figure 6.8). The Au/PVP-AgNPs/PANSA/SA-CYP2E1 
nanobiosensor was used as the working electrode in an air-saturated buffer cell solution 
which was stirred at 500 rpm. The nanobiosensor was polarized at -250 mV and the 
background current was allowed to decay to a constant value which occurred after about 430 
s. Upon addition of  2 µM PYR into the cell solution, the amperometric response of the 
nanobiosensor was allowed to attain steady state value which took about 25 s indicating that 
the response of the nanobiosensor can be achieved in real time. The detection limit was 
calculated to be 0.054 µM which implies that the nanobiosensor can be applied to systems 
where the concentration range is 0.054 µM to 24 µM as indicated by the calibration curve in 
Figure 6.9. The Michaelis-Menten parameters; KM, KMapp and IMAX were also determined and 
found to be 6.0 µM, 1.41 µM and 1.51 x 10-6 µA respectively. 
 
Figure 6.8: Steady state responses of pyrazinamide at applied potential of -250 mV with 
response time of 25 s 
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 Figure 6.9: Calibration curve of pyrazinamide for the Au/PVP-AgNPs/PANSA/SA-
CYP2E1 nanobiosensor  
 
 
6.1.1.4 Electrocatalytic Reduction of Rifampicin (RIF): 
Figure 6.10 A illustrates the cyclic voltammetric responses of the Au/PVP-
AgNPs/PANSA/EG-CYP2E1 nanobiosensors in the absence and presence of RIF under 
aerobic and anaerobic conditions in the presence of buffer solution. The voltammogram show 
that as the potential was scanned reductively from +800 mV to -300 mV, the cathodic current 
steadily increased to a maximum value after which the current decreased until the switch 
potential was reached. However, scanning anodically no peak was observed.  DPV (Figure 
6.10 B) was used to further confirm data observed in CV. One prominent peak was observed 
in the cathodic scan when the RIF’s concentration was increased steadily from 2 μM to 14 
μM.  As indicated in Scheme 6.4 this defined cathodic peak depicts the coupling of a fast 
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electron transfer reaction taking place at the electrode surface to a fast chemical process in 
which the reduced electro-active species have been used up. During the cathodic scan CYP 
(Fe3+) was reduced to CYP (Fe2+) as a result of the binding of RIF to the active sites of EG-
CYP2E1 which was then used up in a fast follow-up chemical reaction, making it unavailable 
for re-oxidation during the anodic scan. This is why there is no corresponding anodic peak. 
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Figure 6.10: (A) CV and (B) DPV responses at different rifampicin concentrations for the 
Au/PVP-AgNPs/PANSA/EG-CYP2E1 nanobiosensor 
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KEY: 
CYP4+, 3+, 2+ - Different oxidation states of Cytochrome P450-2E1 
PANSA/Ag - poly (8-anilino-1-naphthalene sulphonic acid)/ silver nanoparticle 
Nanocomposite 
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Scheme 6.4: Reaction scheme showing the metabolism of rifampicin using the Au /PVP-
AgNPs/PANSA/EG-CYP2E1 nanobiosensor 
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The irreversible cyclic voltammograms recorded in aerobic conditions suggests that 
there is a binding of molecular oxygen to the CYP (Fe2+) heam redox centre of the enzyme 
(Iwuoha et al. 2004). As indicated in Scheme 6.4, this process involves a second electron 
which is responsible for the cleavage of the di-oxygen bond leading towards the generation of 
products (Shumyanteva et al. 2005). In the case of the biotransformation of RIF by the 
Au/PVP-AgNPs/PANSA/EG-CYP2E1 nanobiosensor, the product generated is a carboxylic 
acid form of RIF. The initial step in the biotransformation is the formation of 
formylrifampicin after the first reduction process. Following that this product is further 
reduced to the carboxylic acid form of RIF which is later released. In human traces of 
formylrifampicin are detected in urine but at very low concentrations. These products were 
also obtained in a study by Loos et al. 1986 involving the pharmacokinetics of oral and 
intravenous RIF’s administration to chronicallt ill TB patients. HPLC studies by Koicha et al. 
1983 also revealed the presence of these metabolites in a study involving the biochemical and 
microbiological bioavailability of RIF in pulmonary tuberculosis patients. 
The nanobiosensor response time was evaluated from steady state amperometry 
experiments (Figure 6.11) performed at -250 mV. In the experiment, the Au/PVP-
AgNPs/PANSA/EG-CYP2E1 nanobiosensor was used as the working electrode in an air 
saturated buffer cell solution which was stirred at 500 rpm. The response time was estimated 
to 25 s and the detection limit was estimated to be 0.05 µM while a sensitivity of 1.40 
µA/µM from the calibration curve stipulated in Figure 6.12 was determined. Even though 
RIF is not a substrate inhibitor of CYP2E1, the parameters KM, KMapp and IMAX were 
estimated to be 5.0 µM, 1.25 µM and 1.78 x 10-6 µA respectively. The peak serum 
concentration of RIF of 5 µg/mL (6 µM) obtained 4 -8 hr after administration of 600 mg RIF, 
was found to be within the linear range of the nanobiosensor suggesting that the 
nanobiosensor can be applied to systems with concentrations from 0.05 µM and above. The 
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Michaelis-Menten parameters confirm the highly electroactive nature of the nanobiosensor 
and its affinity for the biotransformation of RIF. 
 
Figure 6.11: Steady state responses of rifampicin at applied potential of -250 mV with 
response time of 25 s 
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Figure 6.12: Calibration curve for rifampicin for the Au/PVP-AgNPs/PANSA/EG-CYP2E1 
nanobiosensor  
 
 
6.2 Stability and Reproducibility of the Modified Electrodes: 
The stability and reproducibility of the Au/PANSA/PVP-AgNP/CYP2E1, 
Au/PANSA/PVP-AgNP/SA-CYP2E1 and Au/PANSA/PVP-AgNP/EG-CYP2E1 
bioelectrodes was also investigated. When the modified bioelectrodes were stored at 4 0C in 
pH 7.4, 0.1 M phosphate buffer solution for two weeks, the current response retained more 
than 90 % of its original response for the Au/PANSA/PVP-AgNP/CYP2E1 nanobiosensor, 
more than 85 % for the Au/PANSA/PVP-AgNP/SA-CYP2E1 nanobiosensor and more than 
80 % for the Au/PANSA/PVP-AgNP/EG-CYP2E1 nanobiosensor. Determination of the 
relative standard deviation (R.S.D) for ten successive measurements of either 2 µM ETH, 2 
µM INH, 2 µM RIF and 2 µM RIF were 3.2 %, 3 %, 2.9 % and 3 % respectively, indicating 
excellent precision for each measurement.  The nanobiosensors were used daily and stored in 
	
	
 
189	
 
pH 7.4, 0.1 M phosphate buffer solution at 4 0C when not in use. The data received from 
these experiments indicated that the current responses only decreased by an average of less 
than 15 % suggesting that the nanobiosensors reported for this work have long-term stability. 
 
6.3 Interference Studies of the Modified Electrodes: 
In the reduction of the TB drugs; INH, ETH, PYR and RIF, several interference 
substances have been reported. These substances include inorganic species such K+, Mg2+, 
Na+, NH4+, Cl-, SO42- and NO3- ions dissolved individually in distilled water and each was 
added individually to 2 µM of each of the TB drugs. Using DPV measurements, the TB drugs 
illustrated increased currents when measured independently while a mixture of each TB drug 
and interferences generated reduced currents upon addition of 1:1 ratio of the interferences 
when the TB drug concentrations were 2 µM individually. It was found that addition of the 
interferences caused a slight decrease of the anodic peak current and hence negligible 
interferences in the range of 2.1% to 2.4 % were observed. 
The following table represents all the parameters determined from the nanobiosensors. 
 
Table 6.1: Compounds and their respective nanobiosensor analyses 
Drug Detection 
Limit (µM) 
Sensitivity 
(µA/µM) 
KM KMapp(µM) IMAX (µA) Response 
Time (s) 
ETH 0.7 1.13 6.3 1.01 2.1 x 10-6 20 
INH 0.65 1.25 5.8 1.34 1.9 x 10-6 20 
PYR 0.054 1.38 6.0 1.41 1.51 x 10-6 25 
RIF 0.05 1.40 5.5 1.25 1.78 x 10-6 25 
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CHAPTER 7 
 
Conclusions and Recommendations 
 
Summary 
 
 
This chapter revisits the specific objectives of the study to report whether the aims of this 
dissertation were achieved, and to give an overview of the success and shortcomings of the 
study. Also reported here is an indication of which areas of this study warrant further 
investigations in the future. 
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7.1 Conclusions: 
For the first time this study has reported the successfull development and application of 
CYP2E1 nanobisensors for the detection of the tuberculosis treatment drugs; isoniazid, 
ethambutol, pyrazinamide and rifampicin. The first specific objective of this study was to 
electrosynthesize PANSA on gold electrode. Thorough characterization of PANSA showed 
that this polymer can be successfully coated on gold electrode to provide a platform for 
immobilization. Secondly, silver nanoparticles were synthesized through a soft solution 
technique in which polydispersed spherical nanoparticles were obtained. Dropcoating silver 
nanoparticles onto PANSA saw a highly electroactive PVP-AgNPs/ PANSA nanocomposite. 
Characterization of the nanocomposite using EIS, TEM, UV-Vis, AFM, CV, DPV and SWV 
indicated a stable platform for the immobilization of the enzyme CYP2E1 as well as the 
CYP2E1 modified forms; SA-CYP2E1 and EG-CYP2E1. The PVP-AgNPs/PANSA 
nanocomposite served as a point of attachment for the enzyme as well as an efficient electron 
mediator between the redox centre of CYP2E1 and the electrode surface. AFM and TEM 
displayed large and globular morphologies for the highly active nanobioelectrodes. The 
results obtained confirmed that the Au/PVP-AgNPs/PANSA/CYP2E1 nanobiosensors were 
successful in the reductive catalysis of the various TB drugs into respective water soluble and 
easy excretable metabolites. The resultant catalytic current responses were amperometrically 
monitored by steady state amperometric, cyclic, differential pulse and square wave 
voltammetric techniques where an increase in current was observed for the respective 
analytes namely; isoniazid, ethambutol, pyrazinamide and rifampicin.   
From the calibration curves, linear ranges were established in which the sensitivities and 
the nanobiosensor detection limits were estimated. The sensitivities of the nanobiosensors 
(INH = 1.25 µA/µM; ETH = 1.13 µA/µM; PYR = 1.38 µA/µM and RIF = 1.40 µA/µM) 
exhibited high sensitivities compared to previously reported studies involving the 
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biotransformation of these drugs. Michaelis-Menten kinetics was used to determine the 
values of KM, KMapp and IMAX of the various nanobiosensor systems. The apparent Michaelis-
Menten constants indicated the nanobiosensors to have high affinity for the respective drugs 
while the detection limits were found to be withinin the nanobiosensor linear range, thereby 
making the nanobiosensor systems suitable for the determination of the respective analytes in 
serum.  
 
7.2 Recommendations for Future Study: 
 The following aspects of the nanobiosensors for the determination of tuberculosis 
treatment drugs presented in this work warrent further investigations. 
1. More work needs to be done to improve the electroactivity of PANSA through 
copolymerization or the use of surfactants. 
2. It is proposed that another procedure is required to develop the PANSA/PVP-AgNPs 
nanocomposite in order to improve electroactivity and to allow the nanocomposite to 
be able to immobilize various biological components. 
3. It is also suggested that higher concentrations of the standard solutions of the 
tuberculosis treatment drugs be evaluated and to determine whether the detection 
limits can be further improved. 
4. Inhibition of CYP2E1 by other TB treatments drugs or any other drugs is an important 
aspect of this study that also needs to be explored. 
5. More research needs to be done to improve specificity and selectivity of the 
nanobiosensors in order to discriminate more efficiently between closely related 
forms of tuberculosis treatment drugs or other compounds which could be 
biotransformed using these systems. 
